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Abstract
T ra n s i t io n a l  cell c a rc in o m a  of th e  b la d d e r  is  com m only  
en co u n tered  in  urological p ractice. It affects people of a  relatively 
young age causing  economic and  social d istress to pa tien ts. In order 
to p re v e n t th e  d ise a se  i t  is im p o r ta n t  to u n d e rs ta n d  i ts  
pa thogenesis.
In th is  s tu d y , we have tum origen ica lly  tran sfo rm e d  a  h u m a n  
u ro th e lia l cell by grow ing cells in  a  se ru m  free, fac to r free, 
ehem ically  defined cu ltu re . The tum origen ic  p ro p erty  of the  eell 
w as determ ined by the  generation  of a tum or after inoculation  into 
nude  m ouse.
DNA fin g e rp rin tin g  a n a ly s is  d e m o n s tra te d  th e  com m on b ack  
g ro u n d  of th e  n o n -tu m o rig en ic  h u m a n  u ro th e lia l cell and  its  
tu m origen ic  tra n s fo rm a n t. T h is re s u lt  also show s evidence of 
m u ta tion  occurring during  transform ation .
By analysing  conditioned m edium , a sign ifican t red u c tio n  in  the  
levels of so luble h u m a n  stem  cell factor and  in te rleu k in  l a  were 
found in  tum origenic cell conditioned m edium .
A m odel derived from th is  evidence m ay suggest th a t  tu m o r cells 
undergo  fu rth e r  tran sfo rm atio n  u n d e r n u tr ie n t and  grow th factor 
deprived conditions.
In travesica l ch em o th e rap eu tic  agen ts in  c u rre n t u se  have show n 
m odera te  tum or-k illing  effects w ith  som e system ic or local side 
effects. Iden tification  of a d ru g  w ith  b e tte r  effect an d  less side 
effects is essen tia l for the  successfu l trea tm en t of b ladder tum ors.
Nitric oxide (NO) is a  n a tu ra l p roduct of the h u m an  body w ith a  role 
in  tum or eell-killing. T hus by using  NO as a chem otherapeutic  agent 
we could a t least expect lim ited side effects.
R oussin ’s b lack  sa lt (RBS) is a  novel NO donor. Its cytotoxicity w as 
te s te d  on tu m o rig en ic  (T24) a n d  n o n -tu m o rig en ic  (SV-HUC-1) 
h u m a n  u ro thelia l cells. The cytotoxicity of RBS w as show n to be 
dose- and  con tac t tim e- dependent. This cytotoxicity w as enhanced  
by light irrad ia tion  and  reduced in  the  presence of haem oglobin.
The cytotoxic effect of RBS w as also tested  on CHO cells an d  the 
DNA rep a ir deficient m u ta n t  x rs-5  cell line. B oth  colony form ing 
and  m icronuclei form ing a ssay s dem onstra ted  th a t  x rs-5  cells a re  
m ore sensitive  to RBS th a n  th e ir  co u n te rp a rt. T h is re s u lt  m ay 
in d ic a te  th a t  NO is involved in  th e  ey to tox icity  of RBS and  
furtherm ore th a t  DNA dam age m ight be one possible m echanism  by 
w hich the  cytotoxie effect of RBS is expressed.
Table of contents
Chapter I: Introduction l
1-1 C ancer is a  d isorder of cells 3
1-2 B ladder cancer 12
1-3 Stem  cell factor 20
1-4 Nitric oxide 25
Chapter II: M aterials and M ethods 42
Chapter III: Tum origenic transform ation  
of human urothelial cells and characterization o f their properties 74
3-1 Tum origenic transfo rm ation  of the  cells 79
3-2 Identification of the  transfo rm ed  cells 93
3-3 M olecular changes associated  w ith  transform ed cells 102
Chapter IV: Roussin's black salt a novel nitricoxide donor acts as a cytotoxic agent 118
4-1 Cytotoxic effect of RBS 123
4-2 RBS causes DNA dam age w ithin  target cells 144
Bibliography 153
Appendix 177
flCKNOlüLEDGEMENTS
I Luould l ike  t o  e x p r e s s  my s i n c e r e  g r a t i t u d e  t o  my 
s u p e r v i s o r ,  Dr. f l n d r e m  C. R i c h e s  f o r  h i s  c o n t i n u a l  
e n c o u r a g e m e n t ,  i n v a l u a b l e  a d v i c e ,  e n t h u s i a s t i c  he lp  a n d  
e x c e p t i o n a l  p a t i e n c e  t h r o u g h o u t  t h e  du ra t i o n  o f  my s t u dy .
i mou ld  a l so  l ike to t h a n k  
Mrs .  J .  Melvi l le ,  Mr.  J .  Ma ck i e  a nd  Mr. R. J .  S t u a r t  f o r  t h e i r  
s u p e r b  t e c hn i c a l  a s s i s t a n c e .
Or. I. M e g s o n ,  Dr. "P" an d  Dr. S. N. Rob inson  f o r  t h e i r  u se f u l  
s u g g e s t i o n s  c on ce r n i ng  my mork .
Dr. F. Ul. Fl i tney f o r  a l l oming  m e  t o  u se  his l a b o r a t o r y  and  Dr. 
R. R. Bu t l e r  f o r  supp ly ing  m a t e r i a l .
Spec ia l  t h a n k s  shou ld  go t o  Dr J.fl.  G raves  f o r  his e n t h u s i a s m  
an d  p a t i e n c e  in he lp ing  m e  go t h r o u g h  t h e  DNfl f i n g e r  p r i n t ing  
e x p e r i m e n t .
My v e ry  spec i a l  t h a n k s  to  Simon and  Rian f o r  t h e i r  g r e a t  
h e l p  in r e a d i n g  a n d  c o r r e c t i n g  Engl i sh  m i s t a k e s  in my 
m a n u s c r i p t s .
I m ou l d  l ike t o  t h a n k  t h e  Mi n i s t r y  o f  D e f e n c e  o f  t h e  
Republ ic  o f  China f o r  o f f e r i n g  m e  t h e  s c h o l a r s h i p ,  a n d  t h e  
N a t i o n a l  D e f e n c e  M e d i c a l  C e n t r e  f o r  g i v i n g  m e  t h e  
o p p o r t u n i t y  t o  s t u d y  a b r o a d .
My f ami ly  g ive s  m e  e v e r y  e n c o u r a g e m e n t ,  m i t h o u t  t h e i r  
full s u p p o r t  t h i s  m o r k  could no t  h a v e  b e e n  f i n i shed .
Introduction
Chapter I 
Introduction
1-1 Cancer is a disorder o f cells 
1-1-1 Clonal origins of cancer  
1-1-2 Stem  cell m odel o f tum or growth 
1-1-3 M etastasis
1-1-4 Cancer associated w ith DNA alterations 
1-1-5 O ncogenes 
1-1-6 Tumor suppressor genes  
1-1-7 M ultistep oncogenesis  
1-2 Bladder cancer
1-2-1 Risk factors
1-2-1-1 Tobacco 
1-2-1-2 Coffee drink ing  
1-2-1-3 Artificial sw eeteners 
1-2-1-4 O ccupational exposure 
1-2-1-5 C yclophospham ide
1-2-2 H istopathology
1-2-3 Superficial bladder tum ors
1-2-4 Intravesical chem otherapy
1-2-4-1 T hiotepa a s  a  chem otherapeu tic  agent
1-3 Stem  cell factor
1-3-1 W locus
1-3-2 SI locus
1-3-3 Structure of SCF
1-3-4 Biological functions of SCF
1-3-5 Soluble SCF decrease in tum origenic cells
Introduction
1-4 Nitric oxide
1-4-1 NO is the m olecule responsible for the cyto tox ic ity  of  
activated macrophages
1-4-2 C ytotoxicity of nitric oxide
1-4-2-1 Free rad ical
1-4-2-2 Inhibition of m itochondrial resp ira tion  
1-4-2-3 Iron loss
1-4-2-4 Inhibition of DNA syn thesis and  DNA dam age 
1-4-2-5 Affect on o ther p ro teins
1-4-3 Interaction of NO w ith other m olecules
1-4-3-1 Hemoglobin in  Iron inhibition of NO activity 
1-4-3-2 A lbum in and  NO
1-4-4 Other m ain physiological effects o f NO
1-4-4-1 P latelets 
1-4-4-2 C entral Nervous system  
1-4-4-3 Peripheral nervous system  
1-4-4-4 V ascular 
1-4-4-5 O ther system s
1-4-5 NO synthases
1-4-6 Roussin's black salt
Purpose o f present stu d ies
Introduction
1-1 Cancer is a disorder o f cells
It is n o t possib le  to define a  cancer cell in  abso lu te  term s. C ancers 
a re  fully developed tu m o rs  w ith  m alig n an t n a tu re  w hich  p re se n t 
w ith  the  ability to invade and  destroy the su rround ing  tissu es  and  to 
sp re a d  to  o th e r  p a r ts  of th e  body  w here  th e y  m ay  g en e ra te  
se co n d a ry  tu m o u rs . T he n o rm al division a n d  d iffe ren tia tio n  of 
som atic  cells in  m u ltice llu lar o rgan ism s requ ires a  precise contro l 
m echan ism  in  th e  organism . T um or cells differ from  norm al cells 
in  t h a t  th e y  d e m o n s tra te  th e  fa ilu re  of s u c h  c o n tro llin g  
m echanism s, and  have achieved a  degree of autonom y.
1-1-1 Clonal origins o f cancer
Evidence from (1) s tu d ie s  of w om en heterozygous for the  2 allelic 
form s of the  enzym e g lucose-6 -phosphate  dehydrogenase, the  gene 
for w h ich  is on th e  X -chrom osom e, d em o n stra ted  th a t  th e  sam e 
m em ber of the  X -chrom osom e p a ir  is functional in  all cells of a  
given tu m o r (Linder, D. e t al 1965), (2) im m unological s tu d ies  have 
show n th a t  all cells in  a  B-cell lineage tu m o r syn thesize  th e  sam e 
im m u n o g lo b u lin  (M artensson , L. 1963), (3) cy togenetic  s tu d ie s  
have show n th a t  all th e  cells of a  tu m o r p resen t a  specific abnorm al 
karyo type (Nowell P. C. 1975) w hich  ind ica tes th a t  m o st can cers  
m ay  a rise  a s  a  clone from  a  sing le  cell of orig in . However, 
su b p o p u la tio n s w hich  differ in  sensitiv ity  to cytotoxic d rugs and  in  
genetic  s tab ility  have b een  iso la ted  from  a  fresh  p rim ary  tu m o r 
(Shapiro, J .  R. e t al 1981). Indeed, th e  cells in  m o st tu m o rs  are  
quite he terogenous due to the ir adap ta tion  for survival. They survive 
n a tu ra l  and  artificial selection th ro u g h  heterogeneity  by producing
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new  v a r ia n ts  a n d  by  u tiliz in g  su b p o p u la tio n  in te ra c tio n s  to 
c o u n te ra c t an y  d estru c tiv e  in fluence  (H eppner, G. H. 1984). A 
s im ila r  c o n c e p t is  h y p o th es iz ed  a s  "clonal evo lu tion" w h ich  
encom passes  two m ajor p rincip les (1) tu m o rs  are  clonal in  origin 
(2) tu m o rs  p rog ress on  th e  b a s is  of genetic in stab ility  w ith in  the  
n e o p la s tic  p o p u la tio n  lead in g  to th e  se q u e n tia l em ergence  of 
m u ta n t  su b p o p u la tio n s  w ith  in c reas in g ly  m a lig n a n t p ro p ertie s  
(Nowell, P. C. 1976).
B u t in  view of the  large n u m b ers  of cells w hich  are a t  r isk  in  an  
a d u lt o rgan ism , th e  relative ra rity  of cancer an d  an a ly sis  of th e  
c h a ra c te r is tic s  of c lones of ex p erim en ta l tu m o rs  in d ica te  th a t  
tu m o rs  have a  m u ltice llu la r  orig in  (Reddy, A. L. e t al 1979). A 
p roposa l th a t  several tran sfo rm ed  cells come together to create  a 
m icroenvironm ent w hich  p erm its  th e ir  un lim ited  pro liferation  and  
production  of a  m alignan t lesion h a s  been  m ade, and  th a t  it is the  
cum ulative effect of selective p ressu re s  w hich leads to a  m onoclonal 
s ta te  (Woodruff, M. F. A. e t al 1982; Alexander, P. 1985). R egardless 
of w h e th e r n eo p la sm s a re  m u ltic lo n a l or m onoclonal in  origin, 
tu m o r cells p rog ress to he te rogenous su b p o p u la tio n s  w ith  a  wide 
ran g e  of p h en o ty p ic  c h a ra c te r is t ic s  by th e  tim e th ey  c an  be 
clinically diagnosed (Poste, G. et al 1980).
1-1-2 Stem cell model of tumor growth
In  no rm al ep ithelia l tis su e  grow th, cell p ro d u c tio n  an d  cell lo ss 
m u s t  be b a la n ce d  to m a in ta in  s te ad y  s ta te  a n d  th e  to ta l cell 
population  can  be regarded as  constitu ting  a  cell division h ierarchy  
w ith  stem  cells a t  one extrem e and  differentiated cells a t th e  o ther 
ex trem e. S tem  cells have  two critica l fu n c tio n s  th a t  is  c lonal
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expansion  an d  self renew al. In clonal expansion  stem  cells m ay ac t 
a s  the  in itia tin g  cell in  a  cell division and  d ifferen tiation  p rocess 
eventually  giving rise to the  en tire  clonal h ierarchy. W ith respec t to 
cell renew al, stem  cells m ay undergo  cell division to p roduce  stem  
cell d a u g h te rs  w h ich  rep la ce  th e  s te m  cell u se d  in  c lona l 
expansion . D ifferentiated cells a re  considered  to have little or no 
capac ity  for p ro liferation  (C airns, J .  1975). S ince h u m a n  tu m o rs  
arise  p redom inan tly  in  t is su e s  w hich  function  as  stem  cell system s 
in  th e  norm al s itu a tio n  and  tu m o rs  are  tis su e  specific, a  stem  cell 
m odel of tu m o r grow th h a s  been  postu la ted  (MacKillop, W. J .  et al 
1983) an d  th is  concept p red ic ts  th a t  in  add ition  to stem  cell and  
d iffe ren tia ted  end  cells, a n o th e r  category  of p ro lifera ting , n o n ­
renew ing  tra n s it io n a l  cell e x is ts  w ith in  th e  to ta l  tu m o r  cell 
popu la tion . Several p ieces of evidence su ch  a s  tissue-specific  cell 
d ifferentiation  existing in  tu m o rs  an d  only a  frac tion  of cells from  
h u m a n  tu m o rs  exhib iting  self renew al capacity , su p p o rt th e  view 
th a t  stem  cells exist in tu m o r m asses. In the case  of tum ors aris ing  
in  conditionally  renew ing tis su e s  su c h  as liver the  applicability  of 
th is  m odel is doub tfu l (Buick, R.N. e t al 1984). A lthough a  sm all 
frac tion  of tu m o r cells m ay form  colonies in  a  sem isolid  m edium  
an d  th e  ab ility  of a  cell to  form  a  colony im plies s u b s ta n t ia l  
p ro liferating  capacity  (H am burger, A. W. et al 1977), th is  does n o t 
necessarily  equate  w ith  a  stem  cell. S tem  cells are responsib le  in  
vivo for m an ife s ta tio n s  of tu m o r grow th w hile clonogenic cells 
d em o n stra te  a  p ro liferating  su b p o p u la tio n  in  tis su e  cu ltu re  (Steel, 
G. G. 1977; B uick R. N. e t al 1984).
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1-1-3 M etastasis
M etastasis  is the  developm ent of secondary  tu m o rs  th a t  are  n o t in 
d irec t c o n ta c t w ith  th e  in itia l p rim ary  neop lasm . The ab ility  to 
p roduce  m e tas ta s is  is a  p roperty  of m alignan t tu m o r cells a lthough  
th is  p h en o m en o n  c an  be observed  in  n o n -ca n ce r cond itions eg. 
frag m e n ts  of cho rion ic  t is s u e  sp re a d  to lu n g  or liver d u rin g  
developing of p lacen ta  (Douglas, G. W. e t al 1959) b u t  cancer cells 
will keep on proliferating in th a t  rem ote a rea  while chorionic tissu e  
will die a n d  d isa p p e a r  w ith  th e  cessa tio n  of p regnancy . U sing 
m odern  su rg ica l te c h n iq u e s  a n d  aggressive a d ju v a n t th e ra p ie s , 
m o st local p rim ary  can cer can  be e rad ica ted  an d  th e  m ajority  of 
cancer d ea th s  are caused  by m étastasés.
To successfu lly  m etasta size , c an cer cells requ ire  several d is tin c t 
p ro p erties  th a t  enab le  them  to invade locally and  p e n e tra te  in to  
b lood  v esse ls  o r ly m p h a tic s , evade of h o s t  im m u n e  defence 
m echan ism s, a rre s t and  im plan t in the  vessel wall a t  new  locations, 
u ndergo  ex trav asa tio n  in to  su rro u n d in g  tis su e  an d  e s tab lih  new  
grow th (Poste, G. et al 1980). V arious factors have been  proposed as 
be in g  im p o rta n t in  th e  m alig n an cy  of c an c e r  cells , in c lu d in g  
p ro te o ly tic  e n z y m e s , tu m o r  a n g io g e n ic  f a c to r s ,  p la te le t  
ag g lu tin a tin g  capacity , a d h es io n  m olecules, ex trace llu la r  m a trix  
c o m p o n e n ts  s u c h  a s  la m in in  a n d  f ib ro n e c tin  a n d  m a jo r  
h is to co m p a tib ility  com plex gene p ro d u c ts  (Collard, J .  G. e t al 
1988). C lin ical o b se rv a tio n s  have  show n th a t  c e r ta in  types of 
tu m o rs tend  to m etastasize  to  specific target organs and  th u s  a  "soil 
a n d  seed" th eo ry  h a s  b een  p roposed  (Paget, S. 1889) i.e. th a t  
can cer cells survive in  a  "favorable" place an d  cau se  a  secondary  
tu m o r th e re . A no ther ex p lan a tio n  is th e  haem o d y n am ic  m odel
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w hich re la tes the  site of m e tas ta s is  to the  n u m b er of cancer cells 
delivered to the  organ or the  first capillary  bed they  en co u n ter in 
the  blood flow (Sugarbaker, E. V. 1981) B u t in  a n  experim ent in 
w h ich  tu m o r cells w ere in tra c a rd ia c a lly  in jec ted  in to  an im als , 
a lth o u g h  th e  n u m b e r of tu m o r cells d is tr ib u tin g  to each  targe t 
o rgan  w as co rre la ted  to th e  blood volum e th ey  received, the  
in c id en ce  of m e ta s ts is  of each  organ  did n o t show  th e  sam e 
c o rre la tio n  (M urphy, P. e t al 1985). So it seem s th a t  b o th  
hem odynam ic fac to rs and  selective grow th of ce rta in  cancer cells 
in  certa in  organs co n trib u te  to the influence of th e  organ specific 
m etastasis  of h u m an  cancers.
1-1-4 Cancer associated with DNA alterations
C ancers a p p ea r to a rise  as a  re s u lt  of m ultip le  changes in  the  
ce llu la r genom e lead ing  to d is to rtio n  of e ith er th e  expression  or 
b iochem ical function  of genes. There is m uch  evidence to su p p o rt 
the  co n trib u tio n  of n o n -ran d o m  chrom osom al a lte ra tio n s , in the  
form  of s tru c tu ra l  or n u m erica l a b e rra tio n s , to h u m a n  cancer 
developm ent and  progression  (Sandberg, A. A. et al 1988; Yunis, J . 
J .  1983; Rowley, J . D. 1984). Several congenital d iseases associated  
w ith  in c re a s e d  ch ro m o so m e b re a k a g e , for exam p le  D ow n's 
syndrom e and Klinefelter's syndrom e, have an  increased  incidence 
of c a n c e r  (G ardener-M edw in, D. 1987; L ondon, D. R. 1987). 
Ind iv idua ls w ith  genetically  dete rm ined  tra its  a sso c ia ted  w ith  a 
deficiency in the enzym es necessa ry  to repair lesions in DNA, such  
a s  Bloom 's syndrom e (BS) and  X eroderm a p igm entosum  (XP), are 
strongly  predisposed  to develop m alignan t d iseases (Gordon-Sm ith,
E. C. 1987). In addition  W ilm's tu m o r and  re tinob lastom a are two
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exam ples of m any  h e ritab le  h u m a n  can cers  (C hantier, C. 1987; 
H arris, H. 1987). Finally alm ost all agen ts associated  w ith  neoplastic 
tran sfo rm a tio n  (carcinogen) a re  know n to c au se  DNA m u ta tio n s  
(Ames, B. N. 1979). All these  exam ples su p p o rt the  evidence for the  
genetic origin of cancer a n d  have been  linked  by  th e  discovery of 
oncogenes (Bishop, J .  M. 1987).
1-1-5 O ncogenes
The te rm  "oncogene" w as originally u sed  to denote  a  hypothetica l 
c lass of genes w hich is a covert viral gene th a t becom e activated in  
a  h o s t cell to cause  tu m o r form ation  (H uebner, R. J .  e t al 1969). 
T h is concep t, nam ely  th a t  th e re  a re  genes capab le  of cau sin g  
cancer, is based  largely on s tu d ies  carried  ou t w ith  tran sp lan tab le  
tu m o rs  in  ch ick en s , m ice a n d  ra ts .  Som e re tro v iru se s  in d u ce  
neoplastic  transfo rm ation  in  norm al cells in  cu ltu re  and  suscep tib le  
an im als. T his occu rs w hen  ce rta in  genes -"viral oncogenes"(u-onc ) 
a re  in te g ra te d  in to  th e  h o s t  cell genom e. By u s in g  m o lecu la r 
hybridization, it h a s  been  show n th a t  sequences hom ologous to the  
oncogene region of the  v iru s w ere p re se n t in  th e  DNA of norm al 
cells. T hese  ce llu la r hom ologues of v iral oncogenes have b een  
re fe rred  to  a s  "cellu lar p ro to -oncogenes"( c-onc ). T hese p ro to ­
oncogenes p robab ly  ex isted  in  th e  cellu lar genom e firs t (M inden, 
M. D. e t al 1992) an d  have im plan ted  in to  viral genom e during  the  
recom bination  betw een retroviral and  cellular genom es. In th is  new  
se ttin g  the  ce llu la r genes m ay becom e oncogenic. The genesis of 
retrov iral oncogenes from cellu lar proto-oncogenes h a s  been  called 
"transduction" (Bishop, J .  M. 1987).
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H u m a n  tu m o r DNA c an  be tra n s fe r re d  to N IH /3T 3 em bryo 
fib rob lasts  in w hich it m ay generate  transfo rm ed  cells. They can  
p ro liferate  in  sem i-so lid  m edia, do n o t stop  grow ing w hen  they  
becom e confluen t (loss of con tac t inhibition) and  m ay form tum ors 
in  an im als. A nalysis of the  genes responsible for the transfo rm ation  
reveals a  diverse a sso rtm e n t of oncogenes an d  m ost of them  are  
hom ologous to the  viral oncogene H -ras and  K-ras (Parada, L. F. e t al 
1982; B ishop, J .  M. 1985). O ncogenes identified by gene tran s fe r  
are m u ta n ts  of norm al cellular genes and the m u ta tions activate the 
oncogenes (Bishop, J . M. 1987).
R etroviruses, th a t  do n o t have oncogenes however m ay also cause  
c an c e rs . After th e  in te g ra tio n  of v iral DNA, th e  ex p ress io n  of 
cellu la r genes is a lte red  by b ring  them  u n d e r the  control of the 
viral genom e (Payne, G. S. et al 1982; Nusse, R. 1986). Such events 
are called "insertional m utagenesis". Isolation of genes n ear sites of 
in te g ra tio n  of re tro v iru s  will iden tify  genes resp o n sib le  for the  
transfo rm ation  (Nusse, R. e t al 1982).
C ancer cells have provided c lu es to oncogenes in the  form  of 
m icroscopically visible dam age to chrom osom es. A growing num ber 
of genes involved in tu m o r developm ent have been  identified by 
th e ir  a sso c ia tio n  w ith  chrom osom e tran s lo c a tio n s  (Tsujim oto, Y. 
1985) a n d  a b n o rm a l am p lifica tio n  of large  d o m ain s  w ith in  
chrom som es (Schwab, M. et al 1983; Kohl, N. E. et al 1983). 
P ro to -oncogenes encode p ro te in  w hose n o rm al fu n c tio n  is to 
regu late  cellu lar responses to external signals th a t elicit cell growth 
a n d  d iffe ren tia tio n . T hese p ro te in  p ro d u c ts  are  re lays in the  
e lab o ra te  b iochem ical c ircu itry  th a t  governs th e  p h eno type  of 
verteb ra te  cells. A lthough the  n u m b er of pro to-oncogenes is large, 
th e ir  fu n c tio n s can  be categorized in to  th ree  m ain  b iochem ical
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m echan ism s: (1) phosphory la tion  of p ro te ins w ith  serine, th reon ine  
and  ty rosine as su b s tra te s , (2) tran sm iss io n  of signals by GTPases 
an d  (3) controlling of tran sc rip tio n  from DNA (Bishop, J .  M. 1991).
It does n o t a p p e a r  to be s ile n t "cancer genes" w h ich  becom e 
activated , ra th e r  it seem s th a t  norm ally  active genes w hich  serve 
im p o rtan t cell functions becom e functinally  a ltered  an d  lead  cells 
se p a ra te  from  th e ir  no rm al m ilieu, p ro liferate  independen tly  an d  
th u s  becom e can cers  (Weiner, T. et al 1994). Two m ajor lesions in 
th e  p ro to -oncogenes re sp o n sib le  for th e  tu m o rig en e s is  a re  (1) 
m u ta tio n s  in  th e  DNA th a t  a lte r  th e  constitu tive  activ ity  of gene 
p ro d u c ts  and(2) d e regu la tion  w hich  re su lts  in  overexpression  of 
the  norm al cellu lar p roduct (Land, H. et al 1983b).
1-1-6 Tumor suppressor genes
T um or su p p re sso r  genes are  w ild-type alleles of genes th a t  p lay  
reg u la to ry  ro les in  cell p ro life ra tion , d iffe ren tia tio n  a n d  o th e r  
cellu lar and  system ic processes. It is the ir loss, or inactivation, th a t  
is oncogenic (Sager, R. 1989). A lthough several p ieces of evidence 
su p p o rtin g  the  ex istence of tu m o r su p p re sso r genes are  ind irect, 
th ey  are  non  the  less very persuasive. In the  case  of retinob lastom a 
it h a s  been  found th a t  th e  loss, or inactivation, of bo th  alleles of the 
gene (Rb) lo ca ted  n e a r  1 3 q l4  w h ich  is n e c e ssa ry  for p ro p e r 
differentiation of re tinob lasts  ap p ea rs  to be the  p rim ary  m echan ism  
in  the  developm ent of re tinob lastom a (M urphree, A. L. e t al 1984). 
Evidence com es from som atic  cell hybridization experim ents w hich  
show ed  th a t  fu s io n  of tu m o r  cells w ith  n o rm a l cells a lm o st 
invariab ly  re su lted  in  th e  ou tg row th  of non -tum origen ic  hybrids 
(H a rris , H. 1988). T he  re p e a te d  o b se rv a tio n  of lo s s  of
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heterozygosity  (LOH) of a specific ch rom osom al m ark e r  in  cells 
from  a  p a r tic u la r  tu m o r type, su g g ests  th e  p resence  of a  closely 
m app ing  tu m o r su p p re sso r  gene, the  loss of w hich  is involved in  
tu m o r p a th o g en es is  (H ansen, M, F. e t al 1987). O ncogenes are  
identified by  th e ir positive role in  th e  tran sfo rm ation  of cells, while 
tu m o r su p p re sso r genes function  in  a  fundam enta lly  different way. 
They serve a s  tra n sd u c e rs  of antiproliferative signals and  as p a rt of 
th e  re sp o n se  m ach in e ry  th a t  en ab les  a  cell to  stop  p rog ressing  
th ro u g h  th e  cell cycle, to  d iffe ren tia te , to  sen esce , or to die 
(Weinberg, R. A. 1991), th u s  b locking tran sfo rm atio n  and  driving 
ce lls  to w ard  n o rm a lity  (Sager, R. 1989). D e le tio n  of genes, 
a lte ra tio n  of gene expression , or inactivation  of gene p ro d u cts  are  
the  types of dam age found in tu m o r su p p re sso r genes w hich cause  
lo ss  of fu n c tio n  (B ishop, J .  M. 1991).The p ro g ressio n  of m any  
tu m o rs  to  full m a lignancy  req u ire s  b o th  active oncogenes an d  
inactive su p p re sso r genes in  th e  tu m o r cell genom e (Weinberg, R.
A. 1991).
1-1-7 M ultistep oncogenesis
T um orogenesis in  h u m a n s  and  experim ental an im als is th o u g h t to 
be  a  m u ltis te p  p ro c e ss  (Nowell, P. C. 1976). T h is h a s  b een  
su g g ested  in  a n u m b e r  of w ays (1) S ta tis tica l a n a ly s is  of age- 
d e p en d e n t tu m o r in c id en ces have suggested  m u ltip le  successive  
in d ep en d en t s tep s  for the  form ation  of a  neop lasm  (Klein, G. e t al
1985). (2) Patho log ical s tu d ie s  show  th a t  tu m o rs  p rogressively  
acqu ire  new  phen o ty p es by  p a ss in g  th ro u g h  a  se ries  of d is tin c t 
stages su c h  as an ap las ia , m etap lasia  and  neop lasia  (Land, H. e t al 
1983b). (3) In an im al m odels the  p rocess h a s  been  categorized into
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in itia tion , prom otion  an d  p rogression  (Farber, E. 1984). M olecular 
and  cellu lar evidence of m u ltis tep  tum origenesis is now  becom ing 
a p p a re n t. O ncogenes of e ith e r  ce llu la r, o r v ira l o rig in , w hen  
w orking alone are  u n ab le  to tran sfo rm  p rim ary  em bryo cells to a 
fu lly  tu m o r ig e n ic  p h e n o ty p e . T h ey  c a n  h o w ev er in d u c e  
tum origenecity  w hen  w orking in  collaboration (R assoulzadegan, M. 
e t al 1982; Ruley, H. E. 1983; Land, H. e t al 1983a). It h a s  been  
suggested  th a t  a t le a s t two types of change in  cell physiology are  
needed  to convert a  no rm al cell to a  fully tum origen ic  cell, one 
occurring  in  the  cytoplasm  and  one in  the  n u c leu s (Weinberg, R. A. 
1985; 1989). A s tu d y  on co lo recta l c an c e r h a s  in d ica ted  th a t  
m ultip le m olecular events are  n ecessa ry  to convert colonic m ucosa  
to a n  invasive  c a rc in o m a  a n d  th a t  c e r ta in  of th e se  ev en ts  
correspond  to pathological stages of the  d isease (Fearon, E. R. e t al 
1990). It seem s th a t  m a lig n an t tu m o rs  a rise  from  a  p ro trac ted  
sequence of events, each  s tep  in  th e  sequence creates an  additional 
phenotypic aberration  (Bishop, J .  M. 1987).
1-2 Bladder cancer
Nearly one h u n d red  years ago the  occurence of b lad d er cancer w as 
co n n ec ted  w ith  a n  en v ironm en ta l agen t (Rehn, L. 1895). M any 
s tu d ie s  have show n th a t  increased  incidence of b lad d e r cancer is 
assoc ia ted  w ith  highly industria lized  a reas, e ither world wide (Doll,
R. e t al 1970) or locally (Levin, M. L. et al 1960) w ith  h ighest ra te s  
found in th e  U nited S ta te s  and  D enm ark  (Skeet, R. G. 1990). It is 
th e  fo u rth  m ost com m on cau se  of cancer d ea th s  am ong A m erican 
m en  over th e  age of 75 y e a rs  a n d  th e  m ale to  fem ale ra tio  of 
occurrence is approxim ately 3:1 (Catalona, W. J .  1991). In B ritain  it
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ra n k s  sev en th  am ong  th e  c an c e rs  in  m an  an d  e leven th  am ong 
w om en an d  th e  h ig h es t ra te  a p p e a rs  in  S co tland  (Davies, J .  M. 
1982). In E ngland and  W ales b ladder cancer develops in  ab o u t 2% 
of m ales a n d  0.5%  of fem ales (Skeet, R. G. 1990). One in  six  
th o u sa n d  a d u lts  will be affected by  b lad d er tu m o rs  each  y ear in  
Scotland (Kaye,. S. B. e t al 1988). In the  Republic of C h ina  there  is 
an  u n u su a lly  h igh  incidence of b ladder cancer in  the  so u th e rn  p a rt 
of T aiw an province w here b lack  foot d isease  is endem ic. It m ay be 
due  to exposure to arsen ic  w hich  reaches high levels in  the  wells of 
th a t  a rea  (Chen, C .-J. et al 1986). B ladder cancer is extrem ely ra re  
in  th e  f irs t two decades of life, an d  the  incidence beg ins to rise  
sh a rp ly  a fte r  th e  fifth  decade  of life w ith  over 50%  of c a se s  
occurring  after the  age of 70 in bo th  sexes (Skeet, R. G. 1990).
1-2-1 Risk factors
T here are  several factors w hich  have been  described  in  association  
w ith  increased  incidence of b ladder cancer:
1-2-1-1 Tobacco
T his is th e  m o st im p o rtan t know n preven tab le  c a u se  of b lad d er 
c an cer (M orrison, A. S. 1984) .The firs t clinical s tu d y  show ing the  
assoc ia tion  of sm oking and  b lad d er cancer w as p u b lished  in  1956 
(L ilienfeld, A. M. e t a l 1956). T he m e c h a n ism  of b la d d e r  
ca rc in o g en es is  of c igare tte  sm oking  is sug g ested  to  be due  to 
u rin a ry  excretion of b o th  a lp h a  a n d  b e ta -naph thy lam ine  w hich are 
u ro thelia l carcinogens (Hoffman, D. e t al 1969). Relative risk  is over 
tw o for c ig a re tte  sm o k e rs  c o m p a red  w ith  n o n -sm o k e rs . A 
significant dose-response re la tionsh ip  h a s  been  show n w ith  respec t 
to in c reas in g  c igare tte  co n su m p tio n  w ith  n early  h a lf  of b lad d er
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tu m o rs  in m en an d  a  q u a rte r  in w om en being  d irec tly  due  to 
cigarette sm oking (Claude, J . e t al 1986). In addition  the  severity of 
b ladder tum ors is significantly  h igher in sm okers (Thompson, I. M. 
e t al 1987). R isk  of tu m o r developm en t a p p e a rs  to d ecrease  
following sm oking  cessa tio n , b u t  only slowly (Howe, G. R. et al 
1980; Vineis, P. et al 1984).
1-2-1-2 Coffee drink ing
The assoc ia tion  betw een  coffee d rink ing  and  b lad d e r cancer h a s  
been  suggested  since 1971 (Cole, P. 1971). A s tu d y  u sing  nearly  
3 0 0 0  p a tie n ts  a n d  5 8 0 0  c o n tro ls  h a s  show n  a  s ta tis t ic a lly  
significant relative risk  of 1.6 in m ales and 1.2 in fem ales for coffee 
d rinkers over non-coffee d rinkers (Hartge, P. e t al 1983). However, 
in  D enm ark  w here caffeine co n su m p tio n  exceeds th a t  of U nited 
Kingdom by a factor of 9 and  w here there  is the  h ighest incidence 
of b lad d er tum or, no assoc ia tion  w as noted  (Jensen , O. M. et al
1986). As coffee c o n su m p tio n  an d  c igare tte  sm oking  are  often 
in tim ately  linked, it appears  th a t  if there  is a  re la tionsh ip  betw een 
coffee drinking  and b ladder cancer, it is weak.
1-2“ 1-3 Artificial sw eeteners
A c lin ica l a sso c ia tio n  of a rtific ia l sw ee ten e rs  (saccharin ) an d  
b lad d er tum ors h a s  been  suggested  in C anada. The relative risk  of 
m ales w ith a  h isto ry  of sacch arin  usage over controls is 1.6 b u t no 
increase  risk  w as noted  in wom en (Howe, G. R. et al 1977). A large 
scale  case control s tudy , conducted  by N ational C ancer In stitu te , 
h a s  no t su b s ta n tia te d  any  positive re la tionsh ip . Only those  who
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reported  very frequen t u se  of artificial sw eeteners appeared  to have 
a  sm all e levated r isk  of b lad d e r can cer an d  th e  dose resp o n se  
p a tte rn  w as irregu lar (Morrison, A. S. e t al 1983).
1-2-1-4 O ccupational exposure
As m en tio n ed  before n e a rly  one cen tre  ago, th e re  h a s  b een  a 
d e sc rip tio n  of th e  developm en t of b la d d e r  c a n c e r  in  w orkers 
exposed to aniline dye (Rehn,L. 1895). It h a s  been  estim ated  th a t  
be tw een  18 an d  35%  of all b lad d e r tu m o rs  in  m en  a re  due  to 
occupational exposure, b u t  only 1-6% of tu m o rs in  wom en re su lt 
from  s im ila r  ex p o su re  (M atanosk i, G. M, e t al 1981). M any 
com pounds are now  know n to cause  uro thelia l cancer in  m an, they  
are  all a rom atic  am ines an d  have a  s im ila r chem ical s tru c tu re . 
E stab lished  carcinogens include be ta -naph thy lam ine , benzidine, 4- 
am inod ipheny l a n d  4 -n ito rd ip h en y l (W allance, D. M. A. 1990). 
Several in d u stria l p rocesses have high  occupational r isk  of b ladder 
tu m o rs  includ ing  1. chem icals an d  dyes, 2. ru b b e r  an d  tyres, 3. 
petro leum , 4, lea ther, 5. p rin ting , 6. p lastics, 7. p a in ts , 8. organic 
chem icals, 9. clerical work, 10. ha ird ressing . All th ese  jo b s involve 
c o n ta c t w ith  ag en ts  w hich  in c rease  the  r isk  of b lad d e r tu m o rs  
(Thom pson I. M. J r .  et al 1990).
1-2-1-5 C vclophospham ide
C yclophospham ide is the  alkylating agent in  w idest clinical u se  and  
in  m any  an itcan ce r tre a tm e n t protocols. The p a re n t com pound is 
inactive and  p rim ary  activation takes place in the  liver. These active 
m etabo lite s  are  tra n sp o rte d  in to  cells an d  p robab ly  decom posed
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there  to acrolein and  phospham ide  m u sta rd  (Erlichm an, C. 1992). 
T here is a  repo rt of 45-fold increased  risk  of b lad d er tu m o rs  in 
p a tie n ts  w ho h a d  p rev iously  received cyclo phospham ide  w hen  
com pared w ith a sim ilar u n trea te d  population (Fairchild. W. V. et al 
1979).
1-2-2 H istopathology
The u r in a ry  b lad d e r is lined  by a  specia lized  ep ith e lium , the  
u ro the lium  is com posed p redom inan tly  of tran s itio n a l epithelium . 
The m ost su p e rfic ia l cells, th e  u m b re lla  cells, have a  u n iq u e  
s tru c tu re  an d  are in tegral to the b a rrie r  action of the  epithelium . 
C a p illa r ie s  e x is t in  th e  co n n ec tiv e  t is s u e  (lam in a  p ro p ria ) 
im m e d ia te ly  d eep  to th e  b a s e m e n t  m e m b ra n e , w h ich  lies 
u n d e rn e a th  the  su rface  ep ithelium . The b ladder wall consists of 3 
loosely  in te rw oven  lay e rs  of sm o o th  m u sc le  an d  th e  o u te r  
adventitial coat con ta ins arteries, veins and lym phatics (Wheater, P.
R. et al 1979 ; Corm ack , D. H. 1984). A lthough the epithelial lining 
of the  u rin a ry  b lad d er c o n stitu te s  a relatively sm all p roportion  of 
th e  m a ss  of b lad d e r, its  tu m o rs  com prise  m ore th a n  95%  of 
m alignancy  of th is  organ. T ransitiona l cell carcinom a accoun ts for 
90%  of th e se  c ase s , sq u a m o u s  cell c a rc in o m as  for 8% an d  
adenocarcinom a for the  rem aining 2% (Olssen, C. A. e t al 1979). 
C arcinom a of the  tran sitional epithelium  m ay be the resu lt of a wide 
sp re a d  biological change  w hich  affects m ost, if n o t th e  en tire  
u ro thelium , if one a rea  h as  undergone m alignant change then  it can 
be a ssu m ed  th a t  the  whole u ro th e liu m  h a s  been  exposed to the 
sam e u rine  borne or endogenously  produced carcinogen. This field 
ch an g e  co n cep t p ro p o ses th a t  su b s e q u e n t tu m o rs  a rise  from
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preneop lastic  changes or in situ  carcinom a, progressive grow th of 
th e se  lesions lead s to new  occurrence. Evidence su p p o rtin g  th is  
concept is derived from re su lts  of selected site or random  biopsy 
m ateria ls  ob tained  from visible lesions as well as from  ap p aren tly  
norm al looking m ucosa  (Melicow, M. M. et al 1952; A lthausne, A. F. 
e t al 1976; Cooper, T. P. 1977; Soloway, M. S. e t al 1978). T hus 
b la d d e r  tu m o rs  u su a lly  p re s e n t in  m u ltifoca l le s io n s  e ith e r  
synchronously  or successively, so th a t a lthough  a tum or(s) m ay be 
successfu lly  erad ica ted  a t the  tim e of d iagnosis new  ones em erge 
e ith e r a t the  sam e site  (recurrence) or a t an o th e r site  w ith in  the  
b lad d e r (Webb, J .  N. 1990). T um or cell im p lan ta tio n  h a s  been  
dem onstra ted  in the  b ladder of experim ental an im als (Weldan, T. E. 
et al 1975) and  clinical observation  of frequent u re th ra l or b ladder 
n eck  rec u rren c e  of tu m o rs , lead s  to the  im p lica tion  th a t  the 
im plan ta tion  of tum or cells a t the tim e of tra n su re th ra l resection  is 
an  etiological factor in new  occurrence of b ladder tu m o rs (Hinman,
F. 1956). T hese fac to rs m ake th e  m an ag em en t of th is  d isease, 
especially the  superficial b ladder tum ors, particu larly  difficult.
1-2-3 Superficial bladder tum ors
A pproxim ately 70 to 85 per cen t of individuals w ith b ladder cancer 
will have th e ir  in itia l tu m o r confined to th e  m u co sa  or lam ina  
p ropria  (Torti, F. M. et al 1984). A lthough m any of these  are easy  to 
t r e a t  by endoscop ic  resec tio n , tu m o r re c u rre n c e  o ccu rs  a fte r 
com plete resection in abou t 50-70%  of patien ts. M any tum ors recur 
w ith  a  h igher degree of m alignancy th a n  the p rim ary  tum or and  in 
10-15%  of p a tien ts  th e  tu m o r will invade in to  the  m uscle  layers 
(Green, L. F. et al 1973). It is believed th a t  superfic ia l b lad d e r
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c a n c e r  c o n s t i tu te s  a n  e n tity  d is t in c t  from  m u sc le -in v a s iv e  
tran s itio n a l cell carc inom a (Kaye, K. W. e t al 1982). T his u n iq u e  
ch a rac te ris tic  of superfic ia l b lad d e r tu m o r req u ires  a n  add itional 
t r e a tm e n t  in  m o s t p a tie n ts  a s  a  su p p le m e n t to en d o sco p ic  
re s e c tio n  a n d  to g e th e r  w ith  rep e titiv e  follow u p  cystoscopy . 
In trav esica l in stilla tio n  of d ru g  to tre a t  the  d isease  is  th e  m ost 
im p o rtan t option for th is  purpose.
1-2-4 Intravesical chem otherapy
T he an a to m ic  p o sitio n  of th e  u r in a ry  b lad d e r m ak es it  read ily  
accessib le  from  ou tside  th e  body u sing  a  cystoscope or a  catheter. 
Local in s til la tio n  of a n tic a n c e r  c h e m o th e ra p e u tic  a g e n ts  in to  
b ladder w ould allow for a  h igh  concen tra tion  of d rug  to ac t directly 
on tu m o r cells and  the  en tire  u ro thelium  of b lad d er for a  relatively 
long period  of tim e th u s  in h ib iting  the  grow th of p re-n eo p lastic  
le s io n s  a n d  e ra d ic a tin g  v iab le  tu m o r  cells. T he tro u b le so m e  
system ic  toxicity  of the  an tin eo p la s tic  agen ts w ould therefo re  be 
k e p t m in im al. A lthough  in  n o rm a l co n d itio n s  th e  u ro th e liu m  
fu n c tio n s  a s  a  b a rr ie r  to  p rev en t th e  a b so rp tio n  of u rin e  b u t  
a n tic a n c e r  d ru g s  can  be ab so rb ed  th ro u g h  th e  u ro th e liu m  in 
d ise a sed  b la d d e r a n d  u n d e r  non-physio log ica l co n d itio n s. Five 
m ajor factors influence the  absorp tion  of d rugs th rough  the  bladder: 
m o le c u la r  w e ig h t o f th e  d ru g , pH of th e  so lu tio n , d ru g  
concentration , changes of uro thelia l surface and  length  of exposure 
du ra tio n  of the  u ro thelium  to d rug  (Torti, F. M. e t al 1984). 
M olecular weight: S tu d ies  of v a rio u s su lfonam ides in d ica te  th a t  
com pounds w ith  m olecular w eight > 200 AMU are  n o t absorbed  in
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appreciab le  am o u n ts . Sm aller m olecules are ab so rbed  by passive 
diffusion (Jones. H. C. et al 1961).
pH of the  solution: The nonionized (absorbable) species of a d rug  
will p redom inate  in  a  so lu tion  w hose pH exceeds the  pKa of the  
agent and  potentially  facilitate the absorption  of the  drug.
D rug concen tra tion : If passive diffusion is a m ain  m echan ism  of 
d ru g  a b so rp tio n  th e n  th e  co n ce n tra tio n  g rad ie n t of the  agen t 
betw een the  p lasm a and  the  so lu tion  contained in  the  b ladder is a 
decisive factor in the  absorptive process.
C hanges in the urothelial surface: As m alignant change progresses it 
h a s  been  d em o n stra ted  th a t  m em branes becom e m ore perm eable 
(Soloway, M. S. 1977). H ypervascularity  of b ladder m ucosa  appears  
a fter surg ical in s tru m e n ta tio n  or infection. B are a re a s  of b ladder 
wall after for exam ple tra n su re th ra l resection of tum or, w hich have 
lost the  p ro tection  from uro thelium . All of these  conditions have a 
high rate  of d rug  absorp tion  (Pavone-M acaluso, M. e t al 1976).
Time of d rug  co n tac t w ith the  uro thelium : D ata  sugg est th a t  the 
m ain  effect caused  by increasing  con tact tim e m ay re su lt from toxic 
su b s ta n c e s  w hich  cau se  in creased  exfoliation w ith  d en u d a tio n  of 
u ro thelium  (Murphy, W. M. et al 1981).
Several d rugs have b een  u sed  a s  in travesica l ch em o th e rap eu tic  
agen ts in the trea tm en t of superficial b ladder tum ors. M any of them  
are  ab andoned  due to th e ir  toxicity or lack  of th e ra p eu tic  effect, 
cu rren tly  one of the m ost com m only used  drug is th io tepa.
1-2-4-1 Thiotena as a  chem otherapeu tic  agent
T h io tepa  is a po ly functiona l aky la ting  agen t an d  following th e  
form ation of ethylenim ine rad icals alkylate biological m olecules. Its
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m ain  cytotoxic effect appears to be the  akylation the  b a ses  of DNA 
causing  cross-linking  of DNA s tra n d s  (Erlichm an.C . 1992). Its first 
u se  a s  in travesical chem otherapeu tic  agen t w as in 1961 (Jones, H.
C. e t al 1961). The u s u a l  dose is Im g /m l an d  ab o u t 2-25%  of 
p a tie n ts  receiving th is  tre a tm e n t will develop m yelo su p p ress io n  
w hich  is th e  m ajor side  effect of th io tep a  (England, H. R. et al 
1981). W hen u sed  as a definitive th e rap y  for low grade superficial 
b ladder tum ors approxim ately  two th ird s  of p a tien ts  have show n a 
com plete  or p a r t ia l  re sp o n se  (Torti, F. M. e t al 1984) As a 
prophylactic  agent, it h a s  been  dem onstra ted  th a t  the  disease-free 
in terval after tra n s u re th ra l resection  of tu m o r can  be significantly  
prolonged (Schulm an, C. C. et al 1982), and  it also decreases the 
ra te  of recurrence  (Koontz, W. W. et al 1981). The optim al cytotoxic 
ag en t for in trav esica l a d m in is tra tio n  h a s  n o t been  conclusively  
identified in  random ized tria ls  (Raghavan, D. et al 1990). T hiotepa 
h a s  been  u sed  widely w ith  m inim al toxicity and  is cu rren tly  the  
s ta n d a rd  to w hich  o th e r ag en ts  are  com pared  (Soloway, M. S. 
1988).
C ontrolled cellu lar proliferation and  differentiation in vivo involves 
m ultip le  levels of coord ination . A key role how ever is played by  
so luble factors includ ing  the  diverse group of secre ted  m olecules 
know n as th e  po lypep tide  grow th  fac to rs. T h a t grow th  fac to rs 
m igh t co n trib u te  to th e  p ro cesses  of tran sfo rm atio n  in  vivo w as 
suggested  by experim ents on virally transform ed cells and  w ork on 
the  iso la tion  of grow th factor genes by the ir ability  to tran sfo rm  
m ouse fibroblast in vitro. S tem  cell factor h a s  been  suggested  as a 
p le io tro p ic  g row th  fa c to r  w ith  b io log ical a c tiv itie s  in  th re e
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m ig ra to ry  cell lin e ag e s  d u r in g  e m b ry o n a l d ev e lo p m en t a n d  
po stn a ta l life. It m ay have oncogenic potential.
1-3 Stem  cell factor
M utation  a t  the  D om inant spotting  (W) and  S te e l  (SH loci in  mice, 
w hich d isplay a  sim ilar phenotype characterized  by anem ia, lack of 
h a ir  p ig m en t a n d  s te r ility , affect th e  d ev e lo p m en t of th re e  
u n re la ted  stem  cell popu lations: n eu ra l crest-derived m elanocytes, 
germ  cells and  hem atopoietic  p rec u rso r cells (Russell, E. S. e t al
1979). The genes affected by th ese  m u ta tio n s  a re  know n to be 
located  on chrom osom es 5 and  1 0  respective ly  an d  to con tro l 
d ifferent cellu lar p rocesses. N um erous stu d ies  have suggested  th a t 
W  m u ta tio n  ac ts  w ith in  the  stem  cell popu lations. Defects due to 
the  SI m u ta tio n  can  be rescu ed  by  norm al env ironm en ts and  its 
effects are  therefo re  m ediated  th ro u g h  the  m icroenv ironm en t in 
w hich  stem  cells function  (Mayer, T. C. 1970 ; M ayer, T. C. et al 
1968 ; McCulloch, E. A. et al 1964 ; 1965). These d a ta  m ay reflect a 
receptor-ligand re la tionsh ip  betw een the p ro d u cts  of the  W and  81 
genes (Chabot, B. e t al 1988).
1-3-1 W locus
The W  locus encodes the  c -k it  oncogene, w hose gene p ro d u c t (c- 
Kit) is  a tra n s m e m b ra n e  ty ro s in e  k in a se  re c e p to r  th a t  is 
s tru c tu ra lly  sim ila r to th e  recep to rs  for p la te le t derived grow th 
factor (PDGF) and  colony s tim u la tin g  factor 1 (CSF-1), Severe W  
alleles (W42) are due to m u ta tion  in the k inase  dom ain of c-/cit DNA
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an d  d isp lay  no de tec tab le  c-Kit k in ase  activ ity  (Tan, J .  C. e t al
1990), while m ore sub tle  phenotypes (W44) re su lt from a s tru c tu ra l 
re a rra n g e m e n t in  the  genom e an d  a p p ea r to be re la ted  to the  
reduced  am o u n t of c-Kit pro tein  (Geissler, E. N. et al 1988).
1-3-2 SI locus
The ligand  for c -k it  recep to r h a s  been  iden tified  as th e  gene 
p roduct of the  SI locus by several laboratories and given a variety  of 
nam es w hich  reflect its  pleiotropic effects. It in c lu d es "Stem cell 
factor" (SCF) (Zsebo, K. M. e t al 1990 a  ; b), "Kit ligand" (KL) 
(Flanagan, J .  G. et al 1990; H uang, E. et al 1990), "Mast cell growth 
factor" (MGF) (William, D. E. et al 1990; A nderson, D. M. e t al
1990), an d  "Steel factor" (SLF) (Witte, O. N. 1990 ; M orrison- 
G raham , K. et al 1993). SCF will be used  as the  p ro d u ct of SI locus 
an d  refer to  ”s c f '  a s  i ts  gene for th e  d isc u s s io n  followed. 
H om ozygous le thal SI m u ta tio n  con ta in  a large deletion of the s c f  
locus while no, or m inor, s tru c tu ra l  a lte rn a tio n s  in  hom ozygous, 
viable SI m u ta tio n  are observed (Copeland, N. G. e t al 1990). The 
hom ozygous m u ta n t m ice are viable d isp lay  severely defect 
phenotype, and  only produce the  soluble form of SCF (Flanagan, J .
G. e t al 1991).
1-3-3 Structure o f SCF
The n u c leo tid e  seq u en ce  of the  cloned SCF cDNA encodes a 
p red ic ted  tra n sm e m b ra n e  po lypeptide  w ith  a lead er sequence , 
e x tra c e llu la r  dom ain , m em b ran e  sp a n n in g  reg ion  a n d  sh o r t  
cytoplasm ic tail (Anderson, D. M. et al 1990). SCF in  h u m a n  and
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m ouse system s is now  know n to b o th  con ta in  the  2 2 0 -am ino acid 
p ro te in  a n d  th e  2 4 8 -am ino  ac id  p ro te in  w h ich  is effic ien tly  
p ro teo ly tically  cleaved a t  a  site  encoded by  th e  p rim ary  mRNA 
tr a n s c r ip t  w ith in  exon  6  a n d  re s u l ts  in  a  164 -am ino  acid , 
biologically active, secre ted  SCF. The 220-am ino  acid  form  of the  
p ro te in  is p ro d u ced  from  a n  a lterna tive ly  sp liced  second  mRNA 
tra n s c r ip t,  w h ich  lac k s  th e  exon 6  seq u en ce  a n d  is therefo re  
m em b ran e  b o u n d  (Toksoz, D. e t al 1992 ; F lanagan , J .  G. e t al 
1991). M urine SCF h a s  two d is tin c t proteolytic cleavage sites. The 
second site, located in  exon 7, is utilized only in  the  absence  of the 
p rim ary  site  an d  th is  ap p ea rs  to be species-specific, since h u m a n  
SCF rem ain s largely m em brane-assoc ia ted  a t  th is  site  (M ajum dar,
M. K. e t al 1994). The secreted  form of SCF involves bo th  a  separa te  
b iosyn thetic  pa thw ay  an d  p o st-tran s la tio n a l proteolytic cleavage to 
release  the  ex tracellu lar dom ain.
1-3-4 Biological functions o f SCF
B oth  th e  so lub le  an d  tra n sm e m b ra n e  form  of SCF have grow th 
factor activities (Anderson, D. M. e t al 1990). The m olecu lar lesion 
in  the  Sid allele is a  deletion of the  tran sm em b ran e  and  in trace llu lar 
dom ains of SCF. The p resence of a  defective stem  cell phenotype in  
th is  m ouse im plies th a t  p roduction  of soluble SCF is n o t adequate  
for no rm al biological function . T his ind ica tes th a t  the  m em brane- 
b o u n d  form  of SC F m ay  be im p o rta n t in  m ed ia tin g  cell-cell 
adhesion  and  in te rac tio n  and  have a  critical biological role in  the  
in ta c t organism  (Godin, I. e t al 1991; Dolci, S. et al 1991; F lanagan,
J . G. e t al 1991). M urine, or ra t, soluble SCF is highly hom ologous to 
its  h u m an  co u n te rp art and  is active on h u m an  cells, b u t  the  h u m an
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pro tein  is 800 fold less active on m ouse or ra t  cells (Martin, F. H. e t 
al 1990). M em brane bound  SCF increases bo th  the  overall n um bers 
an d  colony sizes of p rim ordial germ  cells (PGC), while secreted  SCF 
cau ses  a  large increase  in the  initial survival and  m otilities of PGC, 
b u t  does n o t prom ote long-term  survival in cu ltu re  (Godin, I. e t al
1991). A lthough SCF is required  for survival it is n o t sufficient for 
proliferation of PGCs in  cu ltu re  (Dolci, S. e t al 1991).
B oth  form s of SCF prom ote th e  proliferation of m a s t cell lines. In 
com bination  w ith  o th e r fac to rs so luble SCF a c ts  in  a  synerg istic  
m an n e r to induce  myeloid and  ery thro id  lineage colony form ation, 
s u c h  fac to rs  in c lu d e  e ry th ro p o ie tin  (EPO), g ran u lo cy te -co lo n y  
s t im u la t io n  fa c to r  (G-CSF), g ra n u lo c y te -m a c ro p h a g e -co lony  
s tim u la tion  factor (GM-CSF), and  in te rleuk in  IJS,3 ,6 ,7  (IL 1J3,3,6,7). 
Soluble SCF itse lf does n o t trigger d ifferentiation of hem atopoietic  
p ro g en ito rs ; it  e n h a n c e s  th e ir  p ro lifera tive  p o te n tia l, p e rh a p s  
play ing  a  role in  th e  activa tion  of prim itive haem atopo ietic  cells 
(Anderson, D. M. e t al 1990; M artin, F. H. et al 1990; Nocka, K. et al 
1990; Zsebo, K. M. e t al 1990a).
1-3-5 Soluble SCF decrease in  tum origenic cells
In a  n u m b er of sm all cell lu n g  cancers, 8 8 % (22 /25 ) have been  
found to express c-k it mRNA. 76% (19/25) of the  exam ined tum ors 
ex p ressed  SCF mRNA an d  am o n g st th e se  95%  ex p ressed  bo th  
form s of mRNA (Rygaard, K. e t al 1993). O ther h u m a n  solid tum or 
cell lines express the  c-Kit receptor, m em brane b o u n d  and  soluble 
SCF (Turner, A. M. e t al 1992). Ind ica tes th a t  th is  recep to r/lig an d  
system  m ay have an  au tocrine  function  in  tum ors (Rygaard, K. e t al 
1993 ; T u rn er, A. M. e t al 1992). The c -k it  p ro to -o n co g en e  is
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ex p ressed  in  a  m ajo rity  (20 /25 ) of s tu d ied  a c u te  m yelob lastic  
leukem ias in  c o n tra s t to u n d e tec tab le  expression  in  norm al bone 
m arrow  and  is functional in  te rm s of its  su p p o rtin g  pro liferation  
(Ikeda, H. et al 1991). The concen tra tion  of soluble SCF in pa tien ts  
w ith  m yelodysplastic  syndrom e (MDS) is significantly  lower w hen 
com pared  w ith  norm al sub jec ts  an d  th is  m ay be due to abnorm al 
SCF p roducing  cells in  MDS or an  increase  in  c-Kit recep to rs on 
th e  surface of tum or cells (Bowen, D. e t al 1993).
C hem otherapeu tic  agen ts  have been  widely used  as one option of 
can cer tre a tm e n t in recen t years. B ecause of toxicity  to no rm al 
tis su e , a t p re se n t only a  lim ited choice of d ru g s is available for 
clinical use.
Nitric oxide is a n a tu ra l  occu rring  p ro d u c t of th e  h u m a n  body 
w hich  h a s  a cytotoxicity effect on tu m o r cells. In th is  resp ec t it 
m ight be a good candidate  as a chem otherapeutic  agent.
1-4 N itr ic  oxide
Nitric oxide (NO), a  gas u n d e r  a tm ospheric  conditions, h a s  been  
e lec ted  "The m olecu le  of th e  y e a r  1992" by  th e  A m erican  
A ssociation  for th e  A dvancem ent of Science. Jt a cc o u n ts  for th e  
biological p roperties of endo thelium  derived relaxing factor (EDRF) 
(Palmer, R. M. J .  et al 1987 ; 1988a), rep resen ts  a  com pletely novel 
c lass of n eu ro n a l m essenger (Snyder, S. H. et al 1992) and  is the  
endogenous stim u la to r of soluble guanylate  cyclase. In addition, NO 
is an effector m olecule released  by m urine m acrophages and o ther
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cells a fte r im m unolog ical ac tiv a tio n . So far, th e  only c learly  
e s tab lish ed  role for th is  NO is as a  cytotoxic m olecule a g a in s t 
invading m icroorganism s and  tu m o r cells (M oncada, S. et al 1991 ; 
Henry, Y. e t al 1993).
1-4-1 NO is  th e  m o lecu le  resp on sib le  for th e  c y to to x ic ity  of  
activated macrophages
It u se d  to be th o u g h t th a t  n itra te s  (NO3 -) w ere derived from  
d ie ta ry  in ta k e  a n d  en v iro n m en ta l ex p o su re , b u t  en d o g en o u s 
sy n th esis  of 10 pm ol/K g body w eight per day of NO3 - w as observed 
in  h u m a n s  w hich  received a  low NO3 - d iet (Green, L. C. e t al 
1981b). T his p rocess w as orig inally  believed to be a  p ro d u c t of 
in te s tin a l m icrobial m etabolism  b u t germ  free m am m alian  an im als 
could sy n th esis  it a s  well (Green, L. C. 1981a). R ats w ith a  fever 
in d u c e d  by  in tr a p e r i to n e a l  in je c tio n  of E s c h e r ic h ia  coli 
lipopolysaccharide (LPS) endotoxin had  a  m arked  increase  in th e ir 
u rin a ry  o u tp u t of NO3 - and  the  am o u n t of th is  increase  correlated 
w ith  the  degree of fever induced  (Wagner, D. A. et al 1983). These 
re su lts  show ed th a t there  is a  b asa l level of NO3 - syn thesis  and  th a t  
th is  sy n th e s is  can  be e n h an c ed  by s tim u la tio n  of th e  im m une 
sy s tem . How ever in  ex p erim en ts  carried  o u t in  m ice, n e ith e r  
functional T -lym phocytes n o r LPS-responsive B -lym phocytes, were 
requ ired  in vivo and  activated  m acrophages alone w ere com peten t 
in vitro to perform  the LPS-induced n itrite  (N0 2 ‘) /N 0 3 ‘ sy n th esis  
(Stuehr, D. J .  e t al 1985). Activated m urine peritoneal m acrophages 
in  cu ltu re  and  m acrophage  cell lines d em o n s tra te  an  in creased  
production  of NO2 VN O 3 " by the  stim ula tion  w ith interferony (IFN y) 
LPS and  tu m o r necrosis  factor (TNF) (S tuehr, D. J .  e t al 1987b ;
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Ding, A. H. e t al 1988) .This reaction  w as L-arginine dependen t and  
b o th  th e  N0 2 ‘ and  NO3 - form ed w ere derived from  th e  te rm in a l 
g u a n id in o  atom (s) of L -arg in ine  (Iyengar, R. e t al 1987). T his 
p ro cess p roduced  L-citrulIine a s  a  co-product and  w as responsib le  
for th e  cytotoxic activ ities of m acrophages (Hibbs, J .  B. J r .  e t al 
1987a). N G -m o n o m eth y l-L -a rg in in e  (L-NMMA) p re v e n te d  th e  
sy n th e s is  of b o th  of th ese  p ro d u c ts  a s  well a s  th e  expression  of 
cytotoxicity (Hibbs, J . B. J r .  e t al 1987b). An enzym atic activity in  
the  activated  m acrophages converts L-arginine in to  an  in term ediate  
chem ical. The chem ical tu rn e d  o u t to be n itric  oxide (NO), w hich  
quickly  oxidized in to  NO2  an d  NO3  ( M arietta, M. A. e t al 1988; ; 
H ibbs, J .  B. J r .  et al 1988 ; S tu e h r, D. J .  et al 1989). W hen 
m acrophages are  activated  by  endotoxins, lym phokines, and  tum or 
cells  (Nozaki, Y. e t al 1993) th e y  re sp o n d  by  co n v ertin g  L- 
a rg in in e in  to  n itr ic  oxide. In a d d itio n  to m ac ro p h a g e s  an d  
endothelia l cells (Ignarro, L. J .  e t al 1987), n eu tro p h ils  (McCall, T.
B. e t al 1989), Kupffer cells (Billiar, T. R. et al 1989), m icroglial 
cells (Merrill, J .  E. e t al 1993), hepa tocy tes (C urran , R. D. e t al
1989), adenocarc inom a cell line EMT- 6  (Lepoivre, M. e t al 1989), 
a n d  cells from  cerebellum  (Bredt, D. S. 1989), and  ad ren a l g land 
(Palacios, M. et al 1989) c an  gen era te  th ese  L -arg in ine-derived  
m olecules.
1-4-2 C ytotoxicity of nitric oxide
N itric oxide (NO), a  sho rt-lived  , lipophilic, free rad ica l is th e  
p rim ary  n itrogen  oxide form ed by m acrophages an d  som e o th er 
cells in  resp o n se  to lyphok ines and  im m u n o -stim u lan ts . NO gas 
c a u s e s  th e  sam e  toxic p a t te rn  to tu m o r  cells  a s  a c tiv a ted
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m carophages (Hibbs, J .  B. J r .  et al 1988). The c h a rac te ris tic s  of 
toxicity  inc lude  the  in h ib itio n  of m itochondria l re sp ira tio n , the  
inh ib ition  of DNA sy n th e s is  and  the  inh ib ition  of th e  citric  acid 
cycle en 2:yme aconitase, w hich appear in  ta rge t cells and  also affect 
th e  a c tiv a te d  m a c ro p h a g e s  th em se lv es  (D rap ier, J .-C . e t al
1988) .The m e c h a n ism  by w h ich  NO k ills  cells is p re se n tly  
u n k n o w n , b u t  severa l possib le  types of cyto toxicity  have been  
proposed and  sum m arized  in the  table 1 - 1 .
1-4-2-1 Free rad icals
Reactive free rad ical species are  assoc ia ted  w ith several form s of 
tis su e  dam age and  d isease  a n d  also w ith  the  p rocess of ageing 
(Fridovich, 1. 1983 ; Sies, H. e t al 1992 ; Rose, R. C. et al 1993). NO 
is a free rad ica l p o ssess in g  an  ex tra  e lectron  m ak ing  it  highly 
chem ically reactive and  therefore extrem ely labile. Superoxide (O2 '
) is a  com m only encoun tered  in te rm ed iate  of oxygen reduc tion  in 
bo th  biotic and  abiotic sy stem s and  th is  free rad ical co n stitu tes  a 
th re a t to th e  chem ical in tegrity  of living cells (Fridovich, 1. 1983).
NO is know n to rap id ly  reac t w ith  superoxide to form  the  stab le  
peroxyn itrite  an io n  w hich  itse lf  d e m o n s tra te s  a cytotoxic effect 
a g a in st T rypanosom a  Cruzi (Denicola, A. e t al 1993). It h a s  been  
p roposed  th a t  peroxyn itrite  decays to n itrogen  dioxide and  an  
hydroxyl rad ica l w hich  is considered  the  s tro n g e s t ox id an t in 
b iological sy s tem s (Beckm an, J .  S. e t al 1990). F u r th e r  m ore, 
e x p e rim e n ts  have  d e m o n s tra te d  th a t  in vitro NO re a c ts  w ith  
hydrogen peroxide to release  large am oun ts of chem ilum inescence 
w ith  the  c h a ra c te ris tic s  of the  h ighly  cytotoxic species, sing le t 
oxygen (N oronha-D utra, A. A. et al 1993).
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1-4-2-2 Inhibition of m itochondrial resp ira tion
The fa ilu re  of re s p ira tio n  is c au se d  by  th e  n e a rly  com plete  
in h ib i t io n  of th e  n ic o t in a m id e  a d e n in e  d in u c le o t id e  
(NADH) : u b i q u i n o n e  o x i d o r e d u c t a s e  c o m p le x ,  th e  
succ ina te :ub iqu inone  oxidoreductase  complex (Granger, D. L. e t al 
1982) and  acon itase  (Kilbourn, R. G. et al 1984), all iro n -su lp h u r 
(Fe-S) associated  enzym es (Hibbs, J .  B. J r . e t al 1990). E xposure of 
Fe-S  g ro u p s to NO re s u l ts  in  n itro s y l- lro n -su lp h u r  com plex  
form ation (Reddy, D. et al 1983). N itrosylated Fe-S com plexes have 
b een  detected  by e lectron  p a ram ag n e tic  reso n an ce  spectroscopy  
(EPR) in N O -producing  m acro p h ag es (L ancaster, J .  R. J r .  et al
1990) and  m acro p h ag e-in ju red  ta rg e t cells (D rapier, J .-C . et al
1991).
1-4-2-3 Iron loss
Tum or cells th a t  develop cy tostasis and  inhibition of m itochondrial 
re s p ira tio n  in  re sp o n se  to ac tiv a ted  m ac ro p h ag e s , re le a se  a 
s ig n ific an t frac tio n  of th e ir  in tra c e llu la r  Fe c o n te n t a n d  th is  
p h en o m en o n  does n o t show  in  the  m etabo lic  in h ib ito r- tre a te d  
tu m o r cells (Hibbs, J . B. J r .  e t al 1984 ; W harton, M. et al 1988). 
A ctivated m acrophages in h ib it acon itase  in  the  ta rg e t cells a s  a  
re su lt of the  loss of an  iron atom  from the 4Fe-4S c lu s te r w ithin the 
acon itase  active site and  acon itase  activity of dam aged target cells 
can  be res to red  by in cu b a tio n  w ith  ferrous ion u n d e r  reduc ing  
conditions (Drapier, J . -C. et al 1986). Addition of an  NO -generating 
agen t "sodium  n itro p ru ssid e  " to the nonhem e iron  storage pro tein
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fe rritin  re su lts  in  the  release  of Fe and  th is released  Fe catalyses 
lipid peroxidation (Reif, D. W. et al 1990).
1-4-2-4 Inhibition of DNA syn thesis  and  DNA dam age
A p rom inen t action of m acrophage-derived NO in tum o r cells is the 
inh ib ition  of th e ir  DNA sy n th esis  (K rahenbuhl, J .  L. et al 1974). 
In te rru p tio n  of DNA sy n th esis  is n o t sim ply a  consequence of the 
in h ib itio n  of m ito c h o n d ria l re sp ira tio n , one of th e  p o ten tia l 
m olecu lar ta rg e ts  is ribonucleo tide  red u c tase  (RNR) (Lepoivre, M. 
e t al 1990). RNR is a  key enzym e, being ra te-lim iting  in the  DNA 
replication  process, catalysing  the  reduction  of ribonucleotides into 
deoxyribonucleotide p rec u rso rs  of DNA, and  th ereb y  m ain ta in in g  
an d  finely reg u la tin g  th e  pools of the  deoxyribonucleo tides. NO 
q u e n ch in g  of its  ty rosy l rad ic a l (Lepoivre, M. e t al 1991), or 
reaction  w ith  its non-hem e iron, inh ib its  the  RNR and  leads to an 
in te rru p tio n  of DNA syn thesis  (Henry, Y. et al 1993). Moreover, NO 
an d  N O -generating com pounds can  be oxidized to a m u tagen  th a t 
d eam ina tes DNA. M ost DNA sequence changes are  C-T tran sitions, 
co n sis ten t w ith  a cy tosine-deam ination  m echanism  (Wink, D. A. e t  
al 1991). It also in d u ces dose-responsive  DNA s tra n d  b reakage 
(Nguyen, T. T. et al 1991 ; 1992).
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1-4-2-5 Affect on o ther p ro te ins
The inac tiva tion  of su lfhyd ry l-dependen t b ac te ria l dehydrogenase  
h a s  long been  considered critical to the  food preserv ing  p roperties 
of acid n itrite . C ytochrom es P450 , a re  a  m ajor c lass of hem e- 
co n ta in in g  p ro te in s  w hich  ca ta ly se  the  oxidative m etabo lism  of 
e n d o g e n o u s  a n d  ex o g en o u s s u b s ta n c e s .  NO p ro d u c e d  by  
im m unoactiva ted  cell m ediates su p p ress io n  of the  enzym e in vitro 
and  in  vivo (Khatsenko, O. G. e t al 1993). A denosine d iphospha te  
(A D P)-ribosyltransferase. catalyzes the tran sfe r of ADP-ribose from 
NAD to protein  and  is activated by NO (Brüne, B. et al 1989).
1-4-3 Interaction of NO w ith other m olecules
1-4-3-1 Hemoglobin and  Iron inhibition of NO activitv
M acrophage-induced cytotoxicity can  be blocked by iron ( Fe2+ and 
Fe3+), hem oglobin  and  m ethem oalbum in  (W einberg, J .  B. e t al 
1977). B oth  fe rrous hem oglobin  and  m ethem oglobin  rem ove the  
NO from  th e  so lu tio n , a lth o u g h  fe rro u s  hem oglob in  is m ore 
effective (M artin, W. e t al 1986). Hem oglobin, w hich  b in d s n itric  
oxide, in h ib its  so d iu m  n itro p ru s s id e 's  (NO donor) cy to toxic 
activities (Brüne, B. et al 1989 ; Dawson, V. L. e t al 1991), blocks 
vessel re laxation  effect of NO (Palmer, R. M. J .  e t al 1987) and  
in h ib its  iron  release  from ferritin  of ta rg e t cells (Reif, D. W. e t al
1990). Nitric oxide h a s  an  extrem ely high affinity for the  b ind ing  
s i te  of h e m o g lo b in  a n d  b in d s  slow ly  a n d  re v e rs ib ly  to 
m ethem oglobin (Henry, Y. e t al 1993).
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1-4-3-2 A lbum in and  NO
A lthough su lfhydryl-contain ing  p ro te ins (eg. album in) b ind  w ith NO 
read ily  to form  S-N itroso p ro te in  com plexes, th ese  com plexes still 
p o s s e s s  th e  ED R F-like effects of v a so d ila tio n  a n d  in h ib itio n  
aggregation of p la te le ts  (Stam ler, J .  S. e t al 1992), th ey  m ay serve 
a s  a  NO carrier m olecule (McCall, T. e t al 1992) Sim ilarly, a lbum in  
does n o t in h ib it th e  tum oric ida l effect of activa ted  m acrophages 
(Weinberg, J .  B. e t al 1977).
1-4-4 Other m ain physiological effects o f NO
1-4-4-1 P latelets
S tim u la tio n  of e n d o th e lia l-m o n o lay e r cells in  c u ltu re  re le a se s  
p rostacyc lin s and  n itric  oxide w hich  are capable  of inh ib iting  the  
effects of p la te le t aggregation and  adhesion  (Radom ski M. W. et al 
1987 a,b ,c). T here  is a  synerg istic  in te rac tio n  be tw een  NO an d  
p ro stacyc lin s on an ti-agg regation  activ ity  (Radom ski, M. W. e t al 
1987 c) b u t  no su ch  po ten tia tion  on an ti-adhesion . NO h a s  a  role in 
d e te rm in in g  th e  n o n -a d h e s iv e  p ro p e r t ie s  of th e  v a s c u la r  
endo thelium  by a  cGMP m ediated  m echan ism  (Radomski, M. W. e t  
al 1987 a). Nitric oxide syn thase , is p resen t in  h u m a n  p latele ts and  
is dep en d en t on NADPH, free in trace llu la r calcium , inh ib ited  by L- 
NMMA. It is s tim u la ted  to en h an ce  NO sy n th esis  from  L-arginine 
once p la te le t aggregation is in itia ted . NO generated  from  p la te le ts  
a c ts  a s  a  negative  feed b ack  sy s te m  to  m o d u la te  agg regation  
(Radomski, M. W. 1990).
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1-4-4-2 C entral Nervous System
Nitric oxide is a  c en tra l an d  periphera l n eu ro n a l m essenger. It is 
involved in  c lassica l an teg rad e  n e u ro n a l signalling  a n d  also h a s  
u n iq u e  p ro p e rtie s  a s  a  re tro g rad e  tra n s m itte r . In  th e  c en tra l 
nervous system  the  excitatory n eu ro tran sm itte r g lu tam ate  can  elicit 
large in creases  in  cGMP levels and  releases a  diffi^sible m essenger 
w hich  involves cell-cell in te rac tio n  {Garthwaite, J .  e t al 1987). This 
m e sse n g e r is  iden tified  a s  hav in g  p ro p e rtie s  id en tica l to NO 
(G arthw aite, J .  et al 1988 ; B redt, D. S, e t al 1989). S tim ula tion  of 
th e  g lu ta m ate -re la ted  am ino  acid  N -m ethy l-D -aspartase  (NMDA) 
re c e p to r  h a s  b e e n  sh o w n  to  a c tiv a te  s y n th e s is  of NO 
p o stsy n ap tica lly  an d  it  does n o t a c t on  th e  g en e ra to r cells b u t  
d iffu ses  o u t to a c t on  one o r m ore n e ig h b o u rin g  s t ru c tu re s  
includ ing  p resynap tic  te rm in a ls  and  astrocy tes. NO is also form ed 
p resynap tica lly  in  clim bing fibres of the  cerebellum . The effect of 
NO g e n e ra te d  in  th e se  fib res  is  th e  long -te rm  d e p re ss io n  of 
re sp o n ses  in  Punk in je  fibres since exogenous NO cau ses , and  L- 
NMMA blocks, th is  d ep ress ion  (Shibuki, K. e t al 1991). A second 
fu n c tio n  for NO w ith in  th e  CNS m ay re la te  to it 's  toxic effects. 
NADPH d iap h o ra se  positive n e u ro n s  are  re s is ta n t  to th is  toxic 
in su lt. B ecause cNOS is one NADPH d iaphorase , it is possible th a t  
cN O S-containing n eu ro n s  kill cNOS-negative cells (Dawson, V. L. e t  
al 1991). Selective neu ro tox icity  m ay be im p o rtan t d u rin g  b ra in  
developm ent an d  N O -releasing  n e u ro n s  could c o n trib u te  to th is  
p rocess (Bredt, D. S. e t al 1991).
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1-4-4-3 Peripheral nervous system
In the  periphera l nervous system , NO fulfils m any of th e  criteria  of 
a  c lassical n e u ro tra n sm itte r  a lthough  it is n o t re leased  in  q u an ta . 
In h ib ito ry  n o n -ad re n e rg ic , n o n -ch o lin e rg ic  (NANG) n e rv es  are  
th o u g h t to  be im p o rta n t in  th e  au tonom ic  in n e rv a tio n  of th e  
g a s tro in te s tin a l tra c t an d  o th er o rgan  system s. NO could accoun t 
for the  biological activity of th is  transferab le  NANG factor (Bult, H. 
et al 1990). In th e  stom ach , vagal stim u la tion  re leases NO to relax  
gastric  sm ooth  m uscle (Desai, K. M. e t al 1991). In the  vascu la tu re , 
NO released  from NANG nerves m ediates vasodila ta tion  directly and  
m odifies tran sm itte r  ou tpu t.
1-4-4-4 V ascular
The endo thelium  co n trib u te s  to th e  regu lation  of v a scu la r tone by 
v a rio u s  m ech an ism . O ne is  re lease  of a  pow erfu l v aso d ila to r, 
'endothelium -derived  relaxing factor' (EDRF) (Furchgott, R. F. et al
1980). EDRF is  a  lab ile  h u m o ra l ag en t w h ich  m e d ia te s  th e  
re lax a tio n  of v a sc u la r  sm oo th  m usc le  v ia th e  elevation of cGMP 
levels (Moncada, S. e t al 1988). V ascu lar endothelial cells in  cu ltu re  
syn thesize  NO from  L-arginine (Palmer, R. M. J .  e t al 1988a), L- 
NMMA in h ib i ts  th is  s y n th e s is  in  a d ose  d e p e n d e n t  a n d  
enan tiom erically  specific m a n n e r (Palmer, R. M. J . e t al 1988b). 
The co-product of th is  reaction  is L-citrulline (Palmer, R. M. J .  e t al
1989). NO re leased  from  b ra d y k in in -s tim u la te d  e n d o th e liu m  is 
in d is tin g u ish a b le  from  EDRF in  te rm s of it 's  biological activity, 
s ta b ility  a n d  su sce p tib ility  to a n  inh ib ito r, or to a  p o ten tia to r  
(Palmer, R. M. J . e t al 1987 ; H u tch in son , P. J .  A. e t al 1987).
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C onstitu tive  NO sy n th ase  in  th e  endothelial cells provides a  locally 
regu lated  m echan ism  releasing NO con tinuously  in  varying am oun ts 
to regu la te  blood vessel tone (M oncada, S. e t al 1991). A sim ilar, 
tigh tly  regu la ted  physiological vasod ila to r Influence is provided by 
NO released  from NANG nerves in  th e  adventitia  of blood vessels. In 
th e  p en is , NO re leased  from  nerves leads to re lax a tio n  of th e  
co rpus cavem osum  and  m ay con tribu te  to erection in  an im als and  
h u m a n s  (Holmquist, F. et al 1991 ; Ignarro, L. J . e t al 1990).
1-4-4-5 O ther system s
NO regu la tes the  m icrocirculation  of r a t  kidneys. It m ay also play a  
ro le  in  th e  c o n tro l of tu b u lo g lo m e ru la r  feed b ack  a n d  re n in  
secretion  (Nathan, G. 1992). The pulm onary  vasoconstric tion  due to 
hypoxia or pu lm onary  hypertension , is reversed by NO and  it also 
p ro tec ts  ag a in st a d u lt resp ira to ry  d is tre ss  syndrom e (M oncada, S. 
e t al 1992). NO in h ib its  th e  p ro lifera tion  of lym phocytes w hich  
re sp o n d  to m itogens or an tigens , and  p reven ts  th e  ad h esio n  of 
leukocytes to endothelium . Both cNOS and iNOS m ay partic ipa te  in 
the  control of in su lin  release (N athan, G. 1992). Possible functions 
of NO are  outlined in  table 1-2.
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TABLE 1-2 The possible functions of NO
System s/C ells Possible fim ction(s)
V ascular Vessel d ila tation
Nervous N euronal m essenger 
N eurotoxicity
M acrophages Cytotoxicity
P la te le ts Decreases aggregation 
and adhesion
Renal Regulates m icrocirculation 
Determines renin release
P u lm o n ary Reverses pulm onary 
vasoconstric tion
Im m uno logy Inhibits lym phocyte proliférât
E ncdocrine Participate insulin release
Information summary from Moncada, S. et al 1992 and Nathan, 
1992.
1-4-5 NO synthases
NO is formed in the  generato r cells, from arginine by a  n itric  oxide 
sy n th a se  a n d  is a sso c ia te d  w ith  s to ich io m etric  p ro d u c tio n  of 
c itru lline . M any d ifferent isoform s of n itric  oxide sy n th a se  (NOS) 
have  b een  ch a rac te rized  and  purified  from  d ifferen t cell types 
(M oncada, S. e t al 1991; N athan , C. 1992; F o rs te rm an n , U. e t al 
1991; Lyons, C. R. e t al 1992). Among the  cytosolic n itric  oxide 
sy n th ases , two m ain  c lasses can  be d istingu ished . The b ra in  and  
endothelial enzym es are bo th  constitu tive, w hereas the  m acrophage
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NOS is inducib le . B oth  c la sses  of NOS are  n ico tinam ide aden ine  
d inucleo tide p h o sp h a te  (NADPH) dependen t. S tru c tu ra l analogs of 
a rg in in e  su c h  a s  N -m onoethy l-L -arg in ine  (NMMA) a re  stro n g , 
a lth o u g h  n o t ab so lu te ly  specific, in h ib ito rs  of NOS a n d  perm it 
d e tec tio n  of th is  enzym atic  reac tio n  in  in ta c t  cells, o rgans, or 
a n im a ls  (Palm er, R. M. J .  e t al 1989; B redt, D. S. e t al 1990; 
M arietta, M. A. 1988; G ross, S. S. et al 1990). M olecular oxygen is 
incorporated  into bo th  NO and  citru lline by b o th  c lasses NOS, th u s  
they  are also dioxygenases (Kwon, N. S. e t al 1990 ; Leone, A. M. e t  
al 1991). B oth  r a t  b ra in  an d  m u rin e  m acrophage NOS have been  
recognized a s  a  C O -binding cytochrom e P450 type hem opro te in  
(Bredt, D. S. e t al 1991 ; L ow enstein, C. J .  e t a l 1992). The 
constitu tive  enzym e is C a^+ /calm odulin  dependen t (Busse, R. et al
1990), an d  re leases NO for sh o rt periods in  resp o n se  to recep to r 
or physical s tim u la tion . The NO released  by th is  enzym e ac ts  a s  a  
tran sd u c tio n  m echan ism  underly ing  several physiological responses 
an d  its  m olecular ta rg e t is guany la te  cyclase (GO), a  hem oprotein . 
T he activa tion  of GO leads to  in creased  levels of cGMP an d  to a  
cascade  of m olecu lar events w ith in  the  targe t cells (Moncada. S. e t  
al 1991). The inducib le  enzym e is C a^+Zcalm odulin in d e p e n d e n t 
(S tuehr, D. J .  1991). It requ ires  d e  novo  p ro te in  sy n th e s is  for its  
expression  (Xie, Q.-W. e t al 1992) an d  the  activity is n o t detectab le 
in  e ither m acrophage cell lines or freshly elicited m acrophages th a t  
have n o t been  activated (M arietta ,M. A. et al 1988 ; S tuehr, D. J .  e t 
a l 1987a). It is re leased  over long periods and  it 's  in d u ctio n  is 
in h ib ited  by  g lucocortico ids (O 'C onnor, K. J .  e t al 1991). The 
properties of these  two c lasses of NOS are listed in  tab le  1-3.
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TABLE 1-3 Sim ilarities and differences between  the two main classes o f NOS
Constitutive Inducible 2.
3- NADPH dependent 2.
4. Dioxygenase
5. P450 type hem oprotein
3- Inhibited by L-arginine analogs 2.
/ca lm odulin  dependent 
S hort-lasting  release lO-
Unaffected by 
glucocorticoids
Ca^+Z calm odulin 
independen t 9-
Long-lasting release 11
Induction inhibited 
by glucocorticoids H-
I. Janssens, S. P. et al 19923. Palmer, R. M. J.. et al 1989
5. Kwon, N, S. e ta l  1990
7. Lowenstein, C. J. e ta l  1992 
9.Stuehr, D. J. e ta l  1991
II. Xie. Q.-W. et oi 1992
2. Marietta, M. A. et al 19884. Leone, A. M, et al 1991
6. Bredt, D, 8. et al 1991
8. Busse, R. et al 1990 
10. Moncada, S. e ta l  1991
1-4-6 Roussin's black salt
R oussin 's b lack sa lt (RBS) belong to a  class of com pounds w hich h as 
been  know n for over a  cen tu ry  (Roussin, F. Z. 1858). The chem istry  
of th is  com pound  is u n iq u e , it a rise s  by a  p ro cess  know n as 
"spontaneous self assem bly" (Sung, S.-S. e ta l  1985). T hat is to say, 
u n d e r  app ropria te  conditions, sy n th esis  occurs from  m ononuclear 
s ta r t in g  m a te r ia ls  w ith o u t th e  d e te c ta b le  fo rm a tio n  of any  
in term ediates. In the  solid s ta te , the com pound is relatively stable.
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particu la rly  if k ep t u n d e r n itrogen and  a t -IQoC. Once in solution it 
will decom pose  to re le a se  NO an d  p ro d u ce s  iro n  oxide an d  
e le m e n ta l s u lp h u r ,  a lth o u g h  it  is u n c le a r  w h e th e r  o th e r  
in te rm ed ia tes  exist (personal com m unication  w ith  Dr. 1 Megson). 
RBS, c o n ta in s  seven  n itro sy l g ro u p s linked  to an  iro n -su lp h u r  
fram ew ork and  relaxes the  a rte ria l m uscle  of a  sm all segm ent of 
p re -c o n tra c te d  ra t  ta il a rte ry . The vasod ila to ry  effect of RBS is 
b locked by m ethylene b lue, an  inh ib ito r of the  so luble guany la te  
cyclase, and  by ferrous hem oglobin, a  NO scavenger (Flitney, F. W. 
e t al 1990). The re lease  of NO from  RBS is accelera ted  du ring  
exposure to laser light (7^=514.5 and  457.9  nm) (Flitney, F. W. et al 
1993). NO inh ib its  the  proliferation of lym phocytes w hich response  
to m itogens or an tigens (N athan, C. 1992), a lthough  th is  inhibition 
is in d ep en d en t of the  sou rce  of NO. RBS c au se s  the  increased  
in h ib itio n  of lym phocyte  p ro life ra tio n , w ith  in c re a s in g  n itr ite  
c o n ce n tra tio n s  in the  c u ltu re  s u p e rn a ta n t  (Rowland, I. J .  et al
1991).
Purpose of present studies
In the scale of tum or incidence b ladder tum ors ra n k  high especially 
in  industria lized  areas. In view of the  fact th a t  the b est way to trea t 
a  d isease is to stop it before it s ta r ts  to develop, it is th u s  im portan t 
to  u n d e rs ta n d  th e  tum origenesis of h u m an  u ro th e liu m  tu m o rs  for 
the pu rp o se  of p revention . A norm al h u m an  u ro th e liu m  cell line 
(SV-HUC-1 a lth o u g h  th eo re tic a lly  sp e ak in g  n o t a n o rm al cell 
because  of its imm ortality) w as used  for tum origenic transfo rm ation  
experim ents. F u rtherm ore  experim ents were carried  o u t to define
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an y  m o lecu la r ch an g es a sso c ia ted  w ith  th is  tra n s fo rm a tio n  by 
assay ing  m edium  conditioned by p a re n t cells and  transfo rm ed  cells. 
For th e  tre a tm e n t of e stab lish ed  b lad d er can cers  or p rophylactic  
m an ag em en t of recu rren ces , local instilla tion  of ch em o therapeu tic  
a g e n ts  in to  th e  p a tie n t 's  b la d d e r  w as perfo rm ed  w ith  lim ited  
su ccess  and  a  wide range of com plications. An ideal d rug  h a s  yet to 
be found an d  undergo trail. NO is a  n a tu ra l p ro d u ct w ith  cytotoxic 
effect of the  h u m an  body. To fu rth e r  probe the  th e rap eu tic  role of 
NO, a  novel NO donor (RBS), w as assayed  for its cytotoxicity on bo th  
n o n - tu m o rig e n ic  (SV-HUC-1) a n d  tu m o rig en ic  h u m a n  (T24) 
u ro th e liu m  cells. A ttem pts to identify  th e  possib le  m echan ism  of 
th is  grow th inh ib ition  effect w ere carried  o u t u sin g  h a m ste r  ovary 
cell(CHO) and  its  rad iosensitive m u ta n t (xrs-5).
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2-1 CeU lines and cultures
2-1-1 SV-HUC-l ce ll line
SV-HUC-1 is a  n o rm al h u m a n  u ro th e lia l cell line w h ich  w as 
im m ortalised  w ith  S im ian v irus 40  (SV40). It h a s  an  unlim ited  life 
sp a n  and  cu rren tly  following a t lea s t 50 passage  of these  cells h a s  
rem ained  nontum origen ic  a s  determ ined  by th e ir inab ility  to form 
tum ors in  athym ic nude  mice. C u ltu res are epithelial in  appearance  
and  show  som e m orphological heterogeneity  in  cell size an d  shape. 
Positive im m u n o h is to ch em ica l s ta in in g  for h u m a n  cy top lasm ic 
k e ra tin  and T an tigen  of SV40 h a s  been  dem onstra ted . (C hristian,
B. J . et al 1987).
M aterials
H am 's F I 2 [Gibco, G rand Island , NY] supp lem en ted  w ith  7% (v/v) 
fetal calf se rum  (PCS) [G lobepharm , U.K.] This m edium , referred to 
a s  "7% PCS P12", also con ta ined  100 u n its /m l Benzyl penicillin, 
100 p g /m l strep tom ycin  [Sigma, USA] and  2 niM L-glutam ine [Plow 
la b o ra to r ie s , U.K.]. D isod ium  e th y le n e d ia m in e te tra a c e tic  acid  
(EDTA) [Sigma] in H anks’s ba lanced  sa lt solution (HBSS).
Cell cu ltu re
Cells w ere grow n in  80cm 2 flask  [N unc,D enm ark] w ith  10 ml 
m edium  and  gassed  w ith  5% COg and  air to reach  a n  optim al pH. 
C aps w ere screw ed a ir  tig h t and  flasks were k ep t in a  37°C dry 
in cu b a to r receiving a  com plete m edium  change 3 tim es a week. 
Passage
All the  m edium  w as rem oved and  the  flasks rin sed  w ith  lOmls of 
0.1%  (w/v) EDTA in  HBSS. F lasks were placed in  a 37°C incuba to r 
for 20 m inu tes w ith fresh  EDTA so lu tion  and  the  cells detached  by 
tapp ing  the  flask  gently. An equal volum e of 7% PCS P I 2 m edium
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w as added to th e  flask  th e n  all th e  fluid tran sfe red  in to  a  30 ml 
un iversa l tube  [Sterilin, U.K.]. The fluid w as centrifuged a t  1000 
rpm  for 1 0  m in u te s  to o b ta in  a  cell pellet, s u p e rn a ta n t  rem oved 
a n d  cells re s u sp e n d e d  in  m ed iu m  by gen tle  p ip e ttin g . The 
cellu lar!ties were determ ined  using  a  hem ocytom eter (Reznikoff, C.
A. et al 1983).
2-1-2 T24 cell line
T24: T his cell line w as originally  called "MGH-Ul", b u t  it's  HLA 
p h en o ty p es (O'Toole, C. M. e t al 1983) an d  DNA fingerp rin ting  
p a tte rn  (M aster, J .  R. W. e t al 1988) are  iden tical to the  T24 cell 
line w hich is derived from a  h u m an  u rinary  b lad d er carcinom a. It 
will p roduce  a  tu m o r following inocu lation  of cell su sp en s io n  in to  
the  cheek pouch of a  h am ste r (Bubenik, J .  et al 1973).
Cell cu ltu re
The m ethod of cu ltu ring  th is  cell line w as identical to th a t u sed  for 
th e  "HUC-1" cells [2.1.1] w ith  th e  exception th a t  Rosewell P ark  
M em orial In s titu te  tis su e  cu ltu re  m edium  1640 (RPMI-1640 )[ICN 
biom edicals UK] su p p lem en ted  w ith  5% (v/v) FCS also  con ta ined  
100 u n its /m l Benzyl penicillin  100 p g /m l strep tom ycin  an d  2 mM 
L-glutam ine w as used.
Passage
The m edium  w as rem oved from flasks. 5m ls of 0.05% (w/v) trypsin  
[Difco UK] in  0.2% (w/v) EDTA and  PBS so lu tion  (PE) were added 
and  swirled gently across the  cells th e n  removed an d  replaced w ith  
fresh  trypsin . This w as removed and  a  th in  layer of trypsin  w as left 
in  the  flask. F lasks were k ep t in a  37®C in cu b a to r  for 5 m in u tes  
u n til cells were observed to round  up . F lasks were gently sh ak en  to 
release the  cells and  m edium  added th en  p ipetted  gently to m ake a
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single cell su sp en s io n . Cells were coun ted  w ith  a hem ocytom eter 
and  passaged into a new flask.
2-1-3 CHO and xrs cell lines  
CHO-Kl C hinese h am ste r ovary cell line
x rs -5 R ad ia tion-sensitive  m u ta n t, w hich is DNA rep a ir  deficient, 
isolated from CHO-Kl ( Jeggo, P. A. et al 1983).
Cell cu ltu re
The m ethod of cu ltu ring  these  cell lines w as identical to those used  
for th e  "H U C-l" cells [2-1-1] w ith  th e  excep tion  th a t  E ag le’s 
m in im al e ssen tia l m ed ium  [Gibco F 15] su p p lem en ted  w ith  10% 
(v/v) foetal calf se ru m  also contained  100 u n its /m l Benzyl penicillin 
100 pg /m l streptom ycin and  2mM L-glutam ine w as used .
Passage
The m ethod of passag ing  these  cell lines w as identical to th a t u sed  
for th e  "T24" cells [2-1-2] w ith  th e  exception  th a t  0.05% (w /v) 
try p sin  w ith  0.7m M  EDTA in  PBS (TE) were u se d  for de tach ing  
cells.
2-2 Cryopreservation and rederivation o f cell lines
2-2-1 Cryopreservation
T he cells w ere h a rv e s te d  a n d  cen trifu g ed . Cell p e lle ts  w ere 
resu sp en d ed  in cu ltu re  m edium  to a  concen tra tion  of 2 x l 0 ®cell/ml 
a n d  a  one te n th  volum e of d im ethy l su lphox ide  (DMSO) [BDH] 
added slowly and  equilib ria ted  by gently sw irling. 1 ml of m ixture 
w as aliquoted  into a  cryotube [Nunc] and frozen slowly in th e  gas 
p h a se  of a  liquid  n itrogen  freezer for a t le a s t 24  h o u rs  before 
im m ersion into the  liquid phase  (-19G0C).
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2-2-2 Rederivation
C ryo tubes w ere carefu lly  rem oved from  liquid  n itrogen , th e  cell 
su sp en sio n  were thaw ed rapid ly  in  a  37°C w ater b a th  and  the  cells 
p u t in to  a  flask. C u ltu re  m edium  w as added drop by  drop slowly, 
flasks gassed  w ith  5% CO2  and  a ir and  kep t in a  37^C incubato r. A 
ch an g e  of m ed ium  w as m ade a fte r th e re  w as evidence of cell 
a ttachm en t.
2-3 SV-HUC-1 ce lls  growth in  serum  free, factors free 
(sff), chem ically defined m edium
2-3-1 Aim and principle
A im : Iso la tio n  of h u m a n  u ro th e liu m  cell v a r ia n ts , called  
"autotrophs" w hich are able to grow using  low m olecular w eight 
m etabolite  p rec u rso rs  and  in  the  absence  of m acrom olecu les 
and  serum  rep lacem ent factors (Hillova, J . et al 1990). 
P rin c ip le : Using a selection p rocedure  w hich sw itches cu ltu re  
conditions of the  cells from a  7% FCS supp lem en ted  m edium  
to a  m ed ium  w ith o u t add ition  of exogenous grow th factors, 
horm ones, or serum .
2-3-2 M aterials and m ethods  
Cells: SV-HUC-1 [2-1-1].
H am ’s F I 2 m edium  added w ith lOOU/ml penicillin, lOOpg/ml 
strep tom ycin  and  2 mM L-G lutam ine th is  referred as "sff F 12" 
0 .05% (w /v) so y a b e a n  try p s in  in h ib ito r  [Sigm a] in  PBS. 
0.1% (w/v) EDTA in HBSS, 0.05% (w/v) Trypsin in  PE.
Cell cu ltu re
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SV-HUC-1 cells w ere h arv ested  a s  described  [2-1-1] b u t  the  
cell pellet w as resu sp en d ed  in  sff F I 2 m edium  an d  acquired  
n u m b er of cells were p u t into 80 cm^ flasks [Nunc] contain ing  
10 m is of sff F I 2 m edium , gassed  w ith 5% CO2  to optim al pH, 
cap  closed a ir tig h t an d  flasks kep t in  a  37°C dry  incubato r. 
O nce cells a tta c h ed  to th e  flask  a  com plete m edium  change 
w as rece ived  every  se c o n d  day . T h ese  su rv iv in g  a n d  
proliferating cells were designated  as "SV-HUC-IN".
Passage
C ells w ere grow n to co n flu en ce  in  f la sk s , m ed iu m  w as 
rem oved, and  cells rin sed  w ith 0.1%  EDTA in HBSS. 2 .5  m is of 
0.1%  EDTA and  2 .5  m is of 0.05% (w /v) try p s in  in PE were 
ad d ed  for 3 m in u te s  an d  rem oved. 5 m is of 0 .05% (w /v) 
soyabean  try p sin  in h ib ito r in  PBS were added for 3 m in u tes  
and  removed. F lasks were kep t a t 37°C for 20 m inu tes w ith 10 
m is of 0.1%  EDTA in HBSS. Cells were de tached  by tapp ing  
the  flask  gently  and  an  equal volum e of sff F12 m edium  w as 
added before all the  fluid w as transfered  into a  30 ml universal 
tu b e  [Sterilin]. The fluid w as centrifuged a t 1000 rpm  for 10 
m in u tes  to ob tain  a cell pellet, su p e rn a ta n t rem oved and  cells 
r e s u s p e n d e d  in  sff F 12  m ed iu m  by g e n tle  p ip e ttin g . 
C ellu larities were determ ined w ith  a hem ocytom eter.
2-4 Assay of cellular tumorigenicity
2-4-1 Aim and principle
Aim: D eterm ination the  tum origenicity  of cells.
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P r in c ip le : In o cu la tio n  of cells in to  congen ita lly  im m uno- 
deficient athym ic n u d e  m ice will lead to the  developm ent of 
tum ors if the  cells are  tum origenic.
2 4  2 M aterials and m ethods
Nude m ice were u sed  [n u /n u , M F l, Olac, U.K], Mice k ep t in 
the  U niversity of St. Andrews Anim al H andling Facility in a  12 
h o u r l ig h t/d a rk  illum ination  cycle, a t an  am bien t tem p era tu re  
of 22 .3°C  (72°F) and  in w hich the  a ir w as filtered. Mice were 
fed w ith  RM 1(E) p e lle ts  [Special D iet Service, U.K.] and  
allowed sterile w ater ad libitum  .
T he cells w ere h a rv e s te d  a n d  c e llu la ritie s  d e te rm in ed  as 
described  previously . The cell pe lle t w as re su sp e n d e d  in  a 
m in im um  a m o u n t of m ed ium  (< 500 pi ) an d  th e  m edium  
contain ing  cells w as sucked  into a  1 ml syringe fitted w ith a  21 
gauge needle. The dorsal a sp ec t of the  neck of the  n u d e  mice 
w as chosen  as the  in jection site. The sk in  w as sterilized w ith a  
70% (v/v) alcohol sw ab and  th e  su b c u ta n e o u s  inocu la tion  of 
cells perform ed. Mice were k ep t in  the  an im al h o u se  and  
in jection  sites were observed twice weekly. T um or grow th w as 
m onitored  u n til au topsy  a t a su itab le  size. In the  case  of no 
tu m o r grow th mice were m onitored for 6 m onths.
2-4-3 Tumor d issection  and tissu e explant culture 
Aim: Growing tum or cells o u t from the  tum or tissue.
M ethod
Mice w ith tu m o rs were killed by cervical vertebrae dislocation. The 
tu m o rs  were excised u sing  sterile  techn ique  and  p u t into a  pe tri 
d ish  con ta in ing  m edium . Excessive connective tissu e  w as rem oved 
and  a  slice of tissu e  w as c u t o u t from the  m iddle of tu m o r th en  
fu rth e r  cu t in to  Im m ^ size fragm ents. The fragm ents were placed
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in a  25cm 2 flask  w ith  7% FCS F I 2 m edium  sufficien t to w et the 
b o tto m  of th e  flask . O nce th e  cells w ere c o n flu en t th ey  w ere 
c u ltu re d  an d  p a ssa g e d  a s  p rev iously  d escrib ed  [2-1-1], T hese 
surviving and  proliferating cells were designated as "SV-HUC-IT".
2-5 Colony formation in semi-solid m ethylcellnlose
2-5-1 Aim and principle
Aim: Cloning of cells.
P rin c ip le : Cells form  colonies in  th e  sem isolid  m ethy lcellu lose. 
T hese colonies can  be a sp ira te d  from  th e  m ethy lce llu lose  and  
regrow in cu ltu re  flasks as a  subclone. (Mcniece, I. K. et al 1986).
2-5-2 Materials and m ethods
M ethylcellulose [Fluka, Germ any] w as p repared  in advance. 2 .145 
gm s of m ethylcellulose and a  m agnetic s tirre r b a r  were autoclaved 
together in a  beaker. 50 m is of boiling Milli-Q w ater were added 
an d  the  so lu tio n  s tirred  c o n tin u o u sly  u s in g  a m agnetic  s tir re r  
[G allenkam p U.K.]. Once cooled, 50 m is of double s tren g th  H am 's 
F I 2 m ed ium  w ere added . The m ix tu re  w as k e p t a t  +4°C w ith  
c o n s ta n t s tirr in g  overnight. (A c lear gel like so lu tio n  sh o u ld  be 
produced by the  next m orning  or it should  be discarded). 20 m is of 
so lu tion  were aliquoted  in to  un iversal tu b es , capped,covered w ith  
tin  foil and  kep t a t -20°C un til required.
Feeder laver
9 m is of 10%(v/v) FCS F I 2 m edium  and  1 ml of m elted 5%(w/v) 
agar [Bacto-Aga, Difco, U.S.A.] were m ixed together and  2 m is of 
th is  p re p a ra tio n  aliquoted  in to  a  60 m m  d iam ete r p las tic  trip le  
ven t petri d ish  [Nunc] and  allowed to set.
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Cellular laver
Cells were harvested  as described previously [2-1-1] and  a required 
n u m b er of single cells were su spended  in  4.5 m is of 10% FCS F12 
m ed iu m . T h is  w as  a d d e d  to  4 .5  m is of 37°C , 2% (w /v)
m ethylcellulose and  m ixed well. 2 ml a liquots were plated  on top of 
each  feeder layer and  d ishes were kep t in a 37°C, 5% CO2  in air, 
fully hum idified in cu b a to r for 21 days. Single colonies w hich were 
identified u sin g  a  d issec ting  m icroscope se t up  to give d a rk  field 
i l lu m in a t io n  [O ly m p u s, J a p a n ]  w ere  rem o v ed  from  th e  
m ethylcellu lose u n d e r sterile  conditions u sing  a 21 gauge needle 
connected  to a 1 m l syringe con ta in ing  0.2 ml of 10% FCS F12 
m edium . Cells w ere p u t  in to  a 25cm ^ flask  [Nunc] w ith  1 ml of 
m edium , gassed  w ith 5% CO2 , cap closed air tigh t and  flasks kep t 
in a 37°C dry incubator. 5 m is of m edium  were added once the cells 
w ere a tta c h e d  to the  flask  and  m edium  changed  th ree  tim es a 
week. T hese surviving and  p ro liferating  cells w ere designated  as 
"SV-HUC-ITS".
2-6 Chromosome studies  
2 .6 .1  Aim and principle
Aim : D istinguish ing  betw een h u m an  and  m urine cells.
P r in c ip le : O bservation  of chrom osom es a t m e tap h ase  in  the  cell 
cycle w hen they  are m ost easily recognized.
2 6-2 Materials and m ethods
G lass slides (76x26 mm) [BDH] w ere p rep a red  in  advance  by 
im m ersion  in  IM hydroch loric  acid  (HCl) overn igh t an d  rin sin g  
w ith w ater. These clean  g lass slides were im m ersed  in  100% (v/v)
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ethano l overnight and  air dried. The slides were kep t in  a  clean box 
and  cooled to -20°C before use.
Cells in  m e tap h a se  w ere a c c u m u la te d  by  ad d in g  0 .0 4 p g /m l of 
colcem id (stock so lu tion : 4pg /m l) [Sigma] to cell c u ltu re s , 3 -4  
h o u rs  before harvesting. Hypotonic trea tm en t of harvested  cells w as 
perform ed by resu sp en d in g  the  cell pellet in 75 mM KCl. After 3 
m in u te s  a t  room  te m p e ra tu re  cells w ere  c e n tr ifu g e d  an d  
s u p e rn a ta n t rem oved. The cell pellet w as d ispersed  by  flicking the  
tu b e  a n d  th e  cells w ere  fixed in  f re sh  C a rn o y 's  fixative  
(M ethanol:Glacial acetic acid = 3:1). This procedure w as repeated  a t 
least 3 tim es by centrifugation and  resuspension  in  Carnoy's fixative. 
(The cells can  be sto red  in the  fixative a t +4°C for several m onths.) 
For chrom osom e sp re a d s , th ese  cells were d isp e rsed  in  a few 
d ro p s of fresh  fixative, d ropped  onto  -20°C  chilled  s lides and  
im m ediately w arm ed by hand . Slides were rapidly dried by h ea t and  
s ta in e d  w ith  3% (v/v) G iem sa [BDH] in  w a te r for 20  m in u te s . 
S ta ined  p repara tions, w hich were rin sed  w ith  w ater and  a ir dried, 
were th en  exam ined u n d e r oil im m ersion by light m icroscopy [Leitz 
w etzlar, Germany].
2-7 Immunocytochemical staining of cells and tissue
2-7-1 Aim and principle
A im : Identification of a  specific an tigen  of the  ta rg e t cells thereby  
estab lish ing  the  origin of the  cells.
P r in c ip le: A p rim ary  an tib o d y  b in d s  to th e  ce llu la r an tigen  of 
interest and  th is  antigen-antibody interaction is further amplified 
by the in troduc tion  of a secondary  peroxidase-conjugated  antibody
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w hich  b in d s  to th e  p rim ary  an tibody . The p ero x id ase  is th e n  
v isu a lised  u s in g  th e  enzym e reac tio n  w ith  3 ,3 -d iam inobenzid ine  
(DAB) in  the  presence of H 2 O2 . This reaction  gives a  brow n sta in ing  
deposit th a t  can  be observed w ith the  light m icroscope.
2 7  2  M aterials and m ethods  
P rim ary an tibod ies:
DAKO-M 821: A  m ouse  m onoclonal an tibody  w hich reac ts  w ith  an  
epitope w hich is p resen t in a  wide range of h u m an  cytokeratins w as 
used . A positive s ta in  ind icates th e  targe t cells are h u m an  epithelial 
in  origin. U sed in  a  1:25 d ilu tion  in  l% (w/v) bovine se ru m  album in  
in  PBS (BSAPBS).
PAb 405: A m ouse m onoclonal an tibody w hich reac ts  w ith a region 
of th e  SV40 T- an tigen  close to the  C -term inus. Positive s ta in ings 
m ay indicate the  ta rge t cells a re  im m ortalized by SV40.
DO-1: A m ouse  m onoclonal an tib o d y  w hich  rea c ts  w ith  h u m an , 
m onkey, bovine m u ta n t and  wild type p53. Epitope in  N -term inus 
region aa  1-45.
Secondary antibodv:
D A K O -P l 61: A ra b b it an ti-m o u se  IgG, H o rse ra d ish  perox idase  
(HRP) conjugated, polyclonal antibody, d iluted 1:100 in  BSAPBS. 
D AK O -M 821 and D AK O -Pl 61 w ere ob ta ined  from  DAKOPOTTS, 
D enm ark. PAb 405  and  DO-1 were obtained from Professor D. Lane, 
D ept of B iochem istry, U niversity of D undee. U sed n e a t in  the  form 
of hybridom a cu ltu re  su p e rn a ta n t, or ascites fluid, d ilu ted  1:500 in  
PBS (Vojtesek, B. e t al 1992).
50 pis of 1x10® cells /m l single cell su sp en sio n  w as dropped on one 
end  of a  g lass slide w hich  h a d  been  sterilized in  advance. T hese 
p rep a ra tio n s  w ere k e p t in  a  hu m id  cham ber an d  in cu b a ted  in  a 
37°C , 5% CO2 , hum idified  in cu b a to r overnight. S lides w ere rinsed
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once w ith  PBS and  fixed in  cold acetone for 20  m in u tes. After a ir 
drying th e  slides w ere flooded w ith  l% (w/v) BSAPBS and  k ep t a t 
3 7 0 c  in  a hum id  cham ber for 60 m inu tes to block the  nonspecific 
b inding  of antibodies. A prim ary  antibody w as added to the cells and 
k ep t in  a  hum id  cham ber a t 37°C for 60 m inu tes. After rinsing  the  
slides 3 tim es w ith BPS to remove the  un -b o u n d  p rim ary  antibody, 
the  secondary  antibody  w as added. Slides were incubated , and  the  
secondary  an tibody  w ashed  off, as detailed  above th e n  developed 
w ith  3 ',3 -d iam in o b en z id in e  (DAB) [Sigma]. DAB w as u sed  a t a 
concen tra tion  of 1 m g /m l in  w ater w ith 0 .03% (w/v) nickle su lp h a te  
(to enhance  the b lack  coloration) an d  activated w ith 0.06%  H2 O 2 . 
Slides w ere k ep t in developing so lu tion  for 5 -10  m in u te s  in the  
d a rk  th e n  rin sed  w ith  w ater. The protocol in all cases rem ained  
essen tia lly  the  sam e w ith the  exception th a t no fu rth e r fixation w as 
req u ired  in  th e  w ax em bedded  tu m o r tis su e  slides w hich  were 
dewaxed in h o t sterile w ater prior to stain ing.
2-8 DNA finger printing 
2 8-1 Aim and principle
A im : Identifying the  p a ren ta l origin of the  cells.
P r i n c i p l e : C e llu la r genom ic  DNA w as c u t  w ith  re s tr ic tio n  
en d o n u c lease , se p a ra ted  by e lec tophoresis , an d  hybrid ized  w ith  
probe. C om parison betw een the  p a tte rn s  of these  sm all fragm ents 
w as perform ed to find evidence of genetic linkage and  m uta tion .
2-8-2 Materials and m ethods
D etailed m ethods and  m ateria ls can  be found in the  A ppendix I. A 
sum m ary  of the whole procedure  is p resen ted  here.
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2-8-2-1 E x traction  of the  genomic DNA
A pproxim ately 1.5x10'^ cells were harvested  using  trypsin  or EDTA 
a n d  w ash ed  3 tim es in  PBS. Cells were d isp e rsed  in  a  1.8 m is 
E ppendorf tube  con ta in ing  1 m l of lysis buffer, 100 pis of 10 m g/m l 
p ro te inase  K, 250 pis of 10%(m/v) SDS and incuba ted  a t  50^C w ith 
gentle  sh ak in g  overnight. DNA w as ex trac ted  from  lysate  by the  
add ition  of a n  equal volum e of phenol(x l), ch loroform /phenol(x2), 
ch loroform (xl) a n d  p rec ip ita ted  in  2 volum es of ice cold 100% 
e th an o l an d  a  h a lf  volum e of 7.5M am m onium  ace ta te . DNA w as 
rin se d  tw ice w ith  70%  e th an o l, d ried  in  air, a n d  d isso lved  in 
lOOpls of TE.
The quality  of DNA w as checked by electrophoresis in  a  0 .8% (w/v) 
agarose  gel w ith  TBE a s  e lectrophoresis buffer a t  80  volts for 45 
m inu tes. The q u an tity  of DNA w as m easu red  by  a  DNA fluorom eter 
[TDK 100, Hoefer Scientific In s tru m en t, USA] an d  a d ju s te d  to a 
concen tra tion  of 250-500  p g /m l in  TE.
2-8-2-2 D igestion of DNA w ith  restric tion  endonuclease  
60  pis of sam p le  DNA w as c u t  by  th e  ad d itio n  of 4 pis of 
endonuclease  H aelll (12u/p l), 8 pis of (lOx)Haelll buffer an d  8 pis 
of 0. l% (w/v) BSA and  in cu b a ted  a t 370C overnight. The d igested 
DNA w as e x tra c te d  b y  th e  a d d itio n  of a n  eq u a l vo lum e of 
p h en o l/ch lo ro fo rm  (xl), chloroform  (xl) an d  purified  in  ice cold 
100% e thano l w ith  2.75M  sod ium  aceta te , before dissolving in  20 
pis of TE.
2 -S -2 -3  S e p a ra tio n  of th e  DNA fra g m e n ts  b v  a g a ro se  gel 
e le c tro p h o re s is
All th e  DNA sam ples and  a  lam b d a  ladder m ark e r w ere ru n  in  a
0.8% (w/v) agarose  gel w ith  TBE as e lec tropho resis  buffer a t 24 
volts for 48 hou rs, th en  ru n  a t 36 volts, after ru n n in g  buffer w as
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changed, for a n o th e r 24 hours. DNA fragm ents were sep ara ted  on 
the  agarose  gel and  d e n a tu re d  in situ. The fragm en ts were th en  
tran sfe rred  from the  gel to a  solid su p p o rt (m em brane), w here they  
w ere im m obilized. A fter p reh y b rid iza tio n  to red u ce  nonspecific  
hybrid ization  by the  probe, th e  m em brane w as hybridized to the  
d e s ired  rad io lab e led  n u c le ic  ac id  p robe. T he m em b ran e  w as 
w ashed  to rem oved u n b o u n d  and  w eakly b ind ing  probe, and  w as 
th en  autorad iographed .
2-8-2-4  T ransferring  DNA to a  m em brane bv S o u th ern  blotting 
The gel w as im m ersed in  0 .25 N HCl for 20 m inu tes to depurina te  
the  DNA, in G S l so lu tion  for 45 m inu tes to d en a tu re  the DNA and  
in  GS2 so lu tion  for 45 m in u te s  to neu tra lize  the  gel. The DNA 
fra g m e n ts  on  th e  gel w ere  t ra n s fe r re d  to a  n itro c e llu lo se  
m em b ran e  [Zeta-Probe GT b lo tting  m em brane , Bio-RAD] by the  
s ta n d a rd  S o u th e rn  b lo ttin g  p ro ce d u re  w ith  (xlO)SSC as th e  
tran sfe rrin g  buffer. Briefly a sh ee t of nitrocellu lose m em brane w as 
p u t on top of the gel w hich w as placed on a  W hatm an 3 MM paper 
w ick tray . Two sh e e ts  of W hatm an  3 MM p ap er w ith  a pile of 
a b so rb a n t p ap er w ere p u t  on top of the  m em brane to keep up  a 
s te ad y  cap illa ry  p re ssu re . D am p a b so rb a n t p a p e r w as rep laced  
severa l tim es in  th e  firs t h o u r  th e n  the  tra n s fe r  py ram id  left 
overnight. M em brane w as w ashed w ith  (2x)SSC and  baked a t 80°C 
in a  vacuum  oven for 30 m inutes.
2 -8 -2 -5  P ro d u c tio n  of th e  p robe  and  h v b rid iza tio n  w ith  the  
m em brane
The probe w as a segm en t of ®^P rad io labe led  RNA w hich  w as 
syn thesized  from  a specific DNA tem plate  in se rted  down s tream  
from  a very  specific b ac te rio p h ag e  tra n sc r ip tio n  p rom oter. The 
pSPT 18.15  w as u se d  a s  a  vecto r an d  lin ea rlized  w ith  th e
M & M  58
res tric tio n  enzym e H indlll. T ranscrip tion  reaction  w as carried  ou t 
w ith  T7 RNA polym erase and  stopped by the add ition  of n ick  stop 
mix. The un inco rpora ted  nucleo tides were rem oved by sp in  colum n 
c h ro m a to g ra p h y  th ro u g h  a  1 m l co lu m n  of S e p h a d e x  G 50 
equilibria ted  w ith  TE. The radioactiv ity  of the  probe w as m easu red  
w ith  a  liq u id  s c in ti l la t io n  a n a ly se r . T he m e m b ra n e  w as 
p reh y b rid iz e d  w ith  a  so lu tio n  c o n ta in in g  1% BLOTTO (w /v),
2% (w/v) SDS, a n d  (xl)SSC a t  64°C overnight. 6x10'^ cpm  RNA 
probe w as added  to the  sam e ch am b er and  hybrid ized  a t 65^0  
overnight. The m em brane w as w ashed  in a sh ak in g  w ater b a th  a t 
65°C  for 45 m in u tes  w ith  3 changes of w ash  so lu tion  contain ing  
(xl)SSC, 0.1% (w/v) SDS an d  w rapped  in  S a ran w rap  a fte r it h ad  
been  a ir dried.The m em brane w as exposed to X-ray film and kep t a t 
-70°C  for 2 days w ith  two intensifying screens followed by 14 days 
w ith o u t s c re e n s . F ilm s w ere developed an d  DNA frag m e n ts  
com pared .
2-9 Assay of cellular DNA content by flow cytometry
2-9-1 Aim and principle
A im : C om parison of the d istribu tion  of DNA con ten t in  tum origenic 
and  non-tum origenic cells.
P r in c ip le : A DNA specific dye is employed to s ta in  cells an d  the  
am o u n t bound  is p roportional to DNA content. Individual cells are  
th e n  d irec ted  th ro u g h  a  la se r b eam  to excite th e  dye, a n d  the 
fluorescence em ission is collected and  displayed as a fluorescence 
d is tr ib u tio n . T his will e n u m e ra te  the  cells co n ta in in g  d ifferen t 
am oun ts of DNA (Barlogie, B. e t al 1983).
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2-9-2 Materials and m ethods
C ells w ere o b ta in e d  a s  p rev iou ly  d esc rib ed  [2-1-1], fixed in  
70%(v/v) e thanol and  kep t in  +40C overnight. E thano l w as removed 
a n d  cells w ere w ash ed  once w ith  PBS by c en tr ifu g a tio n  an d  
re s u sp e n s io n . Cells w ere re su sp e n d e d  a t  1x10® c e lls /m l in  a 
1 m g /m l fresh  so lu tion  of ribonuclease  A (RNase A) [N orthum bria  
Biologicals U.K.] in  PBS and  in cu b a ted  a t 370C for 30 m inu tes. 
P rop id ium  iodide (PI) [Sigma] w as added  to th e  cells to a final 
concen tra tion  a t 4 pg /m l. Cells were d ispersed  th ro ugh  a  21 gauge 
needle. D a ta  for th e  m e a su re m e n ts  of forw ard sc a tte r  v e rsu s  
fluorescence of PI were acqu ired  in  a  flow cytom eter [FACScan, 
B ecton D ickinson USA.] u sing  a softw are package "C onsort *30", 
an d  the  p o pu la tions of the  cells w ith  different DNA co n ten t were 
analysed using  "DNA" software.
2-10 Measurement of doubling tim e of HUC-IT cells
A given n um ber of cells were plated  in  several 25 cm^ flasks [Nunc] 
con ta in ing  cu ltu re  m edium  (7% FCS F 12). They w ere gassed  w ith 
5% CO2 , caps closed a ir tigh t and  kep t in a 37°C in cu b a to r. Cells 
were harvested  and  coun ted  a t regu lar intervals. S ta rting  48 h o u rs  
after p lating  u sing  0.05%  trypsin  in  PE. Cell coun ts  and  viabilities 
w ere dete rm ined  on cells s ta in e d  in  2% (m /v) fas t g reen  u s in g  a 
hem ocy tom eter a s  described  in [2-16-3] and  d a ta  u sed  to p lo t 
grow th curve (Gioanni, J . et al 1985).
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2-11 Vital stain of cellular foci
2-11-1 Aim and principle
A im : D em onstration  of the  living cells m aking u p  the  foci form ed in 
cu ltu re  flask.
P rinc ip le : Using confocal m icroscope to show  the  fluorescein in  the  
living cells.
2 .1 1 .2  Materials and m ethods
SV -H U C-ITS cells w ere grow n in  25 cm^ fla sk  a s  p rev iously  
described un til foci formed. F lasks were rinsed  3 tim es w ith PBS, a 
m ixture of 15 pi of a  stock  so lu tion  of 5-carboxyfluoresein d iacetate  
(5 C-FDA) [Sigma] ( lO m g/m l in A nalaR  acetone) and  5 m is of PBS 
w as added  to th e  flask. F la sk s  w ere in cu b a te d  a t 37oC for 10 
m in u tes , s u p e rn a ta n t  rem oved an d  flasks rin sed  once w ith  PBS. 
Cells in  flasks w ere observed  u s in g  a  la se r sc an n in g  confocal 
im aging system  w hich were operated  in  con junction  w ith a Nikon 
d iapho t inverted  fluorescence m icroscope [BioRad, MRC 600 USA], 
488nm  light as a illuninating  source (Bruning, J . W. 1980).
2-12  In vitro m urine high proliferative p oten tia l colony- 
forming cell (HPP-CFC) assay
2-12-1 Aim and principle
A im : Q ualita tive  d em o n s tra tio n  of th e  p resence  of cy tok ines in 
m edium  conditioned by HUC-1 and HUC-IN cells.
P rin c ip le : Based on the  ability  of certain  cytokines to in te rac t w ith 
o ther hem atopoietic growth factors to stim ula te  the  proliferation of
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HPP-CFC from m urine  bone m arrow  in double layer, sem isolid agar 
cu ltu re  (McNiece, I. K. et al 1986).
2-12-2  M aterials and M ethods
Production  of condition m edium : Cells were grown to confluence in 
10 ml of 7% FCS F12 (for HUC-1) or sff F12 (for HUC-IN) m edium  
in 80 cm2 flasks. M edium  w as com pletely rem oved and  replaced by 
10 ml of fresh  m ed ium  and  cells c u ltu red  for a  fu r th e r  3 days. 
M edium  w as h a rv e s te d  an d  cen trifu g ed  a t  3 0 0 0  rpm  for 15 
m inu tes, aliquoted and  frozen (-20°C) un til required.
R ecom binan t m u rin e  g ranu locy te-m acrophage  colony s tim u la tin g  
fac to r (rm u GM-CSF) [Im m unex  U.S.A.] u se d  a t  an  op tim al 
concen tra tion  of 40U /m l,
R ecom binant h u m an  m acrophage colony stim ula ting  factor (rhu M- 
CSF) [Genetic In stitu te  U.S.A.] u sed  a t 50U /m l.
R ecom binant m urine  stem  cell factor (rmu SCF) [Immunex] u sed  a t 
10 ng /m l.
M urine bone m arrow  cells w ere p rep a red  from  8 -10  w eeks old 
CBA/H mice w hich were killed by cervical dislocation. Fem ora were 
d issec ted  u n d e r sterile  condition, fem oral jo in ts  w ere tran ssec ted  
an d  a  1ml syringe co n ta in in g  m edium  w ith  a  23 gauge needle 
in se rte d  in to  th e  ep iphysea l cartilage  of the  knee  jo in ts . Bone 
m arrow  cells w ere flu shed  o u t from  the  fem oral cavities a n d  a  
single cell su sp en s io n  produced by gently draw ing the  cells th rough  
a 23 th en  a  25 gauge needle. C ellularities were determ ined  w ith a 
C oulter coun te r [ZM, C oulter E lectronics, U.K.].
This a ssay  u ses  a com bination of hem atopoietic CSF and  employs a 
b ilayer ag ar c u ltu re  tech n iq u e . A feeder layer co n ta in in g  CSFs 
un d erlies  a cellu lar layer. CSFs diffused from the  feeder layer to
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influence  th e  pro lifera tion  an d  d ifferen tiation  of cells w ith in  th e  
upper layer.
U nderlaver
A com bination  of CSFs were added to a  volum e of 37°C D ulbecco's 
m ed iu m  [Gibco, U.K.] c o n ta in in g  20% (v/v) h o rse  se ru m  (HS) 
[Globepharm , U.K.] sufficient to produce a  to ta l of 9 m is. 1 m l of 5% 
(w/v) m elted agar [bacto Agar, Difco, U.K.] w as added and  2 m is of 
th is  p rep a ra tio n  were aliquoted in to  60 m m  diam eter p lastic  triple 
ven t pe tri d ish es [Nunc]. The agar w as allowed to se t and  th ese  
feeder layers were stored in a 37°C ,5% CO2  in air, fully hum idified 
in cu b a to r un til required.
Cellular laver
1ml of 2x10®/m l of m urine  bone m arrow  cells and  1 ml of 3%(w/v) 
m elted  ag ar w ere added  to 8 m is of 37°C D ulbecco 's m edium  
con ta in ing  20%(v/v) HS. 2 ml a liquots of th is  m ixture were p lated  
on top of th e  p rev iously  p rep a red  feeder layer. The ag ar w as 
allow ed to se t  a n d  in c u b a te d  in  37°C, 5% CO 2  in  air, fully 
hum idified incubato r for 14 days.
A ssav of the colonies
12 to 24 h o u rs  p rio r to coun ting  1 ml of au toclaved  so lu tion  of 
Im g /m l in  no rm al sa line  of 2(4-iodophenyl)-3-(4-n itrophenyl)-5- 
p h en y lte trazo liu m  chloride  (INT)[BDH, U.K.] w as added  to each  
cu ltu re  d ish  and  incuba tion  continued. As viable cells proliferate in 
v itro  th ey  convert th e  co lo u rless  té trazo liu m  s a l t  to a w a te r 
inso lub le  red  form azan w hich p rec ip ita tes inside the  cells (Bol, S. 
et al 1977).
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2 -1 3  E nzym e lin k ed  im m uno-sorbant a ssay  (ELISA) for 
hum an stem  ceU factor in  m edium  conditioned  by HUC-1 
and HUC-IT ceHs
2-13-1 Aim and principle
A im : Q uan titative  determ ination  of h u m an  stem  cell factor (SCF) in 
the  conditioned m edium .
P r in c ip le : M onoclonal an tibody  specific for SCF im m obilizes th e  
fa c to r  in  th e  c o n d itio n ed  m ed iu m . A seco n d  enzym e-linked  
polyclonal an tibody  b in d s  to the  fac to r and  a  colour reac tio n  is 
developed in  p roportion  to the  am o u n t of SCF b o u n d  in  the  in itial 
step .
2-13-2  M aterials and m ethods
C onditioned m edium  w as p repared  as previously  deta iled  [2-12-2] 
u s in g  7% FCS F12 m edium  for b o th  SV-HUC-1 a n d  SV-HUC-IT 
cells.
ELISA k its u sed  were com m ercially available. [BIOTRAK, A m ersham  
U.K.], [Q uantikine. R&D system  U.S.A.].
P rocedure as p e r  m an u fac tu res  in stru c tio n s. Briefly, sam ples were 
ad d ed  to th e  te s t  m icro  t itre  w ells w hich  w ere p reco a ted  w ith  
m onoclonal m urine antibody aga in st SCF. B ound SCF w as m easured  
using  polyclonal SCF antibody conjugated to h o rse rad ish  peroxidase.
A curve of op tical d en sity  v e rsu s  the  co n cen tra tio n  of SCF w as 
generated  u sing  s ta n d a rd  recom binan t h u m an  SCF. C oncentration  
of SCF in  th e  sam ple  w as dete rm ined  by  com paring  th e  optical 
density  of the  sam ples to th is  s ta n d a rd  curve. The a ssa y  range for 
h u m a n  serum  SCF concentra tion  is 31 .3pg /m l to 2000pg /m l.
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2-14 Murine thym ocyte proliferation assay
2-14-1 Aim and principle
A im : The detection  of in te rleuk in  one(ILl)-like activity.
P rin c ip le :
1. A su b p o p u la tio n  of thym ocytes (T lym phocytes) exposed to ILl 
express in te rleu k in  two (IL2) receptors.
2. A subpopu la tion  of thym ocytes in te rac t w ith a  subop tim al levels 
of m itogen (Concanavalin A) and  release IL2.
3. IL2 s t im u la te d  IL 2 -re c e p to r  e x p re s s in g  ce lls  u n d e rg o  
pro liferation .
4. T hym ocyte p ro life ra tio n  is d e tec ted  by tr it ia te d  thym id ine  
incorporation , and  is rela ted  to the  level of ILl (K rakauer, T. et al 
1982).
2-14-2 M aterials and m ethods
P re p a ra tio n  of m u rin e  thym ocy tes: T hym ocytes w ere h a rv ested  
from th e  2-3  w eeks old CBA/H mice w hich were killed by cervical 
sp ine  d islocation .T he tho rac ic  cavities were opened u n d e r  sterile  
co n d itio n , th e  th y m u s  g lan d s  s itu a te d  above th e  h e a r t  w ere 
rem oved and  a single cell su sp en s io n  of thym ocytes w as produced 
in  RPMl 1640 m edium  [ICN] su p p lem en ted  w ith  10%(v/v) FCS, 
lO O u/m l benzyl penicillin , lOOpg/m l strep tom ycin , an d  2mM L- 
g lu tam ine . C ellu larities w ere de te rm ined  w ith  a  C oulter co u n te r 
[ZM, C oulter E lectronics, U.K.] and  ad justed  to lO ^cells/m l.
M itogen: C oncanavalin -A  (ConA) will itse lf  s tim u la te  thym ocyte 
pro liferation . A subop tim al con cen tra tio n  of ConA w hich  will no t 
itse lf  s tim u la te  thym ocyte p ro lifera tion  w as de te rm ined  (1 pg/m l) 
for u se  during  the  assay  of ILl activity.
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T ritia ted  thym idine: [m ethyl-® Hjthym idine ([®H]TdR) [Am ersham ] 
specific activity, 185G B q/m m ol, w as d ilu ted  to a  w orking so lu tion  
of 300  K B q/m l w ith  RPMI 1640 m ed ium  co n ta in in g  4 0 IU /m l 
gentam icin .
100 pi of 10^ th y m o c y tes /m l an d  50 pi of 4 p g /m l ConA w ere 
added  to a  n u m b er of fla t-bo ttom ed wells of a  96 well m icro titre  
p la te  (Nunc, D enm ark) 50 pi of e ith e r conditioned m edium , or a 
range  (2 - 100 U /m l) of reco m b in an t h u m a n  IL l a  [Im m unex, 
U.S.A.] to p roduce an  ILl titra tio n  curve, w as added  to each  well. 
The p late  w as in cuba ted  for 3 days in  a 37°C 5% COg in air, fully 
hum idified  in cu b a to r a fte r w hich 25 pi of 300  K B q/m l [®H]~TdR 
w as added to each  well. Incuba tion  w as con tinued  for 16 ho u rs . 
Cells w ere h a rv e s te d  u s in g  a  T ite rtek  cell h a rv e s te r  [Skatron , 
Norway] onto g lassfiber filter p ap er [Titertek]. After thorough  oven 
drying, individual filter d iscs were placed in scin tilla tion  vials and  2 
m is of sc in tillan t [O ptiphase 'Safe', FSA Laboratories, U.K.] added. 
[®H]-TdR u p tak e  by p ro life ra ting  cells w as d e te rm ined  u s in g  a 
liquid scin tilla tion  counter[LKB1214, R ackbeta, U.K.]. E ach vial w as 
counted  for a  5 -m inute period and  a  coun t per m inute ' (CPM) value 
d e te rm in ed . T his figure reflects th e  p ro life ra tion  of thym ocytes 
stim ulated  by ILl.
2-15 [^H] thym idine incorporation assay determ ining the  
growth-stimulating activity of sff conditioned medium
2-15-1 Aim and principle
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A im  : D e m o n s tra tio n  th a t  th e  p ro life ra tio n  of cells grow n in  
chem ically  defined m ed ium  is en h an ced  by se ru m  free m edium  
conditioned by HUC-IN cells.
P rin c ip le : M easuring  the  rad ioactive thym idine inco rpora tion  can  
be u sed  as  an  index rela ting  to cell proliferation.
2-15-2 M aterials and m ethods
S erum  free conditioned m edium : SV-HUC-IN cells were grown to 
confluence in  a  80 cm2 flask, 10 m is of fresh  H am 's F I 2 m edium  
(no se rum  supplem ent) w as added and  incubation  w as continued  as 
u su a l. The m edium  w as rem oved after 3 days and  centrifuged a t 
3000  rpm  for 15 m in u te s  th e n  sto red  a t -200C u n til  requ ired . 
[®H]TdR [Am ersham ] w as d ilu ted  to a  w orking  so lu tio n  of 300  
KBq/m l w ith RPMI 1640 or H am 's F I 2 m edium .
Cells w ere h arv ested  a s  p rev iously  described  [1-2-1] and  rin sed  
once w ith  PBS befo re  re s u s p e n s io n  in  se ru m  free  c u ltu re  
m e d iu m . 1x10® cells /w ell w ere seeded in a 24 well flat bottom  
tis su e  c u ltu re  p la te  [Nunc]. C onditioned  m ed ium  w as se ria lly  
d ilu ted  w ith  fresh  m edium  (no se ru m  supplem ent) and  added  to 
a p p ro p ria te  w ells. C ontro l w ells co n ta ined  fre sh  m ed ium  only. 
P lates were incubated  in a  5% CO2  in air, fully hum idified incubato r 
a t 37°C for 48 h o u rs  (HUC-1 cells had  one m edium  change after 24 
h o u rs). [®H]TdR w as added  a t 60 K Bq/w ell an d  in cu b a te d  for 
a n o th e r  8 h o u rs  for T 24 cells an d  16 h o u rs  for HUC-1 cells. 
M edium  con ta in ing  [®H]TdR w as rem oved and  p la tes rin sed  twice 
w ith  w arm  PBS to rem ove excess [®H]TdR. B etw een  su ccess iv e  
rin ses , p la tes  were k ep t flooded w ith  fluid to p ro tec t cells from 
su rfa c e  te n s io n  effects w h ich  m ay  d islodge th e m  from  th e  
p lastic .(F in lay , G. J .  1984). 1 m l of cold 5%(w/v) trich lo roace tic  
acid (TCA) [BDH] w as added to each well and  the  p lates kep t a t 4°C
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for 30 m inu tes to fix the  cells. P lates were rinsed  4 tim es w ith  5% 
TCA and  1 ml of a  m ix ture  of 0. IN  NaOH and  0.1% (w/v) sodium  
dodecyl su lp h a te  (SDS) w as added  to each  well an d  in cuba ted  a t 
37°C  for 1 h o u r to dissolve the  acid-insoluble precip itate . After one 
h o u r 0.1 ml of IM HCl so lu tion  w as added to each well and  the to tal 
well con ten ts were aliquoted in to  a  scin tilla tion  tube  con ta in ing  10 
ml of O ptiphase 'safe' [LKB], vortexed and  the  am o u n t of [®H]TdR 
inco rpo ra ted  in to  the  p ro liferating  cells de term ined  w ith  a liquid 
sc in tilla tion  co u n te r [LKB 1214, Rackbeta]. R esu lts  w ere expressed 
a s  a  co n ce n tra tio n  of sff cond itioned  m edium  v e rsu s  [®H]TdR 
u p take  dose response  curve.
2-16 Growth inhibitory effects of Roussin's Black Salt (RBS) 
on exponentially growing cells.
2-16-1 Aim and principle
A im : D eterm ination  of cytotoxic effects induced by RBS 
P rin c ip le: Cytotoxic effects were calcu lated  form the ratio  of living 
d ru g  tre a te d  cells to living n o n d ru g  tre a te d  cells w h ich  w ere 
exponentially  growing.
2-16-2 Materials and m ethods
Cell lines: H u m an  u ro th e lia l cells, n o n -tu m o rig en ic  SV-HUC-1 
(doubling  tim e 40 h o u rs), tum origen ic  T24 (doubling  tim e 19 
hours).
D rug: H epan itro sy l-tri-p3 -th ioxo te tra fe rra te  (mw:553) also know n 
as "R oussin 's black salt" (RBS) (Roussin, F. Z. 1858) w as synthesized 
a n d  su p p lied  by Dr. A. R. B u tle r  (D epartm en t of C hem istry , 
U niversity of St. Andrews) in pow der form. RBS w as diluted serially
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in  PBS. D rugs so lu tions were sterilized by filtration  th ro u g h  a  0 .22 
|im  pore d iam eter filter [Millipore].
All th ese  a ssa y  w ere perform ed in  a  d a rkened  room  an d  a  lam p 
(40W) filtered w ith  ILFORD 904  safe light g lass w as u sed  a s  a n  
illum ination  source.
A desired  n u m b er of viable cells (1x10^ ce lls /flask  for T24 cells and  
1 .5 x 1 0 5  c e lls /f la sk  for SV-HUC-1 cells) were seeded  in  25 cm% 
flasks and  in cu b a ted  u n d e r s ta n d a rd  condition for 48 ho u rs . Cells 
w ere allow ed to a t ta c h  a n d  ach ieve ex p o n en tia l grow th . The 
su p e rn a n t m edium  w as rem oved an d  flasks rin sed  twice w ith PBS 
th e n  4 .5  m is of se rum  free m edium  added. The whole flask  (except 
cap) w as covered w ith  tin  foil to exclude light. 0 ,5  m l of lOx 
co n cen tra ted  d ru g  so lu tion  w as added (0.5 ml of PBS for control 
group) to begin  th e  assay . After a  60 -m inu te  in cu b a tio n  a t 37°C , 
m edium  contain ing  d rug  and  the  tin  foil were removed. F lasks were 
rin sed  twice w ith  PBS a n d  5 m is of fresh  se ru m  su p p lem en ted  
cu ltu re  m edium  added. Incubation  w as con tinued  for a  period of a t 
le a s t 2 cell doubling  tim es (2 days for T24 cells, 4 days for SV- 
HUC-1 cells). D uring  th is  period th e  cells in  contro l group (PBS- 
treated) were in  exponentia l grow th.
2 -16  3 A ssessm ent o f the viable cells
M edium  w as rem oved an d  flasks rin sed  w ith  try p sin  once th e n  1 
m l of fresh  try p sin  w as added . Cells were dislodged after a  sh o rt 
in cu b a tio n  period, d isaggregated by gently p ipetting  an d  d ilu ted  in 
se ru m  supp lem en ted  m edium . The to ta l volum e of cell su sp en s io n  
p re sen t w as im portan t to allow the  calcu lation  of the  to ta l nu m b er 
of viable cells. 50 pi of 2%(w/v) fas t green [Sigma] in  0 .1 5M NaCl 
w ere added to each  ml of cell su sp en sio n  and  in cuba ted  a t 370C for 
10 m in u tes . Viable cells ,w hich  did no t s ta in  green, w ere coun ted
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w ith  a  hem ocytom eter. R esu lt were expressed a s  the  percentage of 
cell proliferation, defined by the ratio  of viable cells of d rug  trea ted  
cells to non  d rug  trea ted  cells.
2-17  Growth inhibitory effects o f laser-irradiated RBS on  
exponentially growing cells
2-17-1 Aim and principle
Aim : D em onstration  the  photosensitiv ity  of RBS.
P rinc ip le : As [2-16-1].
2-17-2 Materials and m ethods
L aser irrad ia tio n s  w ere conducted  in  th e  labo ra to ry  of Dr. F.W. 
Flitney's w hich w as darkened  and  used  a red safelight (60W) as the 
sole m eans of illum ination  An Argon ion laser (Spectra Physics Ltd., 
type 168-09) w as the source  of irrad ia ted  light an d  4 5 7 .9nm  wave 
length  light used .
The m ethod u sed  here w as the  sam e as [2-16-2] b u t PBS instead  of 
se rum  free m edium  w as used  as cu ltu re  fluid for the  period of d rug  
exposure and  a selected in tensity  of laser light w as used  to irrad iate  
th e  cells . T he c o n tro l g ro u p  received  only  PBS. F or som e 
experim ents RBS w as dilu ted in  a  10%(w/v) bovine se rum  album in 
[Sigma] in  PBS so lu tion  w hich w as sterilized by filtration th rough  a 
0 .22  pm pore d iam eter filter [Millipore]. C ellu larity  of viable cells 
w as determ ined as [2-16-3].
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2-18  H em oglobin su pp ression  o f th e growth inhib itory  
effects of RBS
2-18-1 M aterials and m ethods
F erro -haem oglob in  w as p rep a red  by d issolving 1 mM of bovine 
hem oglobin  (Sigma) in  PBS. A ten  fold m olar excess of sod ium  
dith ionite (Na2 S 2 0 4 ) w as added and  dialysed against 100 volum es of 
PBS for 12 h o u rs  a t 4°C w ith 3 changes of dialysis fluid to remove 
the  Na2 S 2 0 4 . Ferro-haem oglobin so lu tion  w as sterilized by filtration 
th ro u g h  a 0 .2 2  pm  p o re  d ia m e te r  f ilte r  [M illipore]. T he 
c o n c e n t r a t io n  o f h e m o g lo b in  w a s  d e te r m in e d  b y  a 
hem oglobinm eter (HemoCue, Sweden) and  sto red  in  a liquo ts a t - 
20°C  ( M artin, W. et al 1986). The m ethod w as as [2-16-3] and  [2- 
17-2] w ith  th e  ad d itio n  of ferro -haem oglob in  so lu tio n  an d  the  
cellularity  of viable cells w as determ ined as [2-16-3].
2-19 Colony formation survival curve of OHO and xrs cells
2-19-1 Aim and principle
Aim: D em onstration of the  possibility th a t  RBS causes DNA dam age. 
P rin c ip le : U sing the  different survival of two cell lines w hich differ 
in DNA repair to indicate  DNA dam age.
2-19-2 Materials and m ethods
Cells (2 x 1 0 5  of CHO, 4 x 1  Q5 of xrs) were grown in 25 cm^ flasks and  
kep t in  a  s ta n d a rd  cu ltu re  condition for 48 h o u rs  allowed to a tta c h  
and  grown in exponential phase . M edium  w as rem oved and  flasks 
were rinsed  twice w ith PBS. Different concen tra tions of RBS in PBS 
were added (as a  control PBS only w as added) and  flasks k ep t a t
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3 7 °C  for 1 h o u r. F la sk s w ere rin se d  twice w ith  PBS an d  cells 
d e ta c h e d  w ith  TE. C ell n u m b e rs  w ere  o b ta in e d  u s in g  a  
hem ocytom eter. An app rop ria te  n u m b er of cells (200-10000) were 
p la ted  in  90m m  tis su e  c u ltu re  grade pe tri d ish es w ith  10 m l of 
10%(v/v) FCS E agle's m inim al essen tia l m edium  an d  k ep t in a  5% 
C O 2  in  air, 37oC fully hum id ified  in cu b a to r. A fter 14 days the  
m edium  w as poured  o u t and  the  d ishes were rin sed  w ith  PBS. Cells 
w ere fixed w ith  m ethano l for 10 m in u tes  and  s ta in  w ith  10% (v/v) 
G iem sa [BDH] in  w ater.for 10 m in u tes  and  air-dried.
S coring :
F o r e ac h  su rv iv a l cu rve , tr ip lic a te  d ish e s  w ere seed ed  p e r  
trea tm en t. Colonies con ta in ing  m ore th a n  50 cells w ere scored as 
considered  to o rig ina te  from  viable cells B etw een 20  an d  450 
co lon ies w ere co u n ted  for e ac h  tre a tm e n t. T he p e rcen tag e  of 
survival w as calculated  by  reference to controls.
2-20 Micronuclei assay o f CHO and xrs cells after exposure 
to RBS
2-20-1 Aim and principle
Aim: D em onstration  of the  possibility th a t  RBS causes DNA dam age. 
P rin c ip le : U sing th e  difference in  m icronucleus form ation  betw een 
two cell lines w hich differ in DNA repa ir to indicate  DNA dam age.
2-20-2  M aterials and m ethods
Cells (4x10^ of CHO and  6x104 of xrs) were grown in a  24  well flat 
bottom  tissu e  cu ltu re  p late  [Nunc, Denm ark] and  k ep t in  a  5% CO2  
in  air, 37°C, hum idified  in cu b a to r for 48 h o u rs , allowed to a tta c h  
and  grow exponentially. The p late  w as rinsed  twice w ith  PBS before
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1 ml of 10 pM of RBS in PBS w as added to each well (control cells 
received PBS only) and  p la te  k ep t a t room  te m p e ra tu re  for 40 
m inu tes. RBS w as rem oved and  the  p late  rin sed  twice w ith  PBS. 1 
m l of 10% FCS E agle's m inim al essen tia l m edium  were added  to 
each  well th e n  cy tochalasin  B (Cyto B; stock  so lu tion  3 m g /m l in 
DMSO) [Sigma] w as added to give a  final concen tra tion  of 3 pg /m l. 
The p late  w as kep t in  a  5% CO2  in  air, 37°C, hum idified  in cu b a to r 
for 16-24 ho u rs . Cells were de tached  w ith  TE and  d ispersed  onto 
clean slides by centrifugation using  a  S handon  C ytospin 2 (800 rpm  
for 10 min). Slides were fixed in m ethanol for 10 m inu tes, sta ined  
in 56% (v/v) J e n n e r  [BDH] in  w ater for 5 m in u tes  and  25% (v/v) 
G iem sa in  w a ter for 10 m in u tes , w ith  rising  in  w ater after each  
stain.
S co ring :
B inuclear cells con ta in ing  m icronuclei clearly sep a ra ted  from  and  
sm aller th a n  one-ten th  of the  m ain  nuc leus, were scored (Arlett, C.
F. e t al 1989). A to ta l of 100 b in u c lea te  cells w ere scored  p e r  
sam p le  p e r  ex perim en t. R e su lts  w ere ex p re ssed  as  th e  to ta l 
n u m b er of m icronuclei per  100 b inuclea r cells.
2-21 Turnbull blue reaction of RBS-treated cells
2-21-1 Aim and principle
Aim : D em onstration  th a t RBS is bound  to target cells.
P rincip le : Ferrous sa lts  becom e blue w hilst undergoing the  T urnbu ll 
reaction  (Culling, C. F. A. 1957).
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2-21-2  M aterials and M ethods
One drop of a  single cell su sp en sio n  w as p ipetted  onto one end of a 
sterile g lass slide. P repara tions were kep t in  a hum id  cham ber and  
in cu b a te d  in  a  37^0 , 5% COg, hum id ified  in c u b a to r  overnight. 
S lides were rinsed  3 tim es w ith  PBS. RBS w as th en  added to cells 
w hich  were th e n  k ep t in  a  hum id  cham ber for 10 m inu tes. After 
r in s in g  3 tim es w ith  PBS to rem ove u n b o u n d  RBS, slides were 
dipped in to  5% (w/v) am m onium  su lph ide  (Sigma) for 1.5 h o u rs  
th e n  rinsed  w ith  distiled w ater. E qual p a rts  of freshly  prepared  2% 
(w/v) p o tass iu m  ferricyanide and  2% (v/v) hydrocholric  acid were 
m ixed toge ther before slides were im m ersed  in  th e  so lu tion  and  
k e p t th e re  for 30  m in u te s . S lides w ere w ash ed  th o ro u g h ly  in 
distiled w ater and  allowed to a ir dry.
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Chapter III 
Tumorigenic transform ation  of human urothelial cells and characterization of their properties
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Fig 3-1-1 Photomicrographs of cellular foci.
Fig 3-1-2 Photomicrographs of vital stained cells within foci.
Fig 3-1-3 Photomicrographs of confluent living cell cultures.
Fig 3-1-4  Photomicrograph of primary culture of tumor tissue.
Fig 3-1-5 Photomicrographs of H&E stained sections of tumors.
Fig 3-2-1 Photomicrographs of model karyotype of cells.
Fig 3-2-2 Photomicrographs of SV40 T antigen stained tumor tissue.
Fig 3-2-3 Photograph of DNA fingerprinting of three types of cells 
Fig 3-3-1 Schematic diagram of HPP-CFC assay.
Fig 3-3-2 Schematic diagram of thymocyte proliferation assay.
Fig 3-3-3 DNA histogram of flow cytometry assay.
Fig 3-3-4 Growth curve of SV-HUC-IT cells
Fig 3-3-5 Growth - stimulating activity of sff conditioned medium.
Fig 3-3-6 HPP-CFC assay of stem  cell factor-like activity.
Fig 3-3-7 Concentration of h SCF of conditioned medium.
Fig 3-3-8  ILl-llke activity of conditioned medium.
Table 3-1-1 T um origenicity of SV-HUC-IN cells
Table 3-1-2 Tum origenicity of SV-HUC-1 cells
Table 3-1-3 Tum origenicity  of SV-HUC-IT cells
Table 3-2-1 D istribution  of chrom osom e num bers of HUC cells
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S u m m a ry
T um origenesis of h u m a n  u ro th e lia l cells is a  m u ltis tep  p rocess. 
In itia lly  n o rm a l h u m a n  u ro th e lia l cells a re  im m orta lized  by 
tran sfec tion  w ith SV40. S ubsequen tly  they  becom e tum origenic by 
e ither exposure  to chem ical carcinogens or by tran sfec tion  w ith a  
second oncongene (Bookland, E. A. et al 1992; Kao, C. et al 1992). 
The objective of th is  s tu d y  w as to d e m o n s tra te  th a t  SV40- 
im m o rta lized  h u m a n  u ro th e lia l  cells c an  be tu m o rig en ica lly  
transfo rm ed  by som e o ther m eans: cells grown in  a se ru m  free, 
factor free, chem ically  defined c u ltu re  for a period of tim e. The 
tum origenicity  of cells w as determ ined by the  generation  of a  tum or 
a fte r inocu la tion  in to  n u d e  mice. The origin of tran sfo rm ed  cells 
w as confirm ed by com paring  the  DNA fingerprin t profile of bo th  
tra n s fo rm a n t an d  p a re n ta l  cells. F u rth e rm o re  a  novel b a n d  of 
hy p erv a riab le  DNA frag m en t found  in  tra n s fo rm a n t cells m ay 
ind icate  m u ta tion . The levels of concen tra tion  of h u m a n  stem  cell 
factor and  h u m an  ILl a  -like activities were lower in  the  m edium  
conditioned by transform ed cells th a n  by pa ren ta l cells. This model 
of tran sfo rm ation  m ay correlate  w ith  the  heterogeneity  of behavior 
or phenotype of cells w ith in  a  tum or. It is possib le  th a t  tu m o rs 
deprived  of no rm al levels of grow th  fac to rs an d  n u tr ie n ts  (eg. 
a ro u n d  th e  a re a  of c e n tra l  n ecro sis) m ay  u n d e rg o  fu r th e r  
tra n s fo rm a tio n  th u s  lead in g  to  th e  h e te ro g en e ity  in  c lin ica l 
conditions associated  w ith tu m o r cells.
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Outline
In th is  ch ap ter, tum origen ic  tran sfo rm a tio n  of h u m a n  u ro thelia l 
cells is d iscussed  in  3 sections.
In the  first section , tu m o rig en ic  tra n s fo rm a tio n  of the  ce lls , a 
m ethod  of tran s fo rm a tio n  is described  an d  th e  developm ent of 
tum origenicity  am ong transfo rm ed  cells is illu stra ted .
In th e  second  section , id en tific a tio n  of tra n s fo rm e d  c e lls , th e  
origin of transfo rm ed  cells from p a ren ta l cells is dem onstra ted  and  
evidence for th e  possibility  of the  m u ta tio n  of transfo rm ed  cells is 
p resen ted  .
T hird ly  changes ap p earin g  in  tran sfo rm ed  cells a re  reviewed in  
m olecular changes associated  w ith transform ed cells.
Transform ation 79
3-1 Tum origenic transform ation of the cells
3-1-1 Introduction
Properties of transfo rm ed  cells.
Norm al fibroblasts or epithelial cells in  prim ary  cu ltu re  can  survive 
in  c u ltu re  cond itions for only a  lim ited period. In th e  course  of 
cu ltivation  th e  p roperties  of cells m ay change, th ey  m ay undergo  
a lte ra tio n s and  becom e transfo rm ed  cells w ith  un lim ited  life span . 
The a lte ra tio n s m ay arise  spo n tan eo u sly  or after th e  trea tm e n t of 
c u ltu re s  w ith  various agen ts. T ransform ed cells differ from  norm al 
cells  in  severa l w ays, th e  m ain  m a n ife s ta tio n s  in c lu d in g : (1 ) 
D ev e lo p m en t of oncogen ic ity ; cells  w ill form  tu m o rs  w h en  
im p lan ted  in to  syngeneic or im m une-deprived  m ice. (2) Loss of 
anchorage  dependence of growth; cells m ay grow in  su sp en s io n  or 
in sem isolid m edia su c h  as agar. (3) Loss of con tact inhibition; cells 
m ay pile up  in to  colonies or foci. (4) D ecreased se ru m  dependence; 
cells m ay proliferate in  m edium  w ith  low concen tra tion  of se ru m  in  
w hich  no rm al cells m ay  be u n ab le  to grow. (Vasiliev, J .  M. et al 
1981).
Som e DNA-containing v iruses su c h  as sim ian  v irus 40  (SV40) and  
polyom a v irus have show n the  capability  to tran sfo rm  fibroblastic 
an d  epithelial cu ltu res . S usceptib le  cells are  infected w ith  SV40 in 
two d ifferent w ays: "permissive" or "non-perm issive". In the  course  
of perm issive  infection , in fec tious v irions a re  form ed in side  the  
cells. Releasing of m atu re  v irus particles causes lysis an d  cell death . 
N on-perm issive infection is assoc ia ted  w ith abortive infection an d  
cell survival. A very sm all po rtion  of abortively infected cells m ay
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ca rry  th e  v iral genom e in  a n  in teg ra ted  s ta te  a n d  p re se n t -with 
p ro p e rtie s  of tran sfo rm e d  cells. T he com m on fea tu re  of SV40- 
tra n s fo rm e d  cells is th e  p re sen c e  of two p ro te in s  w h ich  are  
tran s la te d  from the  early region of viral genome nam ely  large T and  
sm all T an tigens . A lthough th e  m ech an ism  of tran sfo rm a tio n  by 
SV40 is c u rre n tly  u n k n o w n , th e  possib ility  of large T a n tig en  
p laying  a n  im p o rtan t role h a s  b een  inferred  by th e  evidence th a t  
large T an tigen  is localized in  th e  n u c le u s  of tran sfo rm ed  cells. 
Large T  an tig en  a lone is capab le  of converting  n o rm al rec ip ien t 
cells in to  tran sfo rm ed  cells (Kriegler, M. et al 1984) an d  it b in d s 
w ith tum or su p p re sso r gene p ro d u cts  (RB and  p53) (DeCaprio, J .  A. 
e t al 1988; McCormick, F. e t al 1981).
A lthough several es tab lished  an im al cell cu ltu re  system s have been  
u se d  to  s tu d y  th e  tu m o rig en esis  of ep ithe lia l cells, b e ca u se  of 
species differences and  organ specificity, one of th e  b e s t w ays to 
u n d e rs ta n d  tum origenesis in  th e  h u m a n  b lad d er is to u se  h u m an  
u ro the lia l cells to perform  in vitro s tud ies . The SV-HUC-1 cell line 
is a  norm al h u m an  uro thelia l cell line w hich h a s  been  im m ortalized 
by  SV40, and  d em o n s tra te s  som e fea tu res  of a  tran sfo rm ed  cell 
except th a t  it is un ab le  to form tum ors in athym ic mice (C hristian,
B, J .  e t al 1987). T h is cell line h a s  b een  u se d  for s tu d ie s  of 
oncogenic agen ts by  assay ing  th e ir ability to induce tum origenicity  
in  the  SV-HUC-1 cells (Bookland, E. A. e t al 1992).
Cells grow n in  c u ltu re  need  a n  env ironm en t w h ich  fulfills th e  
re q u ire m e n ts  for su rv iv a l a n d  p ro life ra tio n . To ach ieve  th is  
p u rp o se , se ru m  is th e  m o st w idely u se d  su p p le m e n t to a n  
incom plete cu ltu re  m edium . It su p p lies  m ain ly  ho rm onal factors, 
a tta c h m e n t an d  sp read ing  fac to rs an d  tra n sp o rt p ro te in s (M aurer,
H. R. 1986). The com position of se ra  are complex, n o t all of them
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have been  identified and  a  relatively large varia tion  in  com ponents 
ex is ts  be tw een  b a tc h e s  an d  betw een  d ifferent spec ies of origin. 
T h u s cells grown in  a  serum -free  cu ltu re  condition m ay provide a 
system  w hich  avoids u n c e rta in tie s  im posed by b a tc h  varia tions of 
undefined  se ru m  com ponen ts (W aym outh, C. 1984). In addition , 
su c h  a  serum -free cu ltu re  system  h a s  advantages for s tu d ies  of the  
in te rac tion  of horm ones or d rugs w ith  cells and  s tu d ies  of n u tritio n  
a n d  secre tion  a t  th e  cellu la r an d  m olecular level (B arnes, D. e t al 
1980). M am m alian  cells grow n in  sy n th e tic  m ed iu m  req u ired  
com binations of factors w hich can  carry  ou t the  functions of serum . 
O ccasionally , in  th e  ab sen ce  of th ese  su p p le m e n ts , a  se lec ted  
au to s tim u la ted  cell m ay grow (Hill, M. et al 1989). In som e cases of 
se ru m  deprivation  s im u lta n eo u s  tum origen ic  tran sfo rm a tio n  m ay 
occur in  p rim ary  cell cu ltu res  (Andresen, W. F. 1967) an d  im m ortal 
cell lines (Hill, M. e t al 1991). B ecause  SV40 im m orta liza tion  of 
h u m a n  ep ithelium  does no t give rise  to a  tum origenic cell (Hill, M. 
e t al 1991), we w an ted  to know  w h e th er the  SV-HUC-1 cell line 
will grow in a  se ru m  free conditions an d  fu rtherm ore  will the  cells 
undergo  tum origenic transfo rm ation?
3-1-2  Procedures
3-1-2-1 Isolation of au to troph ic  v a rian ts  of SV-HUC-1 cells 
SV-HUC-1 cells w ere grown an d  p assaged  a s  described  in  [2-1-1]. 
D ifferent cell d e n s itie s  (from l .S x lO ^ /c m ^  to 3 x l0 4 /c m ^ )  were 
seed ed  in to  a  se ru m  free, fac to r free (sff) chem ically  defined  
m edium  for a  variable  period of tim e and  au to troph ic  cell v a rian ts
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w hich were designated  as SV-HUC-IN were iso lated  a s  described  
in  [2-3-1].
3-1-2-2  Phenotype changes of SV-HUC-IN cells 
M orphological ch an g es of SV-HUC-IN  cells w ere observed  and  
p h o to g ra p h e d  u s in g  a n  in v e rted  m icro scope  eq u ip p e d  w ith  
p h o to g rap h  facilities [D iavert inverted  m icroscope [Leitz W etzlar 
Germany] equipped w ith  Wild photo autom at), u sing  Agfa 25 film.
3-1-2-3 Vital s ta in  of cellular foci
1 .5x105  of SV-HUC-ITS cells were grown in a  25 cm^ flask  w ith 
7% FCS F12 m edium  un til foci form ed and  sta ined  w ith  5|Lig 5 C- 
FD A /m l PBS as described  in  [2-11]. Cells were observed u sing  a 
la se r scan n in g  confocal im aging system  w hich  w ere operated  in 
c o n ju n c tio n  w ith  a N ikon  d ia p h o t  in v e r te d  f lu o re sc e n c e  
m icroscope [BioRad, MRC 600 USA], 488nm  light as a  illum inating  
source.
3-1-2-4 Tum origenicity a ssay  of SV-HUC-IN cells 
T um origenicity  of cells w as determ ined  by assay ing  the  frequency 
of tu m o rs  a ris in g  in  a thym ic  n u d e  m ice a fte r s u b c u ta n e o u s  
in o cu la tio n  of 4 -10  x lO ^ SV -H U C-IN  cells a n d  tu m o rs  w ere 
m onito red  for a  period  of tim e as  described  in  [2-4]. SV-HUC-1 
cells cu ltu red  in 7% or 1% FCS F12 were used  in  the  sam e protocol 
as  a  con tro l s tu d ie s  All the  n u d e  m ice a t  the  tim e of s ta r tin g  
experim ents were 6 - 8  w eeks old. As a positive control, cells of the  
T24 line, a h u m an  b lad d er carcinom a cell line, w hich give rise  to 
tu m o rs  w ith in  4 w eeks were periodically inocu lated  in to  th e  nude  
mice a t a cell dose of 5x105 ceils.
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3 “ 1-2-5 T um or tissu e  expiant cu ltu re  and  developm ent of SV-HUC- 
IT  cells
T um ors form ed in  n u d e  m ice Avere d issec ted . Sm all p a rts  of the  
tu m o rs  were exam ined h istopathologically  an d  the  re s t  of tum ors 
w ere used  in tissu e  exp lan t cu ltu re  as described  in  [2-4-3]. Cells 
grown ou t from one specific tu m o r were designated a s  SV-HUC-IT.
3-1-2-6  Cloning SV-HUC-ITS cells
2 1  days a fte r 8 . 8 x 1 0 5  of SV -H U C-IT c e l l s / c m ^  w ere seeded in 
sem isolid  m ethylcellu lose, m any  colonies form ed an d  a  clone of 
cells from  one su c h  colony w as d esigna ted  a s  SV -HUC-ITS as 
described  in [2-5] .
3-1-2-7  Tum origenicity  of SV-HUC-IT and  SV-HUC-ITS cells 
The tum origen icity  w as de term ined  as described  in  [2-4] and  cell 
doses of 10-15 m illion cells for each inoculation  were used .
3-1-3 R esult
3-1-3-1 Isolation of au to troph ic  cell varian ts
W hen SV-HUC-1 cells were tran sfe rred  to sff conditions, they  took 
m ore th a n  24 h o u rs  to adhere  to the  polystrene p lastic  surface of 
cu ltu re  flasks, th en  cells e ither rem ained  qu iescen t or died. After a 
lag period a few cells s ta r te d  to form  colonies a n d  con tinued  to 
p ro life ra te . T hese  cell v a r ia n ts  (SV-HUC-IN) w ere  su c ce ss fu lly  
su b cu ltu red  and  expanded in sff conditions fu rtherm ore  they  could 
be c ryopreserved  and  rederived  in  th e  a b sen ce  of se ru m . No 
evidence of cell survival and  pro liferation  w as observed in flasks 
w hich  were in itially  seeded  w ith  less th a n  2 x l0 4 /c m ^  (data no t 
show n).
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3-1-3-2 C hanges of phenotype
SV-HUC-IN cells piled up  to form cellu lar foci. T hese foci were 
observed du ring  exponential growth and  post confluence (Fig. 3-1- 
1) and  th is  phenom enon was no t observed in SV-HUC-1 cells. Cells 
a ro u n d  foci appeared  to have a n o n -random  a rran g em en t. They 
grew  in a rad ia ted  sty le  w ith foci a t cen te r (not show n). Vital 
s ta in in g  of th e s e  foci a n d  o b se rv a t io n  w ith  c o n fo c a l 
scan n in g m icro sco p e  revealed th a t  these  foci w ere com posed of 
living cells (Fig. 3-1-2).
U nder the  sam e grow th conditions, post confluent c u ltu res  of SV- 
H U C -IT  cells becam e sp in d le  sh a p ed  and  grew  d ense ly  w ith  
n u m ero u s  m itoses. W hile SV-HUC-1 eells still kep t th e ir  cobble 
stone appearance  w ith fewer cells in m itosis (Fig. 3-1-3).
Fig. 3-1-1 Cellular foci formed by SV-HUC-IN cells grown in sff condition. Phase 
contrast micrograph showing piling up of cells and formation of cellular foci. (A) At 
low power many foci are seen in the culture flask, each white spot represents one 
focus of cells. Bar=35pm. (B) The single focus of cells, one cell in m itosis can be seen  
at the top of cells. Bar=7pm.
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Fig. 3-1-2 Vital staining of cells within foci. SV-HUC-IT cells grown in 7% FCS F12 
were stained with 5-carboxyfluoresein diacetate and absented under a confocal 
laser scanning microscope illuminated with 488nm  light. (A) Lower power field 
showing many cellular foci. (B) Single focus of piling up cells. Cells were artificially 
orange colored and bright golden staining rellected fluorescent in viable cells. Bars. 100pm for (A) and 50pm for(B).
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Fig. 3 -1 -3  Phase contrast photom icrographs of living cell cu ltu res. (A) 
Postconiluent (30 days in culture without passage) culture of SV-HUC-1 cell, cobble 
stone appearance of cells with few mitoses. (B) Postconiluent culture of SV-HUC-IT 
cells showing more densely packed cells with num erous m itoses.Bar=7pm for (A) 
and (B).
3-1-3-3  Tuniogenicitv of SV-HUC-IN cells
S u b c u ta n e o u s  in o cu la tio n  of cells som etim es re su lte d  in the  
form ation of a sm all soft cyst-like lesion w hich d isappeared  w ithin 
ten  days. In th is  experim en t, a tu m o r w as defined a s  a h a rd  
palpab le  m ass w hich arose and  persisted  after the  in itial swelling 
w as gone. At different stages in the course of expansion , SV-HUC- 
IN cells were inocu lated  in to  nude mice (table 3-1-1 colum n 2). 
T here were seven experim en tal g roups w ith a to ta l of 17 nude 
mice. Four mice developed tum ors (table 3-1-1 colum n 31. Tum ors 
grew in nude  mice from 13.6 to 32 w eeks before being d issected  
(table 3-1-1 colum n 4). Alm ost all tu m ors reached  the  size of 3-5
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m m  in d iam eter except one in  group 3 w hich progressed  to 12 m m  
in  d iam eter (data  n o t shown). The cell doses for each  inocu lation  
were 4-10 m illion cells (table 3-1-1 colum n 5),
Group Weeks in sff medium
llimorfrequency Weeks * of tumor growth
Ceildose(million)
1 24.9 0/2 7.22 24.9 1/3 32 73 35.9 1/2 19.6 54 34 0/3 45 40.5 1/3 13.6 56 45 0/2 107 44.5 1/2 20 10
* duration between cell inoculation and tumor dissection In weeks.
Table 3-1-1 Tum origenicity assay  of SV-HUC-IN cells
In control stud ies , con tinuously  passaged  SV-HUC-1 cells (table 3-
1 - 2  colum n 2 ) and a  population  of cells adap ted  to and  continuously  
c u ltu red  in 1% FCS F I 2, w ere u sed  (table 3-1-2  co lum n 4). No 
tu m o r developed in  e ither control experim ents (table 3-1-2 colum n 
3) w ith sim ilar cell doses (table 3-1-2 colum n 5).
Group Weeksinmedium
Tumorfrequency % FCS inMedia
Celldose(million)
1 27.7 (P56) 0/3 7 102 74.28 (P78) 0/2 7 103 122.3 (P96) 0/5 7 104 25.5 0/2 1 95 26.5 0/3 1 13
Table 3-1-2 Tum origenicity assay  of SV-HUC-1 cells
3-1-3-4  T um or tissu e  explant cu ltu re
The tu m o r from  a  m ouse in  group 3 w as u sed  to derive exp lan t 
cu ltu res  in 7% FCS F I 2 m edium . A lthough a t the  beginning a  m ix 
epithelial and  fibroblastic cu ltu re  w as observed (Fig. 3-1-4), after a
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few p a ssa g e s  fib ro b las ts  g radua lly  d isap p ea red . The rem ain ing  
epithelial outgrow th of tum or tissu e  were sueeessfu lly  grown and 
su beu ltu red  and were designated as "SV-HUC-IT".
Fig. 3-1-4 Primary culture of tumor tissue. 45 days after initial explantation, tumor 
cell(t) migrated out from tumor tissue(T) and was surrounded by m ouse firoblasKO. Tumor tissue was grown in 7% FCS F I2 medium. Bar=14pm.
3-1-3-5 H istopathological fea tu res of tum ors
Form alin fixed and  wax em beded tum or seetions were sta ined  with 
H&E. The p ictu re  show n in Fig. 3-1-5 w as a typical appearance  of 
tu m o rs , ep ithelial-like cells were a rranged  in a pap illary  p a tte rn  
w ith fibrotic cen tra l cord. No large varia tions of nuclei size were 
observed. The type of cells and  the  grade of cell d ifferentiation are 
sim ilar in tum ors w hich were e ither indueed by SV-HUC-IN, SV- 
HUC-IT or SV-HUC-ITS cells.
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Fig. 3-1-5 Light photomicrograph of H&E stained sections of tumors. (A) Tumor was 
produced after inoculation of SV-HUC-IN cell, epithelial-like cells are arranged in a 
papillaiy pattern with fibrotic central cordUl. Note similar size of round and oval 
nuclei. A fibrous capsule(c) and muscle(m) surrounds the tumor. (B) A similar 
histological appearance is present in this tumor which was induced by SV-HUC-T 
cell. Bar=2.75pm for (A), (B)
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3-1-3-6  Clone of tu m o r cells
Four clones of SV-HUC-IT cells were obtained from colonies w hich 
form ed in m ethylcellulose. Only one clone from th ese  colonies w as 
expanded  in  7% FCS F I 2  m ed ium  an d  designated  a s  "SV-HUC- 
ITS".
3-1-3-7  T um origenicity  of tu m o r cells
U sing  th e  sam e protocol, th e  tum origen ic ity  of cloned an d  n o n ­
cloned tu m o r cells w as de te rm ined . The re su lts  w ere show n in 
tab le  3-1-3 . N on-cloned tu m o r cells were inocu la ted  in to  8  m ice 
and  all of them  developed tum ors while cloned tu m o r cells injected 
in to  7 m ice only 3 developed tum ors . All tu m o rs w ere w ith in  3-5 
m m  diam eter size range.
Group Cell l\imor Weeks * Celltype frequency of tumor dosegrowth (million)
1 HUC-IT 4/4 9.6, 12.4. 15.1, 18.1 152 HUC-IT 3/3 12.3, 16.1, 23 12.53 HUC-IT 1/1 28 154 HUC-ITS 0/2 105 HUC-ITS 0/2 106 HUC-ITS 3/3 5.5. 11.4 11.4 10
* duration between cell inoculation and tumor dissection in weeks.
Table 3-1-3 Tum origenicity a ssay  of tum or explan ta tion  cells
3-1-4 D iscussion
SV 40-transform ed h u m an  cells are rarely  tum origenic in nude  mice 
desp ite  the  fact th a t  these  cells often exhibit p roperties com m only 
a sc r ib e d  to  a n e o p la s t ic  p h e n o ty p e , in c lu d in g  a n c h o ra g e  
in d e p e n d e n t grow th  {Chang, S. E. 1986). E x p ress io n  of SV40- 
a sso c ia ted  fu n c tio n  (im m ortalization) m ay re p re se n t th e  in itia l
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stage of m u ltistep  tum origenesis of SV-HUC-1 cell (Bookland, E. A. 
e t al 1992). C o n sis ten t w ith  th is  m odel th e  SV-HUC-1 cells were 
tran sfo rm ed  by depriv ing  them  of exogenous grow th fac to rs and  
s e ru m  c o m p o n e n ts  in  th e  c u ltu re  e n v iro n m e n t (sff). A few 
p heno typ ic  ch an g es w ere observed , inc lud ing  cells p iling  u p  to 
form  foci in  th e  cu ltu re  flask, h igher cell sa tu ra tio n  d ensity  a n d  
m ost prom inently  the ability to induce tum ors in  nude  mice.
If th e  above m entioned  tran sfo rm atio n  is a  tra n s ie n t phenom enon  
th e n  tu m o r cells in  se ru m  su p p lem en t m edium  m ay  reverse th is  
transfo rm ation . We have proved th a t  th is  is n o t the  case  by growing 
sff derived tum origenic cells in  se ru m  supp lem ented  m edium , they  
re ta in e d  all th ree  p ro p erties . Specifically focus fo rm ation  is n o t 
seen  a s  frequen tly  a s  in  sff s itu a tio n , th ese  cells still have high  
sa tu ra tio n  density  and  th e ir tum origenicity  persisted .
C ells in  c u ltu re  m ay  ex h ib it u n s ta b le  DNA a n d  sp o n ta n e o u s  
tu m o rig en ic  tra n s fo rm a tio n  of a  h u m a n  u ro th e liu m  h a s  b een  
rep o rte d  (C h ris ten sen , B. e t al 1993). How ever no tu m o r w as 
observed w hen long te rm  (up to two years) co n tinuou sly  cu ltu red  
p a re n ta l cells w ere in o cu la ted  periodically  in to  n u d e  mice w hich  
m ay ind icate  th a t  th is  tum origenic tran sfo rm ation  is  n o t occurring  
spontaneously.
W hen p a ren ta l cells w ere cu ltu red  in  lower se ru m  condition (from 
7 % to  1 %) fo r lo n g  te rm  ( 6  m o n th s ) , no  tu m o rig e n ic  
tran sfo rm a tio n  w as observed am ong th ese  cello [table 3-1-2]. For 
th is  reaso n  M. Hill (1991) ru led  o u t th e  possib ility  of selection of 
p re -ex is ten t tum origen ic  cells. However a s  R. A. W einberg (1989) 
p roposed  th e  env ironm en t m ay have an  inh ib ito ry  effect on the  
o n co g en e -b ea rin g  cell, a  c lona l se lec tio n  m odel m ay  s till be 
p o stu la ted  in  th is  experim ent. If tum origenic cells a re  grown along
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w ith  non-tum origen ic  cells b u t  form only a sm all p roportion  of the 
w hole cell p o p u la tio n , th e  tu m o rig en ic  cells will n o t becom e 
d o m in an t b ecau se  non  - tum origenic  cells m ay exert an  inh ib ito ry  
influence on the  grow th of th e  tum origenic cells. W hen grown in 
p ro te in  d ep riv ed  m ed iu m  n o n - tu m o rig e n ic  ce lls  d ied  a n d  
in h ib ito ry  effects on tu m origen ic  cells a re  dem olished . H ence 
tum origenic cells becam e dom inan t in the  popu la tion  and  express 
th e ir  tum origenicity .
C lin ica l b la d d e r  c a n c e rs  a re  h e te ro g e n e o u s  in  th e ir  h is to ­
pathological sub type and  grow th behavior. In vitro, clonally derived 
SV-HUC cells dem o n stra ted  the  capability  to give rise  to different 
histological phenotypes during  tum origenesis (Bookland, E. A. e t al 
1992). In o u r experim en t, tum origen ic ity  is m arked ly  d ifferent 
betw een a clonal tu m o r cell (SV-HUC-ITS) and  its  original tum or 
cells (SV-HUC-IT). This m ay reflect th a t  diversity.
O th e r fac to rs m ay exp la in  w hy som e cells grow b e tte r  in  a  sff 
condition th a n  in  a  se ru m  supp lem ented  m edium . Cells exposed to 
a factor(s) in se rum  m ay com prom ise the  cell's ability  to b ind  and  
hen ce  re sp o n d  to a n o th e r  factor(s) (Cross, M. et al 1991) As 
transform ing  growth factor J3 (TGF J3) m ay play an  inh ib ito ry  role in 
th e  grow th of h u m a n  m egakaryocyte, while in  sff cond itions no 
su c h  inhibitor(s) existed an d  cells gained optim al grow th (Berthier,
R. et al 1993).
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3-2 Identification o f th e transformed cells
3 2  1 Introduction
In la s t  section  d a ta  w as p resen ted  w hich  d em o n stra ted  th a t  SV- 
HUC-1 cells becam e tum origen ic  a fte r growing in  sff condition . 
However there  are  two issu e s  w hich  in connection  w ith  th e  origin 
of tu m o r cells need  to be clarified before we can  be convinced th a t  
SV-HUC-1 cells w ere tum origenically  transfo rm ed . F irstly  we need 
to a sk  the  question  do the  tu m o rs  th a t  arise  in  m ice develop from 
th e  cells w hich  w ere in jected  or are  th ey  sp o n ta n eo u s  events? In 
o th er w ords we need  to prove th a t  cells derived from  m ice tum ors 
or tum or tis su e s  are of h u m an  epithelial cell origin.
M icrofilam ents, m ic ro tu b u les  an d  in te rm ed ia te  size filam ents are  
c o m p o n e n ts  of th e  cy to sk e le to n  p re s e n t  in  th e  cy to p lasm  of 
verteb ra te  cells. In term ediate  size filam ents con ta in ing  kera tin -like  
p ro te in s  (cy to k e ra tin s) are  c h a rac te r is tic  of ep ithe lia l cells. The 
cell type specificity of th e  p ro te ins is largely conserved during  cell 
tran sfo rm ation  an d  tu m o r developm ent (Moll, R. e t al 1982) can  be 
u sed  to d istin gu ish  betw een epithelial and  non-epithelial cells. 
SV-HUC-1 cells positively reac t w ith  an tibodies ag a in st bo th  SV40 
T a n tig e n  (C h ris ta in , B. J .  e t at 1987) a n d  p 5 3  (p e rso n a l 
com m unication  w ith  Dr. M. Armitage). T hus we can  also u se  th ese  
p roperties to determ ine the  origin of cells.
A nother issu e  we m u st ad d ress  is to  ru le  o u t the  possibility  of cross 
co n ta m in a tio n  w ith  a n o th e r  h u m a n  tum origen ic  cell line w hich  
could  also p roduce  tu m o rs  in  n u d e  mice. C ross-con tam ina tion  of 
cell lines by  o ther cells does n o t only h ap p en  frequently  ,b u t also
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occurs in  a  wide range of cell types. This m ay go undetec ted  u n less  
unexpected  experim ental d a ta  or obvious m orphological differences 
give reaso n  to su sp e c t th e  line. T here are for exam ple five separa te  
h u m a n  eosophageal sq u am o u s carcinom a cell lines w hich originate 
from  the  sam e source and  a  com m ercially available m yocardial line 
(G irardi cell from  Flow Laboratories) w hich are  ac tually  HeLa cells 
(van Helden, P. D. e t al 1988). Five h u m a n  b lad d e r cell lines are  
c ro ss-co n tam in a ted  by  T 24 cells (O'Toole, C. M. e t al 1983) an d  
HeLa cells a re  th o u g h t to have possib ly  invaded  m ore th a n  80 
in d iv id u a l lin es  (N elson-Rees, W. A. e t al 1981). The sou rce  of 
e rro rs can  n o t be found easily b u t the  possibilities of a n  aggressive 
cell line invading c u ltu res  an d  gradually  replacing th e  cells over a  
n u m b er of passages, or a n  aggressive line invading flasks in  w hich 
d o rm an t tu m o r cells a re  be ing  m ain ta in ed  a n d  th o se  cells being  
m istaken ly  grown as new  lines have been  proposed (van Helden, P.
D. e t al 1988). In th e  field of cell biology th e  p ro d u c tio n  of 
c o n s is te n t experim en tal d a ta  in  re sea rch  an d  th e  rep roducib ility  
requ ired  in  in d u s tria l scale p rocesses depend on th e  availability of 
re liab le  so u rc e s  of a u th e n tic a te d  c u ltu re s . T here  a re  severa l 
m ethods to  identify  th e  origin of cells i.e. chrom osom e band ing , 
HLA a n tig e n  ty p in g , g ro w th  c h a ra c te r is t ic s , tu m o rig en ic ity , 
exp ression  of viral an tigen  (Conner, B. R. e t al 1980), in d is tin c t 
h istogenesis , isoenzym e e lec trophoresis  (H arris, N, L. e t al 1981) 
an d  im m unofluorescence  (Nelson-Rees, W. A. e t a l 1981). Two of 
th e  m o st com m only u se d  a re  cytogenetic a n d  isozym e ana ly sis  
w h ich  c an  m o n ito r a  cell line  for ch rom osom e defec ts  a n d  
c o n ta m in a tio n  w ith  o th e r cell types. However cy togenetics is  a 
tim e-consum ing  m ethod  an d  needs expert in te rp re ta tio n . It m ay 
n o t identify  in tra -sp ec ies  c ross con tam ination  and  is n o t su itab le
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for cell lines show ing cytogenetic varia tion  over sh o rt term  passage  
(Miele, M. e t al 1989). W ith h u m a n  cell lin e s  seven  or m ore 
enzym es a re  requ ired  to provide th e  iden tification  of a n  allozyme 
pheno type w ith  a  h igh  degree of confidence (Hay, R. J .  1988) an d  
th e  probability  of chance  iden tity  increases w hen m any  cell lines of 
a  collection are typed for genetic u n iq u en ess  (O 'Brien, S. J .  e t al 
1980). M ultilocus DNA fingerprinting with probes 33 ,6  and  33 .15  is 
proving to have the  ability to bo th  specifically identify a  cell line and  
th e  ab ility  to recogn ise  co n ta m in a tio n  by  o th e r  cell lines (van 
Helden, P. D. e t al 1988; G ilbert, D. A. et al 1990). M utation  of cell 
lines m ay also go unde tec ted  for its  effects on th e  charac te ristics  of 
th e  cell line  m ay  be in s ig n if ic a n t in  th e  ea rly  s ta g es . DNA 
fingerprinting h a s  been  used  to identify m u ta tio n s in  lines cu ltu red  
a t  d ifferent lab o ra to ries  of th e  sam e origin (Thacker, J .  M. e t al 
1988). T h is  a p p ro a c h  h a s  a lso  p roved  s u c c e s s fu l  in  th e  
identification  of som atic  change in  cancer (Thein, S. L. e t al 1987) 
and  th e  detection  of d ifferences in  fetal an d  tro p h o b la s t sam ples 
(Butler, W. J ,  e t al 1988 ) A lterations in  cu ltu re  su p p lem en ts  and  
a d a p ta tio n  to serum -free  cond itions do n o t a p p e a r  to  have any  
effect on th e  fingerprin t profile (Stacey, G. N. e t al 1991). R. C arter 
(1989) selected  a  p a ir  of tran sc rib ab le  vectors pSPT 18 an d  pSPT 
19 w hich  con ta ined  opposed RNA polym erase p rom oters from  T7 
a n d  SP 6  p h ag es  flank ing  th e  pU C18 m u ltip le  c lon ing  site , to 
recom bine w ith m inisatellite  regions of 33 .6  an d  33 .15  to yield four 
RNA probes pSPT 18.6, 19.6, 18.15, and  19.15 . The advantages of 
RNA probes over conventional DNA hybrid ization  p robes are: 1. A 
h igh  and  consisten tly  achieved specific activity. 2. A highly defined 
n a tu re ;  a  sing le  n u c le o tid e  c h a in  of defined  len g th , a n d  no 
co m p e tin g  s tr a n d . 3. E ase  of p re p a ra tio n . 4. An RNA/DNA
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h e te ro d u p le x  is m ore s ta b le  th a n  a  DNA/DNA duplex . It w as 
therefo re  decided to u se  pSPT 18.15 RNA probe for u se  du ring  
fingerprin ting  analysis perform ed in  th is  project.
3-2-2  Procedure
3-2-2-1 Chrom osom e s tu d ies
At la te  p a ssa g e s  of SV -H U C -IT  cells no  obv ious fib ro b la s t 
con tam ina tion  w as observed. Cells were p repared  for chrom osom e 
s tu d ie s  a s  d e sc rib ed  in  [2-6] u s in g  colcem id (0.04|j.g/m l) to 
accu m u la te  m etap h ase  cells for 3 to 4 ho u rs . C hrom osom es were 
observed u n d e r oil im m ersion by a  Leitz light m icroscope.
3 -2 -2 -2  Im m unocv tochem ical s ta in in g  of tu m o r cells and  tu m o r 
tissue
5x10^  SV-HUC-IT cells grown on a  g lass slide or dewaxed tum or 
t is su e , w ere trea te d  w ith  a m ouse  m onoclonal an tibo dy  ag a in s t 
h u m a n  cy tokera tin s (DAKO-M821), SV40 T antigen(PA b 405), or 
p53  (DOl). T hen  am plified w ith  a rab b it a n ti-m o u se  IgG, HRP 
conjugated  polyclonal an tibody  (DAKO-P161). Positive sta in in g  w as 
revealed after HRP w as reacted  w ith  Im g /m l of DAB p lu s 0.06%  
(v/v) of H 2 O 2  as d esc rib ed  in  [2-7]. E ach  ex p erim en t h a d  a 
duplicate  negative control in  w hich no first antibody w as added.
3-2-2-3 DNA fingerprin ting analvsis
A bout 1 . 5 x 1 0 7  of SV-HUC-1, SV-HUC-IT, SV-HUC-ITS, and  T24 
cells were used . D etailed p rocedu res  are  con ta ined  in  appendix  1. 
Briefly the  genom ic DNA w as ex trac ted  w ith  phenol and  alcohol, 
H ae III w as u se d  to d ig est th e  DNA, 0.8%  (w/v) ag aro se  gel 
e le c tro p h o re s is  s e p a ra te d  th e  DNA frag m e n ts  th e n  S o u th e rn  
b lo tting  onto a nylon m em brane w as perform ed. Finally fragm ents
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were hybridized w ith  a radiolabelled  pSPT 18.15 RNA probe. The 
au to rad iograph ic  resu lts  were developed on an  x film.
3-2-3 R esults
3-2-3-1 Chrom osom e study
25 m etap h ase  sp read s each from SV-HUC-IN and  SV-HUC-IT cells 
were analysed . The d is trib u tio n  of chrom osom e n u m b ers  is show n 
in table 3-2-1. Both lines showed a modal num ber of 43. a lthough  a 
few m etap h ases in the SV-HUC-IN cells contained  a fewer num ber 
of chrom osom es, it is concluded th a t the chrom osom al p ic tu res for 
the  two lines is very sim ilar (Fig. 3-2-1).
A <
Fig. 3-2-1 Photomicrograph of model karyotype of (A) SV-HUC-IT and (B) SV-HUC- 
IN cells. X 5200.
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Chrom osom e num bers
2 0 32 35 39 40 41 42 43 44 45 64 71 80 8 8
SV -H U C-IT 3 1 2 3 2 7 4 1 1 1
SV-HUC-IN 1 1 1 2 3 2 2 6  4 1 1
Table 3-2-1 D istribu tion  of chrom osom e n u m b ers  of 25 m etaphase  
sp read s  from SV-HUC-IT and  SV-HUC-IN cells.
3-2-3-2 Im m unohistochem ical s ta in ing
B oth SV-HUC-1 and  SV-HUC-IT cells were positively s ta in ed  w ith 
p53 and  h u m an  cytokeratin  im m unohistochem ical sta in ing . Positive 
SV40 T an tigen  s ta in ing  w as revealed on the  w ax em bedded tum or 
tissue  as show n in Fig. 3-2-2.
3-2-3-3  DNA fingerprinting analvsis
The au to rad iog raph  of a DNA fingerprin t w as show n in  Fig. 3-2-3. 
Lane 1 to lane 3 rep re se n t the  hybridizing DNA fragm ents of SV- 
H U C-1, SV -H U C IT  an d  T 24 cells resp ec tiv e ly . T he ce llu la r  
genom ic DNA w as digested vdth  Hae 111 and  hybridized w ith pSPT 
18.15 RNA probe. A bout 16 resolvable hypervariable fragm ents are 
observed in  each  lane in the  4-20 kilobase size range. Lane 1 and  
lane 2  sha red  all except one (arrow) b an d  and  no b an d  sharing  w as 
noted in DNA fragm ents bigger th a n  5.6 Kb betw een lane 3 and  lane 
2 (or lane 1). This is supposedly  because  cells of lane 1 and  lane 2 
are from the sam e origin, different from the cells of lane 3.
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Fig. 3-2-2 Immunohislochemical staining of SV40 T antigen of wax embeded tumor 
tissu e  from a nude m ouse. (A) Negative control, without primary antibody (B) 
Stained tissue, brown deposits represent the sites of T antigen.Tumor was produced after inoculation of the SV-HUC-IN cells. Specimen was dewaxed, reacted with 
antibodies and developed with Im g/m l of DAB at the presence of 0.06% H 202 and 0.03%  nickel sulphate. Primary antibody was PAb405, a m ouse m onoclonal 
antibody against SV40 T antigen. Secondai*y antibody was DAKO-P161, a enzyme 
linked rabbit polyclonal antibody against m ouse IgG.
21I K B3
| 2
11
Fig. 3 -2 -3  DNA fingerprinting of three cell lines. Cellular genom ic DNA was 
extracted, digested with Hae III and hybridized with pSPT 18.15 RNA probe, number 
on the right side of each lane indicates different cell types 1. SV-HUC-1, 2. SV-HUC- 
IT, 3. T24. Arrow indicates the site where novel band appears in SV-HUC-IT cells.
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3 2  4  D iscussion
SV-HUC-IT cells, derived from  a  tu m o r w hich  were p roduced  by 
h u m a n  u ro th e lia l cells an d  grow n in  n u d e  m ice, show  a  sim ilar 
c h ro m o s o m e  p ic tu r e  to  t h a t  o f th e  p a r e n t a l  c e lls .  
Im m u n o h is to c h em ic a l s ta in in g  of th is  cell confirm ed  th a t  it 
con ta ined  c h arac te ris tic s  of h u m a n  epithelium  cells an d  h ad  been  
tran sfec ted  w ith  SV40 T an tigen . All th ese  ind irectly  su p p o rt the  
idea  of SV-HUC-IT cells being  a  tum origenic tra n s fo rm a n t of SV- 
HUC-1 cells. D irect evidence of cell origin com es from  the  DNA 
fingerprin ting  analysis. In Fig. 3-2-3 , lane 1 and  lane  2 sh a red  15 
resolvable fragm ents. A m ean  probability  of band  sh a rin g  of 0 .2  w as 
estim ated  by  A. J .  Jeffreys (1985b). The chances th a t  two cell line 
w ith  d ifferent origin sh a red  15 hypervariab le  DNA fragm en ts are  
very  low (Q.2 iS = ~ 3 x lQ - i i ) .  T his m ean s th a t  cells of lane  1 (SV- 
HUC-1) and  cells of lane 2 (SV-HUC-IT) have th e  sam e origin. In a 
survey  of 27 indiv iduals an d  th e ir p a ren ts, one b an d  in  240 clearly 
resolved  offspring b a n d s  could  n o t be traced  to one or o th e r 
p a re n t. T h is gives a  m u ta tio n  ra te  to a  new  allele  for th e se  
hy p erv a riab le  frag m en ts  of 0 .0 0 4  (1 /240) (Jeffreys, A. J .  e t al 
1985a). T here are  a t le a s t 10 b a n d s  d iscrepancy  betw een  lane  3 
and  lane  2 (or lane  1 a s  well). If cells of lane 3 (T24) and  cells of 
lan e  2  com e from  th e  sam e origin , th e n  all th e se  1 0  b a n d s  
difference m u s t be a  re su lt of m u ta tion . The probability  th a t  th is  is 
co rrect is very low (0.004iO=~io-24)^ These two pieces of evidence 
tak en  together m ay ind icate  th a t  SV-HUC-IT cells a re  derived from 
SV-HUC-1 cell and  n o t sim ply contam inated  by  T24 cells.
In a  DNA fingerprin t analysis of 35 pa tien ts , changes were observed 
in  cancer cells, includ ing  a lte ra tio n s  in  the  relative in ten sitie s  of
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hybrid iz ing  DNA frag m en ts  in  10 c ase s  an d , in 3 cases , th e  
a p p e a ra n c e  of novel m in isa te llite  frag m en ts  n o t seen  in  th e  
co rrespond ing  indiv idual norm al leukocyte DNA profiles (Thein, S.
L. e t al 1987). T his ap p ea ra n c e  of a  novel fragm en t in  a  DNA 
fingerprin ting  profile of d iseased  cells w as also found in  a  P roteus 
syndrom e affected m onozygotic tw in b ro th er (Schwartz, C. E. et al 
1991). The sam e observation is detected in  our resu lt, a  novel band  
ap p ea rs  in  the  DNA fragm ents of SV-HUC-IT cells [arrow in Fig. 3-
2-3]. A lthough th is  change could be due to a  spon taneous m utation , 
as m entioned, the  probability  is low. It is possible th a t th is m u ta tion  
is cau sed  by  growing SV-HUC-1 cells in sff cond itions and  as a 
re su lt the  cells are  tum origenically  transform ed.
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3 3  M olecular changes associated w ith transform ed cells
3-3-1 Introduction
The evidence from section  2 h a s  show n th a t a  tum origenic cell line 
w as derived from a  non-tom origenic cell line. In o th er w ords two 
cell lin es  sh a re d  th e  sam e genom ic b a ck g ro u n d  w ith  d ifferen t 
phenotypic characteristics . F u rth e r stud ies should  focus on changes 
occurring  during  the p rocess of tum origenic transfo rm ation . Firstly, 
does sff conditioned  m edium  co n ta in  factors w hich  su p p o rt cells 
grow n in  sff s itu a tio n s?  Soluble factors, includ ing  grow th factors, 
w hich  p lay  a  m ajo r role in  con tro lling  o rdered  cell grow th and  
d iffe re n tia tio n  in vivo, m igh t also  have a  role in  tum origen ic  
t ra n s fo rm a tio n  a s  v ira lly  tra n s fo rm e d  cells  d isp lay e d  low er 
req u ire m e n ts  for exogenous so u rces  of grow th fac to rs th a n  did 
norm al cells (Buick, R. N. e t al 1992). Is there  any  change in  levels 
of grow th fac to rs in  the  m edium  conditioned by tum origenic  cells 
and  non-tum origen ic  cells?
3-3-2 Procedure
3-3-2-1 Flow cvtom etrv m easu ring  the  fluorescent DNA d istribu tion  
in  cell cvcle
4 g g /m l of p rop id ium  iodide (PI) w as u sed  to s ta in  th e  DNA of 
alcohol fixed SV-HUC-1 and  SV-HUC-IT cells and  m easu red  w ith  a 
flow cytom eter a s  described in [2-9]. D ata  for the  m easu rem en ts  of 
forw ard sc a tte r  v e rsu s fluorescence of PI were accum ulated  in the
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FACScan and  analysed  u sing  a software package "Consort *30" and 
"DNA" software.
3-3-2-2 M easurem ent of doubling tim e of HUC-T cells 
1x10^  of SV -HUC-IT cells w ere p la ted  in  25cm ^ flask, c u ltu red  
w ith  7% FCS F 12 m ed ium . Cell n u m b e r  a n d  v iab ility  w ere 
de term ined  a t  a  regu la r in te rvals as described  in  [2 - 1 0 ] and  d a ta  
u sed  to plot growth curves.
3-3-2-3  G row th-stim ulating  activltv of sff conditioned m edium  
This a ssay  w as described  in [2-15]. F I 2 m edium  conditioned by SV- 
HUC-IN cells u n d e r sff situa tion  w as used . 1x10^ T24 or SV-HUC-1 
cells w ere seeded  in  each  well of a  24 well flat bo ttom  tis su e  
cu ltu re  p late  con ta in ing  2 ml of serially  d ilu ted  (50% to 3.1%) sff 
conditioned m edium . S erum  free m edium  (RPMI for T24 and  F I 2 
for HUC-1 cells) were u sed  as d iluen t and  wells con ta in ing  no cell 
as a back  ground control. C ultu res were incubated  for 48 ho u rs  then  
60KBq of pH]TdR added to each  well and  incu b a tio n  con tinued  for 
a n o th e r  16 h o u rs  for HUC-1 cells and  an o th e r 8  h o u rs  for T24 
cells. D ata  of [3H]TdR u p tak e  of 3 wells for each  tre a tm e n t w ere 
collected and  the  g row th -stim u la ting  activity w as expressed  as a 
ratio  of averaged [^H]TdR u p tak e  by conditioned  m edium  trea ted  
cells over th a t  of co n cu rren tly  p rocessed  con tro l cells. A dose 
re s p o n s e  cu rv e  of g ro w th -s tim u la tin g  e ffec t of in c re a s e d  
conditioned m edium  w as plotted.
3 -3 -2 -4  In vitro  m u rin e  HPP-CFC assay  of stem  cell fa c to r- lik e  
effect in  conditioned m edium
7% FCS F12 m edium  conditioned by SV-HUC-1 and  sff F12 m edium  
conditioned by SV-HUC-IN cells w as used  alone or in  com bination 
w ith  optim al co n cen tra tio n  of rm u  GM-CSF (40 U /m l), op tim al
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co n cen tra tio n  of rh u  M -CSF (50 U /m l) (personal com m unication  
w ith  Dr S. N. Robinson) as the  schem atic  d iagram  show  in  Fig. 3-3-
1. rm u  SCF w as u sed  as positive control of synergistic factor a t 10 
n g /m l. 4x1 Q4 m u rin e  bone m arrow  cells w ere seeded  in  each  
sem isolid  agar d ish  an d  th e  synergistic  activity of th e  conditioned 
m edia w as assayed  as described in [2 - 1 2 ].
Fig. 3-3-1 Stem cell-like activity assay
F actors
SCF
HUG Bone MarrowM + GM
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M + GM
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M + GM
7 Z ^ /////////Æ ^
14 days 37°C
5%C02
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3-3 -2 -5  ELISA a ssa v  for h u m a n  stem  cell fac to r in  conditioned  
m ed ium
7% FCS F12 m edium  cond itioned  by  SV-HUC-1 a n d  SV-HUC-IT 
cells were assayed using  BIOTRAK and  Q uantik ine ELISA kits [2-13] 
p rocedure  as p e r  m a n u fa c tu re s  in s tru c tio n s . H am 's F I 2 m edium  
w as u se d  a s  d ilu en t, P la tes w ere read  w ith  a  D yna tech  5000  
sp ec tro p h o to m ete r a t  450 nm . P lain  F I 2 m ed ium  con ta in ing  7% 
(v/v) fetal calf se rum  as a  negative control.
3-3-2-G M urine thvm ocvte proliferation assav  for IL l-like activitv in 
conditioned  m edium
7% FCS F12 m edium  conditioned  by SV-HUC-1 an d  SV-HUC-IT 
cells were assayed . Thym ocytes were harvested  from  2 to 3 w eeks 
old CBA/H m ice as described  in  [2-4]. A subop tim al concen tra tion  
of ConA of Ip g /m l w as u sed  in th is  a ssay  (personal com m unication  
w ith  Dr S. N. Robinson). To generate  a  s tan d a rd  ILl titra tio n  curve 
100 pi of m ed ium  con ta in in g  1x10® thym ocytes, 50 pi of ConA 
(4pg/m l) an d  50 pi of a  range  (2 to 100 U /m l) of reco m b in an t 
h u m an  ILl a  were added to m ade up  a  total 200 pi in  each  well of a 
96  well m ic ro titre  p la te . To a s sa y  the  IL l-like  activ ity  in  th e  
cond itioned  m edium , 50pl of conditioned  m edium  w as added  to 
the  wells in stead  of IL l-a . After 3 days culture, 25pl of 300 K Bq/m l 
[®H]-TdR w as added to each  well and  incubated  for 16 hours. Cells 
w ere h a rv e s te d  on to  a  g lassfiber filter p a p e r and  rad io iso tope  
u p ta k e  by p ro life ra ting  cells w as de te rm ined  u s in g  a R ackbe ta  
liquid sc in tilla tion  c o u n te r .A sim plified schem atic  d iagram  of the  
procedure  w as show n in  Fig. 3-3-2 and  described detailly in [2-14]. 
The IL l-like activity in  conditioned m edium  w as expressed  in U /m l 
as  read  from the  equivalen t level of u p tak e  in  the  IL l-a  s ta n d a rd  
titra tion  curve.
Fig. 3-3-2 Thymocyte Proliferation Assay
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Transform ation 107
3-3-3 R esu lts
3-3-3-1 The fluorescen t DNA d is trib u tio n  in cell cycle 
DNA h is to g ram  of tu m o rig en ic  (HUC-IT) a n d  n o n -tu m o rig en ic  
(HUC-1) cells w ere show n in  Fig. 3 -3-3 . G O /G l peak  were a t 61 
an d  58.9  channel respectively. Modified DNA index  (DI) is a  value 
given to express the  am o u n t of DNA con ten t ratio  and  is calcu lated  
by the  following equation.
m odal channel NO. of G O /G l peak  of tum origenic cells
DI:
m odal channel NO. of G O /G l peak  of non-tum origenic cells 
No a b n o rm a l p eak s  of fluo rescence  in te n s ity  w ere observed  in 
tum origenic  cells in com parison  w ith non-tum origen ic  cells.
Fig. 3-3-3  DNA histogram of HUC cells (a) nontumorigenic cell SV-HUC-1. 
GO/Gl pealc at channel 58.9. (b) tumorigenic cells SV-HUC-IT, GO/Gl peak at 
channel 61.
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3-3"3-2 D oubling tim e of HU C-IT cells
The log phase  grow th curve of HU C-IT cells w as show n in  Fig. 3-3- 
4 each  p o in t h a d  a t  le a s t 3 in d ep en d en t sam ples. The doubling  
tim e w as m easu red  a s  40 h o u rs  w hich w as the  sam e as its p a re n t 
HUC-1 cells.
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Fig, 3-3-4. Growth curve of SV-HUClT cells in log phase culture in 7% FCS F12 
medium.
3-3-3-3 G row th-stim ulating  activitv of sff conditioned m edium  
The re s u lt  of full range  of serially  d ilu ted  cond itioned  m edium  
u sin g  SV-HUC-1 as ta rg e t cells w as show n in Fig. 3 -3-5a. Optim al 
g ro w th -s tim u la tin g  effect w ere  observed  a t  12.5%  (v/v) of 
c o n d itio n ed  m ed iu m , fu r th e r  in c re a se d  c o n c e n tra tio n  of sff 
conditioned m edium  h ad  less grow th s tim u la tion  effect. A sim ilar 
p a tte rn  of dose response  effect w as observed w ith T24 and  HUC-1 
cells a s  in d ic a to r  cell in  a  range  of optim al c o n ce n tra tio n  of 
conditioned m edium  as show n in Fig. 3-3-5b and  each  d a ta  poin t 
re p re se n te d  th re e  in d e p e n d e n t sam p le s . T he sff co n d itio n ed
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m edium  d em o n stra ted  a  non-cell specific g row th-stim ulating  effect 
in SV-HUC-1 an d  T24 cells.
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Fig. 3-3-5. Growth-stimulating activity of sff conditioned medium (a) full range (3.1- 
50 % v/v) of double diluted conditioned medium, (b) stimulating effect toward T24 
and HUC-1 cells in the optimal range (3.1-12.5 % v/v). Back ground counts as 
determined in wells without cells is <4% of control in (a), and <1% in (b). Each point 
represents a mean of 4 measurements ±SEM.
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3-3-3-4  S tem  cell factor-like effect in  conditioned m edium  
M urine HPP-CFC responded  to grow th factor(s) o r /a n d  conditioned 
m edium  leading to the  form ation of colonies in  soft agar d ishes and  
HPP-CFC derived colonies were defined as those  in  excess of 2 m m  
in  diam eter. Colonies were coun ted  and  re su lts  a re  show n in  Fig. 3-
3-6 . rm u  SC F or cond itioned  m ed ium  alone  h a d  no  effect of 
stim u la tion  of bone m arrow  cells to form colonies. 4± 1.08 colonies 
w ere form ed in  d ish es con ta in ing  rm u  GM-CSF p lu s  rh u  M-CSF. 
W hile 19+2.12 colonies were form ed in  d ishes con ta in ing  rm u  SCF 
c o m b in ed  w ith  th e s e  tw o fa c to rs . T u m o rig en ic  a n d  n o n - 
tum origen ic  conditioned  m ed ium  com bined w ith  M a n d  GM-CSF 
h ad  show n the  synergistic effect w ith  a n  average of 20.25±1.97 and  
20 .75±1.03  colonies w ere form ed respectively.
A stem  cell factor-like synergistic  effect w as observed w ith m edium  
conditioned by SV-HUC-IT cells.
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Fig. 3 -3 -6  Murine bone marrow HPP-CFC assay of stem  cell factor-like activity. (1) 
GM-CSF + M-CSF; [4+1.08]. (2) SCF + GM-CSF + M-CSF; [19+2.12]. (3) Tumorigenic 
CM + GM-CSF + M-CSF; [20.25+1.97]. (4) Non-tumorigenic CM + GM-CSF + M-CSF; 
[20.75+1.03]. Bars represent standard errors of m ean va lues obtain from 4 
independent samples.
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3-3-3-5 Levels of h u m an  soluble SCF in conditioned m edium  
An average 256±43 (±SEM) p g /m l of SCF were detected  in  m edium  
conditioned  by SV-HUC-IT cells (four rep licated  experim ents) and  
a n  average of 550±66 (±SEM) p g /m l of SCF w ere d e tec ted  in 
m e d iu m  c o n d it io n  b y  SV -H U C-1 c e lls  ( th re e  r e p l ic a te d  
experim ents) (Fig. 3-3-7). No c ro ss  species reac tio n  of 7% (v/v) 
fetal calf se rum  w as detected while using  bo th  kits.
T he q u a n ti ty  of h u m a n  s te m  cell fac to r  p re s e n te d  in  th e  
co n d itio n ed  m ed iu m  of tu m o rig en ic  cells is  s ig n if ic an t less  
(p<0 .0 1 ) th a n  th a t of non-tum origenic cells.
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Fig. 3 -3 -7 . Concentration of detectable hum an stem  cell factor in m edium  
conditioned by tumorigenic and non-tumorigenic HUC cells, using ELISA kits.
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3-3-3-6  IL 1-like activltv in  conditioned m edium  
The dose re sp o n se  curve of thym ocyte  p ro life ra tio n -s tim u la tin g  
effect of ILl w ith a  subop tim al dose of ConA (1 pg/m l) w as show n in  
Fig. 3 -3 -8a . T he [^HJTdR u p ta k e  by  m u rin e  th y m o cy tes  a fte r  
tre a tin g  w ith  cond itioned  m ed ium  (four sam p les for each  resu lt) 
w as show n  in  Fig. 3 -3 -8b . T hese  re s u lts  re p re se n te d  25% (v/v) 
c o n ce n tra tio n  of cond itioned  m ed ium  an d  read  from  equ iva len t 
level of u p tak e  in  th e  s ta n d a rd  titra tio n  curve th e  estim ated  final 
concen tra tion  of ILl a  in  conditioned m edium  of tum origen ic  and  
non-tum origenic cells w as 2 .8  U /m l and  10.5 U /m l respectively.
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Fig. 3-3-8 . Human ILl a-like activity of conditioned medium, (a) Standard dose 
response of thymocyte proliferation-stimulating effect of increased concentration  
of ILl a with a suboptimal dose of ConA(l pg/ml). (b) The level of (3H]TdR uptake of 
25% (v/v) concentration  of m edium  conditioned by tum origenic and non- 
tumorigenic HUC cells.
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3-3-4 D iscussion
In the flow cytom etry s tu d ies  the  DNA co n ten t a t G O /G l peak  of 
tum origen ic  cells is  d ifferen t from  th a t  of non -tum origen ic  cells 
However th e ir  DNA index  (1.03) is w ith in  th e  accep ted! 1± 10%) 
lim its of error. (D ressier, L. G. 1990). Tum origenic cells were no t 
a ssayed  for ploidy a s  the  SV-HUC-1 cells u sed  a s  a  s ta n d a rd  are 
pseudo-d ip lo id .
Post-confluent cu ltu re  of SV-HUC-IT cells had  show n th a t  they  had  
h igher s a tu ra tio n  d en sitie s  th a n  SV-HUC-1 cells. The increased  
density , how ever is n o t due to an  increase  in grow th ra te  during  
the  exponential p h ase  of growth. The doubling tim e of tum origenic 
cells grown in  7% FCS F I 2 is 40 h o u rs  w hich  is s im ila r to the  
p a re n ta l non -tum origen ic  cell. T h u s  tum origen ic  cells m ight n o t 
have a grow th advantage over non-tum origenic cells while grown in 
se ru m  supp lem ented  m edium .
We have re a so n s  to believe th a t  in  th e  HPP-CFC a ssay , the  
synerg istic  effect of conditioned  m edium  is n o t solely a ttr ib u ta b le  
to SCF. The dose of rm u  SCF u sed  in the  a ssay  is 20  tim es h igher 
th a n  th e  concen tra tion  of h u m a n  SCF in the conditioned m edium . 
However in  the  HPP-CFC a ssay  the  conditioned m edium  did exhibit 
a  sim ilar synergistic effect. F u rth e r  m ore in  a  different proliferation 
s tim u la tin g  a ssa y  th e  re s u lt  show ed th a t  the  specific activity  of 
h u m an  SCF w as 800 fold less th a n  th a t of ra t  SCF (Martin, F. H. et al 
1990).
D a ta  suggesting  th a t  SV-HUC-IN cells secre te  fac to rs w hich m ay 
s u p p o r t th e ir  own p ro life ra tio n  com es from  a ssa y s  w here  the  
add ition  of conditioned m edium  stim u la ted  the  proliferation of bo th
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T24 an d  SV-HUC-1 cells in  sff cu ltu re . In addition , th is  suggests  
th a t  the  action of th is  factor(s) m ay be non-cell-specific.
The biological effect of grow th factors is m ainly  d ep en d en t on the  
ty ro s in e  k in a se  ac tiv itie s  of m em b ran e  rec ep to rs ; one m igh t 
an tic ipa te  th a t  c o n s tan t stim u la tion  of a  grow th-factor recep to r by 
its ligand w ould lead to a  loss of growth regulation. However th is  is 
in  c o n tra s t  to ou r findings w ith  re sp ec t to SCF and  IL l a .  The 
c o n c e n tra tio n  of SCF an d  th e  activ ity  of IL l a  w ere low er in 
tum origenic cell conditioned m edium . One possib ility  is th a t  there  
are less tum origenic cells to produce the  factors. However in Fig. 3- 
1 - 3  we have show n th a t  sa tu ra tio n  density  is h igher in tum origenic 
cells. Som e o th e r  e x p lan a tio n s  for red u ced  grow th  factor(s) in  
tum origenic cell conditioned m edium  m ay be postu la ted .
A s tru c tu ra lly  a lte red  recep to r th a t  is active in  the  ab sen ce  of 
grow th factor, or en h an ced  ce llu la r resp o n siv en ess  to a grow th 
factor m ay re su lt from  a  change in  the  n u m b er or affinity of the  
recep to rs for the ir grow th factor (Sporn, M. B. et al 1985), B inding 
of g row th  fac to rs  is followed rap id ly  by  in te rn a liz a tio n  and  
degradation  of the  recep to r-ligand  com plex (Schlessinger, J . e t al 
1978) th u s  exhausting  the  growth factor.
C oncepts of how  recep to rs function  have changed in  recen t years 
w ith  th e  rea lization  th a t  m any  recep to rs can  give rise  to soluble, 
non-m em brane-bound  form s and  these  form s m ay have a  biological 
role in th is  regard . Soluble recep tors m ay be form ed by proteolytic 
cleavage of the  ex tacellu lar dom ain, or th rough  a lternative  splicing 
of mRNA leading to expression  of the  ex tracellu lar region . T hese 
soluble form s of recep to rs have been  proposed to ac t as biological 
sin k s th a t  function  to m odula te  or tem per the  biological response  
of th e ir cognate ligand. It m ay be th a t  e ither SCF and  c-Kit m ay
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function  as  a ligand, a  recep to r, or bo th  (A nderson, D. M. e t al 
1990). Levels of th is  a s  yet un iden tified  so lub le  recep to r m igh t 
in c re a se  in  tum origen ic  cells a n d  trap p in g  th e  so lu b le  grow th  
factor leading to a  lower detectable concentration . Similarly, several 
grow th factors a re  p roduced  a s  tran sm em b ran e  p ro te in s th a t  can  
be re leased  by specific proteolytic cleavage to generate  free factors 
(Pandiella, A. e t al 1992). In general, th e  p ro d u c tio n  of grow th 
factors as cell su rface m olecules m ay perm it a  se t of d irect cell-cell 
in terac tions th a t have a  degree of spa tia l organization th a t could no t 
easily be achieved w ith  freely diffusible factors. T hese in te rac tions 
m ay be im p o rtan t in  p rocesses of norm al developm ent, includ ing  
cellu lar m igration and  hom ing, and  could also be involved in  related  
d isease  p rocesses su c h  as tu m o r m e tas ta s is  (M assague, J .  1990). 
A nother function  of th is  form  of grow th factor m ay be to p revent 
the  m olecule from  diffusing aw ay from  the  sites of sy n th esis  and  
thereby  en su ring  high enough local concen tra tions for activation of 
the  responsive  cells (F lanagan , T. G. 1991). A ltera tion  in  th e  
b a lan ce  be tw een  the  diffusib le  an d  m em b ran e -b o u n d  form s of 
growth factors m ay lead to phenotypic abnorm alities (M ajum dar, M.
K. et al 1994) a s  seen  in  A lzheim er's d isease  (Sisodia, S. S. e t al 
1990). IL l a  an d  SCF are  biologically active in  b o th  m em brane- 
bound  and soluble form (Anderson, D. M. et al 1990; Conlon, P. J .  e t 
al 1987). In th is  case the cell m ay have an  increase  in  the  level of 
th e  m em b ran e -b o u n d  form  w ith  a d ecrease  in  th e  level of the  
so lu b le  fo rm  of g ro w th  fa c to r s  le a d in g  to  tu m o r ig e n ic  
tran sfo rm atio n .
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Conclusion
We have estab lished  a system  in  w hich tum origenic cell and  non- 
tum origenic cells sh a re  a  sim ilar DNA fingerprin ting p a tte rn . Using 
th is  system , any  m olecu lar or biological difference w hich  ap p ea r 
betw een the  two cells type m ay rep re sen t changes a ttr ib u ta b le  to 
tum origenicity  and  n o t m erely individual variation.
F urtherm ore  a  h u m an  urothelia l cell line w hich can  be continuously  
cu ltu red  in sff condition is estab lished . Using th is  line to a ssay  the  
grow th regu la tion  effect of a  factor will e rad ica te  the  u n c e rta in ty  
caused  by the serum  com ponents in cu ltu re  m edium .
In o u r experim ent, we found th a t  cells could be transfo rm ed  in a 
se rum  free and  grow th factor free situa tion . This m odel m ay give a 
possib le  exp lanation  to a  clinical observation  of the  heterogeneity  
(m etastasis, d rug  sensitivity) of a cancer: cells were transfo rm ed  in 
a n  a re a  (area a ro u n d  cen tra l necrosis) w here se ru m  com ponen ts 
were deprivated and  th en  expressed  in a different phenotype re su lt 
in th e  heterogeneity .
The level of so luble h u m a n  stem  factor an d  in te r-leu k in  l a  are 
found to be lower in  m edium  conditioned by the  tum origenic  cell 
th a n  by the  non-tum origenic cell. The proposed explanation  for th is  
observation  involves b o th  soluble and  m em brane  b o un d  form s of 
grow th factors a n d /o r  receptors. F u tu re  work could concen tra te  on 
assay ing  pre and  p o s t- tra n s la tio n  levels of bo th  form s of grow th 
factor. S im ilarly possible identification if the  pu ta tive  soluble form 
recep to rs  m ay  he lp  to clarify  th e  m ech an ism  involved in  th is  
finding.
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Chapter IV 
Roussin's black salt a novel nitric oxide donor acts as a cytotoxic agent
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Fig 4-1-1 Growth ratio of SV-HUC-1 cells after treatment with RBS for 1 hour. At a 
range of IjiM to 10p,M, cells have 1 to 99% of growth inhibition.
Fig 4-1-2 Growth ratio of SV-HUC-1 and T24 cells after treatment with different concentrations of RBS for 1 hour. ID5o=5. 16|liM  for SV-HUC-1 and lD5o=4.96|iiM for 
T24 cells.
Fig 4-1-3 Growth ratio of SV-HUC-1 cells after treatment with 4jiM and 7fiM RBS for 
lengths of time vaiying from 30 to 240 minutes.
Fig 4-1-4  Growth ratio of SV-HUC-1 and T24 cells after treatment with different 
concentrations of Thiotepa for 1 hour.
Fig 4-1-5  Growth ratio of IpM RBS-treated T24 cells after either irradiation or 
deprivation from light for 1 hour.
Fig 4-1-6  Growth ratio of T24 cells after treatment with different concentrations of 
RBS and either irradiated with 5mW of laser light (X=457.9 nm) or light deprivation 
for 1 hour.
Fig 4-1-7  Growth ratio of 2pM or 3pM RBS-treated T24 cells after irradiation with 
different intensities of laser light (À,=457.9 nm) for 40 m inutes.
Fig 4-1-8  Growth ratio of RBS-treated T24 cells with or without haemoglobin, (a) 
Cells were treated with 7pM RBS and kept in dark for 1 hour, (b) The same treatment 
as in (a )but with 1 hour light exposure, (c) Cells were treated with 50pM AB-RBS and 
exposed to light for 1 hour.
Fig 4-1-9  Photograph of colum n chromatography after run through of solution  
containing (A) Bovine albumin and RBS. (B) RBS. (C) Bovine haemoglobin and RBS. 
Arrow head indicate that RBS was held up by resin. RBS bound to albumin and 
haemoglobins thus run through the column.
Fig 4 -1-10  Growth ratio of 50jiM AB-RBS-treated T24 cells with or without 5pM 
haemoglobin after irradiation with different intensities of laser light (X=457.9 nm) 
for 40 m inutes.
Fig 4-1-11 RBS-treated T24 cells after the Turnbull reaction. Blue color indicated 
bound ferrous salt. Bar= 1.1pm.
Fig 4-2-1 Survival of CHO and xrs cells after treated with different concentrations of 
RBS for 1 hour.
Fig 4-2-2  Number of m icronuclei per 100 binuclear cells. CHO or xrs cells were 
pretreated with 10 pM RBS for 40 m inutes, cytokinesis was blocked with 3pg/m l of 
Cyto B. Controls were the sam e but without RBS pretreatment. Two separate 
experiments were performed and 3 samples were determined in each experiment.
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sum m ary
We re p o rt th e  cy to toxicity  of n itr ic  oxide (NO) a g a in s t h u m a n  
u ro thelia l cells in vitro and  propose a  possible m echan ism  for th is  
activity. In the  h u m an  body NO h a s  been  identified as a  blood vessel 
d ilator, an  in te r-n eu ro n a l m essenger and  a  cytotoxic agen t against 
b ac te ria  and  tum or cells.
A n i r o n - s u l p h u r  c lu s te r  n i t r o s y l  " h e p to n i t ro s y l - t r i - p 3 -  
th ioxotetraferrate" (R oussin 's b lack  salt, RBS) is a generato r of NO. 
The cytotoxicity  of RBS h a s  been  investigated  u s in g  two h u m a n  
u ro th e lia l cell lines: SV-HUC-1 (derived from norm al tissue) and  
T24 (derived from cancerous tissue). Both cell lines d em onstra te  a 
dose- and  co n tac t tim e- dependency  for RBS cytotoxicity. Grow th 
inh ib ition  of cell induced  by RBS w as increased  in  the  presence of 
light, in d ica tin g  a  p h o to sen sitiv ity  of RBS, an d  red u ced  in  the  
p resence  of hem oglobin.
C hinese h am ste r ovary (CHO) cells and  a  CHO m u ta n t, deficient in 
DNA re p a ir  (x rs -5), w ere  u se d  to in v e s tig a te  th e  p o ss ib le  
m ec h an ism  of ac tio n  of NO. The x r s -5 cell line proved to be 
significantly m ore sensitive to the  cytotoxicity of RBS th a n  the CHO 
cell line, a difference w hich  corre la ted  w ith  a  significantly  h igher 
n u m b er of m icronuclei p re se n t in  RBS-exposed x rs -5 cells. These 
d a ta  suggest th a t  RBS cytotoxicity m ay involve DNA dam age. 
A lth o u g h  in vivo s tu d ie s  need  to be perform ed to a s se s s  the  
p o ten tia l of RBS as a  ch em o th e rap eu tic  agent, c u rre n t findings 
suggest th a t  chem icals w hich release NO m ay have a role in cancer 
trea tm e n t.
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Outline
In th is  chap ter, the  po ten tia l cytotoxic effect of a novel n itric  oxide 
donor-"RBS" is d iscussed  in 2 sections.
In the  first section, c y to to x ic  e ffec t o f RBS. th e  grow th inhib itory  
effect of RBS rela ted  to the  d rug  concen tra tion  and  exposure tim e 
is exam ined. The effect of light irrad ia tion  and  haem oglobin on the  
cytotoxic effect of RBS is illustra ted .
In the 2nd section, RBS cau ses DNA dam age w ithin  target c e lls , the
evidence to show  th a t  RBS c a u se s  DNA dam age w ith in  cells is 
probed  by u sin g  CHO and  its  DNA repa ir deficient m u ta n t x rs -5 
cells.
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4-1 Cytotoxic effect of RBS 
4-1-1 Introduction
There are  two m ain  w ays to erad ica te  cancer from a  patien t: locally 
an d  system ically . T rad itiona lly  c an c e r  w as locally  tre a te d  w ith  
su rg e ry  an d  rad io th erap y  before th e  option of system ic trea tm e n t 
w ith  ch em ica l c o m p o u n d s  b ecam e availab le . A b r ie f  c lin ica l 
rem iss io n  in  a  p a tie n t w ith  lym phom a given n itro g en  m u s ta rd  
d u rin g  W orld W ar II w as th e  firs t do cu m en ted  clin ical u se  of 
chem otherapy .
A nticancer d rugs m ay be classified into a nu m b er of families based  
on e ith e r  th e  m ode of a c tio n  or th e ir  orig in . T hese  in c lu d e  
a lkylating  agents, an tim etabo lites  and  n a tu ra l p ro d u c ts  th a t  have 
an tican ce r activity. A lkylating agen ts are  chem ically  diverse d rugs 
w h ich  m ay  p ro d u ce  a n  in te rm e d ia te  form  c o n ta in in g  e lec tron  
deficient, reactive  alkyl g roups. T hese d rugs undergo  a  p rocess 
know n as alky lation  in  w hich  th e  reactive alkyl g roup  covalently 
b in d s  w ith  chem ical g roups on biological m olecules th a t  have an  
excess of electrons. This re su lts  in a  cytotoxic effect on target cells. 
Alkylation of b a ses  in  DNA ap p ears  to be the  m ajor cause  of le thal 
toxicity.
A n tim etabo lite s, a re  co m p o u n d s w hich  m im ic th e  s tru c tu re  of 
no rm al m etabolites. They m ay com pete as s u b s tra te s  for enzym e 
activity  leading  to the  inh ib ition  of critical b iochem ical pa thw ays. 
M ost d ru g s  in th is  fam ily in h ib it nucle ic  acid sy n th e s is  e ith e r 
directly  or indirectly  and  tend  to be cell cycle dependent.
O ther chem o therapeu tic  agen ts are  draw n from  a  wide varie ty  of 
so u rces like an itb io tics, ho rm ones or p lan t ex tract. Som e of these
RBS 124
w ere d iscovered  by  p u re  c h an c e  an d  th e ir  o rig in  gives little  
indication as to their po ten tial activity against a  p a rticu la r tum or.
In ch em o th e rap y  an  im p o rta n t concep t is th a t  a  given dose or 
course  of th erap y  will kill a  c o n s tan t fraction of the  cell population  
ra th e r  th a n  a  c o n stan t nu m b er of cells and  gives a  greater fractional 
cell-k ill to  m ore rap id  grow ing tu m o r (Gregory, W. M. 1992). 
C hem otherapeu tic  agen ts dam age no t only tu m o r cells b u t  norm al 
tissu e , the  only reason  th a t  chem otherapy  is feasible is th a t norm al 
tissu e  m ay recover som etim es m ore rapidly th a n  the  tu m o r cells.
Nitric oxide (NO) h a s  been  a h o tsp o t of re sea rch  in  recen t years 
an d  is a n a tu ra l p ro d u c t accoun ting  for several sep ara te  biological 
functions w ithin the h u m an  body. NO had  been identified as a  vessel 
d ila to r. As re p re se n tin g  a  com plete ly  novel c la ss  of n e u ro n a l 
m essen g er. Also as a n  effector m olecu le  re le a sed  by m u rin e  
m acro p h ag es and  o th e r cells a fte r im m unological activa tion . At 
p re se n t the  only clearly  estab lish ed  role for NO is a s  a  cytotoxic 
m olecule aga in st invading m icroorganism s and  tu m o r cells. Several 
m ech an ism s for th e  cytotoxic effect of NO have b een  p roposed  
including: toxic free radical, inh ib ition  of m itochondrial resp ira tion , 
iron loss, inhibition of DNA syn thesis and  DNA dam age.
R oussin 's  b lack  sa lt (RBS) h as  been  dem onstra ted  to be a novel NO 
donor. It co n ta in s  seven n itrosy l g roups linked to an  iro n -su lp h u r 
fram ew ork, once in so lu tion  it will decom posed to release NO. The 
vasodilatory  effect of RBS is blocked by hem oglobin and  accelerated 
du ring  exposure to light (À = 514.5  and  457.9  nm ).The cytotoxicity 
of RBS h as  been  investigated using  two h u m an  uro thelia l cell lines: 
SV-HUC-1 (derived from  n o rm al tissue) an d  T24 (derived from  
cancerous tissue). Thiotepa, an  alkylating agent, is widely u sed  for 
local trea tm e n t of b ladder cancer. For the  pu rpose  of com parison.
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th e  cy to tox ic ity  of th io te p a  a lso  w as perfo rm ed  u s in g  b o th  
phenotypes of h u m an  urothelia l cells.
4-1-2  Procedures
4-1-2-1 G row th inh ib ito ry  effects of RBS on exponentia lly  growing 
cells
1x10^ ce lls /f la sk  of T24 cells or 1.5x10^ c e lls /f la sk  of SV-HUC-1 
ce lls  w ere  se ed e d  in  25  cm2 fla sk s  w ith  5 m l of se ru m  
su p p le m e n te d  m ed ium . C ells w ere in c u b a te d  u n d e r  s ta n d a rd  
c o n d itio n s  for 48 h o u rs  a n d  allow ed to a t ta c h  an d  achieve 
exponentia l grow th. The s u p e rn a ta n t w as rep laced  w ith  4 .5  ml of 
se ru m  free m ed ium  afte r two rin se s  w ith  PBS The w hole flask  
(except cap) w as covered w ith tin  foil to exclude light. 0 .5  ml of ten  
tim es final concen tra tion  of d rug  (RBS) dissolved in  PBS w as added 
(0.5 ml of PBS only for control group) to begin the  assay . All a ssay  
p rocedu res were perform ed in  a darkened  room and  a lam p (40W) 
filte red  w ith  ILFORD 904  safe  lig h t g lass  w as u se d  a s  a n  
illu m in a tio n  so u rce . A fter a  6 0 -m in u te  (or d es ig n a ted  period) 
incubation  a t 370C and  the m edium  containing the  d rug  w as sucked 
o u t and  th e  tin  foil cover w as rem oved. F lasks w ere rin sed  twice 
w ith  PBS and  5 m is of fresh  se ru m  supp lem ented  cu ltu re  m edium  
added . In cuba tion  w as con tinued  for a  period of a t lea s t two cell 
doubling  tim es ( 2 days for T24 cells, 4 days for SV-HUC-1 cells). 
D u ring  th is  period th e  cells in  th e  con tro l g roup  (PB S-treated) 
w ere in  exponen tia l grow th. Cells in  all tre a tm e n t g roups were 
d isp e rse d  w ith  t ry p s in  a n d  d ilu te d  in  se ru m  su p p le m e n te d  
m edium . The to tal volum e of cell su spension  p re sen t w as im portan t 
to allow the calcu lation  of the  to ta l num ber of viable cells. Viable
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ce lls  .w h ich  d id  n o t  s ta in  g ree n , w ere  c o u n te d  w ith  a 
hem ocy tom eter a fte r s ta in in g  cells for 1 0  m in u te s  w ith  2 % fas t 
g reen  [2-16]. R esu lts  w ere expressed  as th e  ra tio  of cell grow th, 
defined by the  ratio  of viable cells in  d rug  trea ted  popu la tions to 
n on -d rug  trea ted  populations.
0 .1 5M NaCl so lu tion  w as used  to dissolve drug and  as cu ltu re  fluid 
du ring  the cytotoxicity a ssay  of "Thiotepa".
98% of SV-HUC-1 cells w hich were incuba ted  for 30 m in u tes  in  a 
65°C  w ater b a th  were positively sta ined  w ith fast green  th u s  th is  
w as u sed  as a  non-viable cell control. For each  grow th inh ib ition  
curve, flasks were counted  in  trip licate  for each trea tm e n t.
4 -1 -2 -2  G row th  in h ib ito ry  effects of la s e r - ir ra d ia te d  RBS on 
exponentially  growing cells
L aser irrad ia tio n s  w ere conducted  in a  la se r equipped labo ra to ry  
w hich  w as darkened . A red safelight (60W) w as u sed  a s  the  sole 
m ean s of illum ination . An Argon ion la se r (Spectra  Physics Ltd., 
type 168-09) w as the  source  of irrad ia ted  light an d  4 5 7 .9nm  wave 
length  light used .
The p rocedures were the  sam e as above b u t PBS in stead  of se rum  
free m ed ium  w as u se d  as c u ltu re  fluid for th e  period  of d rug  
exposure. This w as to avoid phenol red in the  m edium  in terfering  
’W ith  light absorp tion  by RBS. A selected in tensity  of laser light w as 
u se d  to irrad ia te  th e  cells an d  tin  foil w as rem oved du rin g  th a t  
period. The control group received only PBS.
4-1-2-3  Hem oglobin su p p re ss io n  of the  growth inh ib ito ry  effects of 
RBS
F erro -haem og lob in  w as p rep a red  as  m en tioned  in  [2-18-1] The 
p ro ced u res  w ere th e  sam e as  above w ith  th e  ad d itio n  of ferro- 
haem oglobin  so lu tion  ju s t  before cells w ere irrad ia ted  w ith  la se r
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light. C ontrols were trea ted  iden tically  b u t no d ru g s were added. 
The absorbance  of light by the  so lu tion  w as determ ined by a  double 
beam  spectrophotom eter.(C ecil, CE594, UK).
4-1-2-4  T urnbu ll reaction  of R B S-treated cells
5x10^  T24 cells were grown on a  g lass slide overnight. Cells were 
trea ted  w ith  lO '^ M RBS (w ithout RBS trea tm en t as control). They 
th en  underw en t the  T urnbu ll reaction  [2-21].
4-1-3 R esult
4-1-3-1 Growth inhibitory  effects of d rugs on exponentially  growing 
cells
E xperim en ts were perform ed to determ ine if th e  cytotoxic effects 
caused  by exposing growing cu ltu re s  of h u m a n  u ro the lia l cells to 
RBS could  be q u a n tita tiv e ly  an d  rep ro d u c ib ly  a s se s se d  u s in g  
different cell pheno types (tum origenic: T24, non-tum origen ic: SV- 
HUC-1).
In experim ents w here a  concen tra tion  of lOpM RBS or m ore w as 
u se d  very  few viable cells cou ld  be co u n ted . However, if th e  
concen tra tion  u sed  w as less th a n  IpM th en  no obvious cytotoxic 
effects on  cells w ere sh o w n  (Fig. 4 -1-1). T h u s  a  ran g e  of 
co n cen tra tio n s  betw een IpM  to lOpM of RBS w as u sed  in  these  
assays.
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Fig. 4-1-1 Growth ratio of SV-HUC-1 cells after treatment with RBS for 1 hour. At a 
range of IjiM to 10|oM, cells have 1 to 99% of growth inhibition.
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Fig. 4-1-2  Growth ratio of SV-HUC-1 and T24 cells after treatment with different 
concentrations of RBS for 1 hour. ID5o=5.16|iM for SV-HUC-1 and ID50=4.96jj.M for 
T24 cells.
Cells w ere exposed  to d ifferen t c o n c e n tra tio n s  of RBS for 60 
m in u tes  and  re su lts  show ed th a t  grow th inh ib ition  in  bo th  h u m an  
u ro th e lia l cell pheno types w as d ep en d en t on co n cen tra tio n . The 
re sp o n se s  w ere s im ila r w ith  ID5o=5.16|u.M for SV-HUC-1 a n d
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ID5o=4.96!aM for T24 cells (Fig. 4-1-2). The ID50 w as defined as 
the  concen tra tion  of d rug  w hich inh ib ited  grow th of the  ta rg e t cells 
by 50%.
T he le n g th  of tim e  cells  w ere exposed  to  th e  d ru g  w as a 
d e te rm in a n t  fac to r  of th e  g row th  In h ib ito ry  effect of RBS. 
Increasing  the  exposure  period of SV-HUC-1 cells to 4|iM of RBS 
from  60 m in u te s  to 1 2 0  m in u te s  resu lted  in a  decreased  grow th 
ratio  relative to controls of 0.5 to 0.25. Sim ilarly for SV-HUC-1 cells 
increased  exposure tim e for h igher concen tra tions of RBS resu lted  
in  g rea ter grow th inhib ition . For exam ple, the relative grow th ratio  
of SV-HUC-1 cells after a  60 m inu te  exposure to 7pM of RBS w as 
0.2, w hilst the  sam e cells exposed to 7pM of RBS for 120 m inu tes 
show ed only a  0.01 relative grow th ratio  (Fig. 4-1-3).
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Fig. 4-1-3 Growth ratio of SV-HUC-1 cells after treatment with 4|liM and 7jiM  RBS 
for lengths of time varying from 30 to 240 minutes.
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Fig. 4-1-4  Growth ratio of SV-HUC-1 and T24 cells after treatment with different 
concentrations of Thiotepa for 1 hour.
T hio tepa  is u sed  as an  an tica n ce r d rug  w ith  a  co n cen tra tio n  of 
1 m g /m l in the  c lin ical tre a tm e n t of b lad d er cancer. A range of 
co n cen tra tio n s  of O .lm g /m l to Im g /m l of th io tep a  w as u sed  to 
a s s e s s  th e  cy to tox ic  effect of th is  d ru g  u n d e r  th e  sam e  
experim en tal condition  u sed  to te s t  the  toxicity  of RBS. R esu lts  
show ed th a t  the  inhib ition  of grow th of h u m an  uro thelia l cells after 
exposure  to th io tep a  w as dose-dependen t. S im ilar resp o n ses were 
observed in  bo th  tum origenic and  non-tum origen ic  cells (Fig. 4-1- 
4).
4-1-3-2 Photosensitivity  of RBS
T24 cells were used  as ta rg e t cells to exam ine the photosensitiv ity  
of RBS. Cells were trea ted  w ith different concen tra tions of the  d rug  
and  e ither exposed to light a t a  d istance  of 150 cm  from  an  SOW 
flu o rescen t light, or k ep t in  d a rk  (as a com parison) for 1 hou r. 
Viable cells were coun ted  a t the  defined end point. By com paring
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th e  grow th ra tio  of cells irrad ia ted  w ith  light relative to  cells kep t 
in  th e  d a rk  it could  be d e m o n s tra te d  th a t  lig h t en h an ced  th e  
cytotoxic effect of RBS. R esu lts  in  Fig. 4-1-5  show  a  significantly  
enheinced cytotoxic effect w as observed in  cells trea ted  w ith  IpM of 
RBS and  irrad ia ted  w ith  light (p<0.01). No viable cells w ere found 
u n d e r  th e  sam e cond itions w hen  cells were trea te d  w ith  lOpM of 
RBS (data no t shown).
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Fig. 4-1-5  Growth ratio of IfiM RBS-treated T24 cells after either irradiation or 
deprivation from light for 1 hour.
To control the  p a ram eters  of light in tensity  and  wave length, a ssay s 
w ere perform ed in  a  la se r ligh t equiped an d  da rk en ed  laboratory . 
Light w ith  a  wave leng th  of 457 .9  nm  w as chosen  for its  optim al 
ab so rp tion  by RBS w ith  th e  p a rticu la r laser available (Appendix III 
p e rso n a l com m unication  w ith  Dr. I. Megson). It w as directed via a  
silver fron t m irror creating  a  45 cm^ irrad ia tion  field w here cu ltu re  
spec im ens w ere located . T his ligh t itse lf h ad  no obvious grow th 
inh ib ito ry  effect on cells a t  in ten sitie s  of u p  to 120 mW (data no t 
show n).
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C ells w ere tre a te d  w ith  d iffe ren t c o n ce n tra tio n s  of RBS an d  
ir ra d ia te d  w ith  an  in te n s ity  of 5mW of specified  ligh t for 40 
m in u te s  or k ep t in  d a rk  for th e  sam e period. V iable cells were 
co u n ted  a t th e  defined endpo in t [4-1-2] and  the  ra tio  of grow th 
relative to contro ls p lotted. R esu lts show ed th a t  the  cytotoxic effect 
of RBS w as significantly enhanced  by irrad iating  w ith  light (Fig. 4-1- 
6 ). For exam ple the  grow th ra tio  of cells trea ted  w ith  4 pM RBS 
and  k ep t in d a rk  w as 0.1. A decrease  to 0 .02 w as found for cells 
trea ted  w ith  an  identical concen tra tion  of RBS b u t irrad ia ted  w ith 
5mW light.
1
I
I
0 -
4 6 820
In dark 
In  lig h t
Concentration of RBS (pM)
Fig. 4-1-6  Growth ratio of T24 cells after treatment with different concentrations of 
RBS and either irradiated with 5mW of laser light (A,=457.9 nm) or light deprivation 
for 1 hour.
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Fig. 4-1 -7 Growth ratio of 2jiM or 3p.M RBS-treated T24 cells after irradiation with 
different intensities of laser light (A.=457.9 nm) for 40 minutes.
The In ten sity  of light w hich  the  cells were irrad ia ted , influenced 
the  in h ib ito ry  effect of RBS. For T24 cells given 2fiM of RBS 
in creasin g  the  in te n s ity  of light from  2mW  to 8 mW  re s u lt  in  a 
decrease  in grow th ra tio  relative to controls of 0 .84  to 0 .33 (Fig. 4- 
1-7). The sam e observation i.e an  increase  in  grow th inhib ition  w as 
m ade w ith  respec t to increased  in tensitie s  of light for cells trea ted  
w ith  different concen tra tions of RBS (Fig. 4-1-7).
4 -1 -3 -3  Haem oglobin su p p re ss io n  of the  grow th inh ib ito ry  effects 
of RBS
Haem oglobin is a  scavenger of NO and  h a s  been  show n to block the 
vaso -d ila to ry  effects of RBS. Several experim en ts w ere perform ed 
to e s ta b lish  w h e th e r haem og lob in  m ight p rev en t th e  cytotoxic 
effect of RBS.
B ecause  v e rteb ra te  haem og lob ins co n s is t of 4 hem e con ta in in g  
polypeptide cha in s and  RBS con ta in s seven n itrosyl groups linked
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to a n  i ro n -s u lp h u r  fram ew ork , doub le  th e  c o n c e n tra tio n  of 
haem oglobin to RBS w as used  in these  experim ents.
T24 cells w ere tre a te d  w ith  7pM of RBS for 60  m in u te s . The 
cytotoxic effect of RBS w as m arkedly  reduced by  the  add ition  of 15 
pM of bovine haem oglobin (Fig. 4 -1 -8a). The sam e observation w as 
m ade w hen specim ens were exposed to light (Fig. 4 -1 -8b).
□  w ith  heam oglobin  (1)
 ^0 -g 0  w ith o u t h ea m o g lo b in  (2)
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Fig. 4-1-8  Growth ratio of RBS-treated T24 cells with or without haemoglobin, (a) 
Cells were treated with 7p.M RBS and kept in dark for 1 hour, (b) The same treatment 
as in (a )but with I hour light exposure, (c) Cells were treated with 50pM AB-RBS and 
exposed to light for 1 hour.
However, by  u s in g  a co lum n gel-chrom otograph  (colum n PD-10, 
P harm acia , Sweden) analy sis  show ed th a t  m olecules of RBS were 
tightly bound  to bo th  haem oglobin and  bovine a lbum in  (Fig. 4-1-9). 
Cytotoxicity of a lbum in bound  RBS (AB-RBS) w as th u s  assessed .
The grow th ratio of cells trea ted  w ith  SOpM of AB-RBS and  exposed 
to light w as 2 log h igher th a n  cells w hich were trea ted  w ith 7pM of 
u n b o u n d  RBS (Fig. 4-1-8  b 2 /c2 ). T h u s a lbum in  itself m ay p ro tec t 
cells against the cytotoxic effect of RBS.
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Sim ilarly, haem oglobin  had  a add itional protective effect on cells 
trea ted  w ith  AB-RBS and  irrad iated  w ith light (Fig. 4 -1 -8c)
Roussins Black Salt 
Na[Fe4S3(NO)7] 
Only
Roussins Black Salt 
&
Bovine Hemoglobin
Roussins Black Salt 
&
Bovine Album in
Fig. 4-1-9  Photograph of colum n chromatography after run through of solution  
containing (A) Bovine albumin and RBS. (B) RBS. (C) Bovine haemoglobin and RBS. 
Arrow head indicate that RBS was held up by resin. RBS bound to albumin and 
haemoglobins thus run through the column.
In  fu rth er te s ts  haem oglobin suppressed  the cytotoxicity of AB-RBS. 
Cells were trea ted  w ith 50pM of AB-RBS th en  exposed to different 
in tensitie s  of 457.9  nm  wave length laser light. A concen tra tion  of 
5|LtM of haem og lob in  w as u sed  in th is  ex p erim en t b e c a u se  it 
perm itted  a significant am o u n t of light to tran sm it th rough  solution. 
By using  a spectropho tom eter it w as determ ined th a t  41.6%  of the 
light w as absorbed by an 1 cm depth  of 5pM haem oglobin. T hus in a
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d ep th  of 2 m m  {solution dep th  in  the  experim ent) the  abso rbance  
will be 8.3%  w ith  91.7%  of ligh t p a ss in g  th ro u g h  so lu tio n  and  
reach ing  the  cells. To en su re  th a t  the  sam e in ten sity  of light w as 
delivered to cells in the  so lu tion  con tain ing  5 pM haem oglobin and  
cells in  the  so lu tion  w ith o u t haem oglobin  d ifferent in ten sitie s  of 
ligh t w ere u sed . The cells in  haem oglobin  received a  120mW  of 
light w h ilst these  cells in  so lu tion  w ithou t haem oglobin  received 
llO m W  of ligh t ( 120x91.7% = 110). By co m p arin g  th e  rela tive  
g row th  ra tio  for th e se  cells i t  w as fo und  th a t  haem og lob in  
significantly  (p<0.05) decreased  th e  cytotoxicity of AB-RBS (Fig. 4-
1- 10).
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Fig. 4-1-10  Growth ratio of SGiiM AB-RBS-treated T24 cells with or without 5gM 
haemoglobin after irradiation with different intensities of laser light (X=457.9 nm) 
for 40 minutes.
4-1-3-4  T urnbu ll reaction  of R B S-treated cells
In Fig. 4-1-11, it can  be seen  th a t  R B S-treated cells becam e b lue 
(while control cells d id n ’t change color) after the  T u rnbu ll reaction. 
T his ind ica ted  th a t  fe rrous sa lt h ad  b o u n d  d irectly  to th e  RBS-
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trea ted  cells. B ecause RBS itself is a ferrous sa lt th en  th is  b ind ing  
ferrous sa lt m ight be the RBS.
Fig. 4-1-11 RBS-treated T24 cells after the Turnbull reaction. Blue color indicated 
bound ferrous salt. Bar =1.1 |im.
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4-1-4 D iscussion
New a n tica n ce r ag en ts  need  to  be te s ted  in vitro to d em o n s tra te  
th e ir  ce llu la r tox ic ity  before fu r th e r  in vivo  in v es tig a tio n s  a re  
perfo rm ed . T here  a re  sev era l m e th o d s  to a s s e s s  th e  ce llu la r  
dam ages caused  by  an tican ce r d rugs and  these  can  be divided into 
clonogenic and  nonclonogenic assays.
Clonogenic assays
T hese are u sed  to m easu re  cell survival after d rug  trea tm en t. Cells 
a re  exposed to the  drug, followed by  plating a t different d ilu tions in 
Petri d ishes an d  in cu b a tio n  for a  period of tim e (usually  2 weeks). 
Colonies w hich form on the  d ishes rep resen t the  surviving fraction 
of th e  colony form ing cells (CFC). D rug  effects c an  be estim ated  
from the  survival ra te  of CFC. Colony form ing cells have a  very large 
p o ten tia l for proliferation and  th e ir  le thality  rep re sen ts  the  cu re  or 
long term  rem ission  of the  tu m o r w ith  trea tm en t (Roper, P. R. e t al 
1976). R equ irem ents of th is  a ssa y  a re  the  p ro d u ctio n  of a single 
cell su sp e n s io n  an d  th a t  th e  cells d e m o n s tra te  a  h igh  p la tin g  
efficiency (Bhuyan, B. K. e t al 1976). In addition , a  p roportional 
re la tionsh ip  betw een the  n u m b er of cells p lated  and  th e  n u m b er of 
co lon ies grow ing in  th e  n o n  d ru g -tre a te d  g roup  sh o u ld  ex is t 
(H am burger, A. W. 1981).
Nonclonogenic assays
DNA p re c u rso r  u p ta k e  a s sa y s  th a t  m e a su re  rad io ac tiv e  DNA 
p re c u rso r  in c o rp o ra tio n  c an  be u se d  a s  a n  in d ex  co rre la tin g  
in h ib itio n  of DNA sy n th e s is  w ith  cell d ea th . D ru g  effects a re  
e s tim ated  from  th e  changed  ra te  of in co rp o ra tio n  of rad ioactive  
p recu rso rs  in to  DNA. It can  however be u n d e r estim ated  due to the  
d ru g - in d u c e d  d e p re ss io n  of lab e led  n u c le o s id e  t r a n s p o r t  or
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c h an g es  in  n u c leo tid e  pools, a n d  over e s tim a te d  d ue  to th e  
blocking of de  novo p a thw ay  in  the  presence  of an tim etabo lites of 
DNA p recu rso rs  [eg. 5-fluorouracil (5FU)] and  enhanced  u tilization  
of exogenous labeled nucleoside (Miyazaki, N. et al 1992). The u se  
of these  techn iques w ith  com pounds w hose m echanism (s) of action  
are n o t know n m ay no t be feasible (Hamburger, A. W. 1981).
The té trazo lium  assay , w hich  m ea su re s  th e  inh ib ition  of cellu lar 
m etab o lism , is  b a se d  on  th e  ab ility  of live cells to  red u ce  a 
te tra z o liu m -b a s e d  co m p o u n d  [3 -(4 ,5 -d im e th y lth iazo l-2 -y l)-2 ,5 - 
d ipheny lte trazo lium  brom ide ] (MTT) to a  b lue  form azan  p ro d u ct 
(Black, M. M. e t al 1953). D rug effects were ca lcu la ted  from  the  
p e rc e n t  c h an g e  of lig h t a b so rb a n c e . T h is  a s s a y  does n o t 
differentiate betw een cytosta tic  and  cytocidal effects on cells and  a 
h igh  back g ro u n d  value will ex ist if m edium  con ta in ing  se ru m  or 
phenol red  is u sed . The a ssay  is lim ited by the fact th a t  m axim al 
ab so rbance  for m any  h u m a n  tu m o r cell lines is approxim ately  1.0 
abso rbance  u n it (Carm ichael, J .  e t al 1987). Chem ical reduction  of 
th e  té trazo liu m  by th e  te s t  ag en ts , chem ical in te rfe ren ce  w ith  
ce llu la r red u c tio n  of té trazo lium  (Alley, M. C. et al 1988) and  a  
v a rie ty  of m etab o lic  c o n d itio n s  (eg. d ep le tion  of g lucose, pH 
changes) (Vistica, D. T. et al 1989) w hich m ay a lte r the  p roduction  
of fo rm a z a n  from  té tra z o liu m  c an  lead  to  a n  in a c c u ra te  
de te rm ina tion  of the  q u an tity  of living cells (R ubinstein, L. V, e t al 
1990).
A screen ing  assay , u sed  by the  N ational In stitu te  of H ealth  (NIH) in 
the  United S ta tes, is u sed  as the initial a ssessm en t of d rugs aga in st 
a panel of h u m an  tu m o r cell lines, u sing  au tom ated  sta in ing  w ith 
sulforhodom ine-B  (SRB) to a sse ss  the n u m b er of viable cells a fter 
d rug  induced  cytotoxicity. SRB is a  b righ t pink am inoxan thene dye
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w ith 2 sulfonic g roups and  is u sed  as a  p ro tein  s ta in . It b inds to 
basic  am ino acid residues of p ro tein  in TCA-fixed cells to provide a 
sensitive index of cellu lar pro tein  con ten t hence a sensitive m ethod 
for m easu ring  d rug  cytotoxicity in  culture. B ackground levels of RBS 
s ta in in g  a re  sensitive  to th e  leng th  of TCA fixation  an d  se ru m  
co n cen tra tio n  in  th e  c u ltu re  m ed ium  (Skehan, P. e t al 1990), in 
ad d itio n  it s ta in s  dead  non-lysed  cells a s  well , so it m ay over 
estim ate  the surviving fraction of cells (Rubinstein, L. V. e t al 1990).
In vital s ta in  assays, dye exclusion is u sed  as an  ind ica to r of cell 
m em brane integrity . As the  m em branes of cells becom e perm eable 
to dyes th e y  a lm o st ce rta in ly  lose th e ir  c lonogenic  capac ity , 
how ever a large n u m b er of le th a lly  dam aged  cells m ay ap p ea r 
"normal" and  m ay exclude dyes for a sh o rt in terval after trea tm en t.
L. M. W eisenthal (1983a) used  fast green as a  vital s ta in  to estim ate 
d rug  cytotoxicity from  the  change in the  ratio  of living cells.to an  
in te rn a l  s ta n d a rd . He a s se s s e d  th e  d ru g -in d u ce d  cy to toxicity  
several days after d rug  exposure thereby allowing for the  expression 
of le th a l dam age and  th e  p ro life ra tion  of su rv iv ing  cells. D a ta  
ob tained  by th is  m ethod  corre la tes well w ith  th a t  from  clonogenic 
assays (W eisenthal, L. M. et al 1983b, Reznikoff, C. A. et al 1986).
If cell lin es a re  to be u se d  for p rec lin ical d ru g  sc reen in g  it  is 
n ecessa ry  th a t  in vitro d rug  sensitiv ities rem ain  relatively stab le  in 
long-term  cu ltu re . The T24 cell line is repo rted  to have a s tab le  
d ru g  re s p o n se  in  lo n g -te rm  c u ltu re , th e re fo re  p ro v id in g  a  
rep resen ta tive  m odel of h u m a n  b ladder cancer and  a n  econom ical 
system  for estim ating  the  cytotoxic activity of d ru g s in preclin ical 
s tu d ies  (M asters, J .  R. W. e t al 1986). A nother cell line investigated 
in  th is  p ro je c t, SV -H U C -1, h av e  a p la t in g  e ffic ien cy  of 
approxim ately  9% a t 1000 cells per d ish , however, no co n sis ten t
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propo rtiona l re la tio n sh ip  could be found  betw een the  n u m b er of 
cells p lated  and  the  n u m b er of colonies observed. This observation  
m ay be due to difficulties associated  w ith the p roduction  of a  single 
cell su sp en s io n  (Finlay, G. J .  1984). It is very difficult to accura tely  
m an ip u la te  the  96 well p late  in  the  d a rk  so it w as decided to u se  
th e  fas t green \4tal s ta in  a ssa y  to determ ine the  inh ib ition  of cell 
p ro liferation  induced  by RBS. The to ta l n u m b er of living cells is 
counted  therefore there  is no in te rnal s tan d a rd  (eg. duck  red blood 
cell) u se d  and  b ecau se  th e re  is no need to d is tin g u ish  betw een  
tu m o r and  non tum or cells no coun ter-sta in ing  is required.
By u sing  viable cells counted  2 cell doubling tim es after cells were 
trea te d  w ith  d rugs a s  the  end point, the  cytotoxicity of RBS w as 
assessed.
The cytotoxic resp o n ses of h u m a n  u ro thelium  to RBS were related 
to th e  d ru g  c o n ce n tra tio n s  (Fig. 4-1-2) an d  to th e  d u ra tio n  of 
exposure (Fig. 4-1-3).
The grow th in h ib ition  of u ro th e liu m  from  d ifferen t donors a fte r 
exposure  to th io tep a  (Fig. 4-1-4) or RBS (Fig. 4-1-2) w ere sim ilar. 
T his re s u lt  w as n o t u n ex p ec ted  as th io te p a  is a  d irec t-ac tin g  
alkylating agen t and  therefore m etabolic differences in  b ioactivation 
betw een cells is no t a  factor (Reznikoff, C. A. e t al 1986). F u rth e r  
m ore, cells were trea ted  w ith  RBS for 1 h o u r in  m ost cytotoxicity 
experim ents, th is  period of tim e m ight be too sh o rt for a d rug  to be 
m etabolically  activate in  cells, hence it m ay be th a t  RBS is also a 
d irec t-acting  drug.
As m en tio n ed  p rev iously  a n tic a n c e r  d ru g s will give a g rea te r 
fractional cell-kill w hen u sed  ag a in st m ore rapidly  growing tum ors.
In ou r experim ents, only a  su b tle  difference in  cytotoxic effect of 
RBS on "norm al" cells (SV-HUC-1) an d  tu m o r cells (T24) w as
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observed. T his m ay be because  e ither ou r experim ental system  is 
n o t sensitive  enough  to d e tec t th e  difference or SV-HUC-1 cells 
them selves are n o t no rm al cells. U sing a panel of tu m o r cells to 
exam ine th e  cytotoxic effect of RBS m ay give a m ore generalized 
p ic tu re  of the  effect.
Cytotoxic responses of h u m a n  u ro teh lia l cells after trea tm e n t w ith  
RBS w ere enhanced  by la se r light irrad ia tion  and  w ere re la ted  to 
in tensity  (Fig. 4-1-6  & 7). A lbum in bound  RBS h a s  less of a  grow th 
inh ib ito ry  effect (Fig. 4 -1 -8c). It w as speculated  th a t  there  were two 
possible  m echan ism s by w hich  haem oglobin m ay rescue  cells from 
cytotoxic effects of RBS: (1) RBS w as b o u n d  to th e  haem oglobin  
therefore like a lbum in  bound  RBS the  extent of the  cytotoxic effect 
of RBS w as decreased; (2) Light w as absorbed  by the  haem oglobin 
th u s  the  in te n s ity  of ligh t delivered to RBS w as decreased  and  
therefore p resen ted  less of a  po ten tial cytotoxic th rea t. To ru le  ou t 
these  two specu la tions, cells were trea ted  w ith a lbum in  bound  RBS 
a n d  th e  in te n s ity  of ligh t w as a d ju s te d  to be eq u a l for each  
specim en. The re su lts  show ed th a t  haem oglobin  h a s  a  protective 
capacity  aga in st the  cytotoxic effect of RBS (Fig. 4-1-10).
The T u rn b u ll reac tio n  (Fig. 4-1-11) d e m o n s tra te d  th a t  RBS is 
b o u n d  to cells. T his phenom enon  m ight explain w hy th e  a lbum in  
b o u n d  RBS h ad  a reduced  cytotoxic effect com pared  to u n b o u n d  
RBS. RBS bind ing  directly  to cells will release toxic m olecules (eg. 
NO) d irec tly  in to  ta rg e t cell w h ils t RBS b o u n d  to a lb u m in  will 
re le a s e  tox ic  m o le cu le s  in to  th e  e n v iro n m e n t w h ich  will 
su b seq u en tly  perfuse  in to  ta rg e t cells. T hus h igher concen tra tions 
of the  d rug  are needed to achieve the  sam e toxic effect.
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RBS m ight release NO to carry  o u t the  blood vessel dilatory effects. 
T h is effect w as en h an ced  by irrad ia tio n  w ith  la se r ligh t an d  w as 
blocked by  NO scavenger-haem oglobins (Flitney, F. W. e t al 1992).
In o u r experim ents the  cytotoxic effects of RBS w ere en h an ced  by  
irrad ia tio n  w ith  la se r  ligh t an d  w ere m inim ised  by haem oglobin. 
T h u s we m ight propose th a t  NO m ay play a  role in  the  m echan ism  
of RBS cytotoxicity.
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4-2 RBS causes DNA damage w ithin target cells 
4-2-1 Introduction
Cells w h ich  differ in  rad io sen sitiv ity  m ay be u se d  to s tu d y  th e  
ex istence in  cells of repa ir m echan ism  for dam age caused  by som e 
a n tica n ce r d rugs, and  th e  re la tio n sh ip  betw een DNA dam age and  
loss of proliferating capacity . C hinese h am ste r ovaiy cell line (CHO- 
K l) a n d  its  X -ray sensitive  m u ta n ts  x rs, provide a  p a rticu la rly  
su itab le  cellu lar m odel (D ahm -D aphi, J .  e t al 1993). x rs-5  is one of 
six X -ray sensitive m u ta n ts  w hich  were derived from  CHO-Kl cells 
by P. A. Jeggo (1983). The m echan ism  of x -ray  sensitiv ity  m ay differ 
from a tax ia  te lang iectasia  (AT) cells because  xrs DNA syn thesis  after 
gam m a-irrad ia tion  show s a  g rea te r degree of inh ib ition  com pared 
to th e  CHO cells (Jeggo, P. A. 1985). x rs-5  show s a  m oderate  level 
o f h y p e r s e n s i t iv i ty  to  UV (2 5 4 n m ) l ig h t  a n d  m e th y l 
m e th a n e su lp h o n a te  (MMS) tre a tm e n t. MMS will c a u se  a  large 
n u m b e r of single s tra n d  b rea k s  of DNA in  the  trea te d  cells. The 
rep a ir  of th ese  single s tra n d  b reak s  h a s  been  show n to be norm al 
(Kemp, L. M. e t al 1984). how ever th e re  is a  d ecrease  in double 
s tra n d  b reak  rejoining (Kemp, L. M. et al 1984; D ahm -D aphi, J .  e t  
al 1993) w hich m ay rela te  to an  a ltera tion  of the  organization of the  
DNA or the  chrom osom e (Schwartz, J .  L. e t al 1990, 1993). 
C y tochalasin  B, a  m etabo lite  from  th e  m old "H elm in thosporium  
dem atiod ium " in h ib its  cy top lasm ic  cleavage an d  a n u m b e r of 
p rocesses concerned w ith  cell m ovem ent. It is believed to in te rac t 
w ith  m icrofilam ents ( W essells, N. K. e t al 1971 ) or directly  w ith  
p lasm a m em brane ( E stensen , R. D. e t al 1971 ). In the  presence of 
cy tochalasin  B n u c lea r division proceeds norm ally  b u t  cells fail to
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se p a ra te  com pletely and  m any  consecutive n u c lea r d ivisions m ay 
tak e  place w ith o u t cleavage ( C arter, S. B. 1967 ) however, DNA 
sy n th esis  is inhib ited  very rapidly  so th a t the  v a st m ajority  of cells 
becom e b in u c le a r  an d  do n o t undergo  fu r th e r  n u c le a r  division 
(Kelly, F. e t al 1973 ) b u t  th is  DNA sy n th esis  in h ib ition  is n o t 
observed  in  SV 40 tran sfo rm ed  cells hence  th ey  becom e highly 
m ultinuclea ted  ( W right, W. E, e t al 1972).
M icronuclei (MN) c o n s is t of acen tric  chrom osom e frag m en ts  or 
w hole chrom osom es th a t  have no t been  inco rpora ted  in  the  m ain  
nu c le i a t cell division. A nalysis of the  frequency  of m icronuclei 
p re s e n t  in a given cell p o p u la tio n  h a s  been  recogn ised  as  a  
com posite index of chrom osom e dam age (Sternes, K. L. et al 1989). 
In d u c tio n  of m ic ro n u cle i c an  be a  very sim ple  an d  sensitive  
ind ica tion  of rep a ir  deficiency w hen  cells a re  exposed in vitro to 
DNA dam aging agen ts (Arlett, C. F. e t al 1989). M. F enech  (1985) 
u se  cy tochalasin  B to block the  cytokinesis of dividing cells. Cells 
w hich have divided will accum ulate  a s  b inuclea tes and  scoring the 
m icronuclei in  th ese  cells can  overcome problem s of m itotic delay 
or differences in  cell cycle tim e an d  enhance  the  precision  of the  
MN assay . CHO and  x rs-5  cells, were th u s  u sed  to investigate  the  
possible m echanism  of action of RBS.
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4-2-2  Procedures
4 -2 -2 -1  C olony fo rm a tio n  a s s a y  of CHO a n d  x rs  cells to 
quantitatively  a sse ss  cytotoxicity of RBS
2 x l0 ^ /f la s k  of CHO or 4x10^ / f la s k  of x rs cells were grown in 25 
cm 2 flasks, k e p t in  a  s ta n d a rd  c u ltu re  cond ition  for 48 h o u rs , 
allowed to a tta c h  an d  grown in  exponentia l p h ase . M edium  w as 
rem oved  a n d  f la sk s  w ere  r in se d  tw ice w ith  PBS. D ifferen t 
co n cen tra tio n s  of d ru g  (RBS) dissolved in  PBS w ere added  (as a 
contro l PBS only w as added) and  flasks kep t a t 37^C  for 1 hour. 
F lasks were rin sed  twice w ith PBS and  cells detached  w ith TE. Cell 
n u m b ers  w ere ob ta ined  u sin g  a  hem ocytom eter. An ap p ro p ria te  
n u m b er of cells (200-10000) w ere p la ted  in  90m m  tis su e  cu ltu re  
grade Petri d ish es w ith  10 ml of 10% FCS (v/v) E agle's m inim al 
e s se n tia l  m ed ium  an d  k e p t in  a  5% COg in  air, 37^C  fu lly  
hum idified incubator. After 14 days the m edium  w as poured  out and  
th e  d ishes w ere rin sed  w ith  PBS. Cells were fixed w ith  m ethano l 
for 10 m inu tes and  s ta in  w ith  10% (v/v) G iem sa [BDH] In w ater, for 
10 m in u tes  and  air-dried . Colonies conta in ing  m ore th a n  50 cells 
w ere sco red  a s  th ey  w ere considered  to o rig ina te  from  colony- 
form ing cells Betw een 20 and  450 colonies were coun ted  for each 
trea tm en t. The percen tage  of survival w as calcu lated  by reference 
to contro ls. For each  survival curve, trip licate  d ishes were seeded 
p er  trea tm en t.
4-2-2-2 M icronuclei a ssay  of RBS -treated  CHO and  x rs cells 
4x10^  CHO or 6x10"^ x rs cells were grown in  a  24 well flat bottom  
tis su e  cu ltu re  p late and  kep t in a  5% CO2 in  air, 37°C, hum idified 
in cu b a to r for 48 ho u rs , allowed to a tta c h  and  grow exponentially .
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The p la te  w as rinsed  twice w ith  PBS before 1 ml of 10 p.M RBS in 
PBS w as added  to each  well (control cells received PBS only). The 
p la te  w as k ep t a t room  te m p e ra tu re  for 40  m in u te s . RBS w as 
rem oved an d  the  p late  rin sed  twice w ith  PBS. 1 m l of 10% FCS 
E agle 's m inim al e ssen tia l m ed ium  w as added  to each  well th e n  
cytochalasin  B (Cyto B; stock  solution 3 m g/m l in DMSO) w as added 
to give 3 final concen tra tion  of 3 )ig/m l. The plate w as kep t in a  5% 
CO 2  in  air, 37°C, hum idified in cu b a to r for 16-24 ho u rs . Cells were 
de tached  w ith  TE and  d ispersed  onto clean slides by centrifugation  
u s in g  a  S h an d o n  C ytospin  2 (800 rpm  for 10 m in). S lides were 
fixed in m ethano l for 10 m in u tes , sta in ed  in  56% (v/v) J e n n e r  in 
w ater for 5 m inu tes and  25% (v/v) G iem sa in  w ater for 10 m inu tes, 
w ith  rin sing  in  w ater after each  s ta in . B inuclear cells con ta in ing  
m icronuclei clearly sep a ra ted  from and  sm aller th a n  o n e -ten th  of 
the  m ain  nuc leus, were scored (Arlett, C. F. et al 1989). A to ta l of 
100 b inuclea te  cells were scored per  sam ple and  a t least 3 sam ples 
w ere de te rm ined  p e r  experim ent. R esu lts  were expressed  as the  
to ta l n um ber of m icronuclei per  100 b inucleate cells.
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4-2-3 R esult
4-2-3-1 Clonal a ssay  of CHO and  x rs cells to quan tita tive ly  a sse ss  
cytotoxicity of RBS
Cells were trea ted  w ith  different concen tra tions of RBS for 1 hour, 
a n  appropria te  n u m b er of cells were seeded in 90m m  tissu e  cu ltu re  
grade petri d ishes. D ishes contain ing  10 ml of se rum  supp lem ented  
m ed ium  w ere in c u b a te d  for 14 days. P la tes w ere s ta in e d  and  
colonies were counted. R esu lts showed th a t the survival of CHO and 
x rs  cells a f te r  t r e a tm e n t  w ith  RBS w as d e p e n d e n t on  RBS 
concen tra tion . A significantly  increased  cytotoxic effect of RBS w as 
no ted  in  x rs cells(Fig. 4-2-1). For exam ple, a  m ore th a n  one log 
difference of survival betw een CHO and  xrs cells w hen trea ted  w ith 
4|iM of RBS.
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Fig. 4-2-1 Survival of CHO and xrs cells after treated with different concentrations 
of RBS for 1 hour.
4-2-S-2 M icronuclei a ssav  of R BS-treated CHO and x rs cells 
F u rth e r  assess in g  th e  possib ilities of DNA dam age caused  by  RBS 
w as carried  ou t u sing  the  m icronuclei assay. Cells grown in flasks
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were trea ted  w ith lOpM RBS ( w ithou t d rug  trea tm e n t as controls) 
for 40  m in u te s  in  th e  d a rk . D rugs w ere rep laced  w ith  fresh  
m edium  contain ing  cy tochalasin  B an d  in cuba ted  for 16-24 hours. 
Cells w ere de tach ed  and  d ispersed  onto clean  slides. Micro nuclei 
sm alle r th a n  one te n th  of th e  m ain  nucle i w ere scored  per 100 
b in u c lea r cells after cells were fixed an d  sta ined . R esu lts in  Fig. 4-
2-1 show ed x rs cells have h igher back  ground level of m icronuclei 
fo rm atio n . F u r th e rm o re  a  s ig n ifican tly  in c re a se d  n u m b e r  of 
m icronuclei appeared  in R B S-treated x rs cells. For exam ple in  one 
experim ent, average m icronuclei in  100 b in u c lea r CHO cells w as 
4 .5 7 + 0 .3 3  w h ich  in c re a s e d  to  4 .98+ 0 .51  a fte r  10 pM RBS 
trea tm en t(p < 0 .3 7 5 ), w hile in  x rs  cells n u m b e r  of m ic ronucle i 
changed from 9+0.71 to 17.64±0.79 (p<0.005).
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Fig. 4-2-2  Number of m icronuclei per 100 binuclear cells. CHO or xrs cells were 
pretreated with 10 pM RBS for 40 m inutes, cytokinesis was blocked with 3pg/m l of 
Cyto B. Controls were the sam e but without RBS pretreatment. Two separate 
experiments were performed and 3 samples were determined in each experiment.
RBS 150
4-2-4 D iscussion
T here a re  several m echan ism s of action  of a n tican ce r d rugs. M ost 
d ru g s  in  c u rre n t  u se  in h ib it ce llu la r pro liferation , com m only by 
inh ib iting  the  syn thesis  of or directly dam aging th e  DNA. Cells from 
m o st in d iv id u a ls  a re  p ro fic ien t in  th e  re p a ir  of DNA dam age 
exhibiting a variety  of DNA rep a ir system s. S tud ies of the  effects of 
d ru g s  on  n o rm al an d  a m u ta n t  va rie ty  of th e  sam e cell type 
defic ien t in  DNA rep a ir  m ay  provide evidence for th e  ex istence  
w ith in  cells of rep a ir  m ech an ism s. On the  o th e r h a n d  they  m ay 
provide an  in sigh t in to  the  m ode of action  of th e  d rug . One of the  
several m ethods by w hich  NO is cytotoxic is th ro u g h  its  ability  to 
c a u se  DNA d am age  [1 -4 -2 -4 ], In p rev io u s  se c tio n s , in d ire c t 
evidence h as  show n th a t  NO m ight be responsib le  for the  cytotoxic 
effect of RBS. By u s in g  CHO cells an d  its  DNA rep a ir  deficient 
m u ta n t  x rs , it m ay be possib le  to d em o n stra te  th a t  RBS h a s  a 
genotoxic effect on the  DNA. For exam ple if RBS only h ad  an  effect 
on cell m em brane th e n  survival of b o th  cell types a fte r trea tm e n t 
w ith  RBS w ould show  no significant difference, however if RBS had  
a  DNA dam aging effect th e n  we m igh t expect reduced  survival in 
x rs cells.
T he se n s itiv ity  to  X -irrad ia tio n  of CHO a n d  x rs -5  cells w as 
exam ined  regu larly  to e n su re  th e  genetic stab ility  relative to th e  
app ropria te  phenotype of the  cells w as reta ined . The concen tra tion  
of cy tochalasin  B requ ired  to  yield optim al n u m b ers  of b in u c lea r 
CHO or x rs  ce lls  w as d e te rm in e d  ( b o th  from  p e rs o n a l 
com m unication  w ith  Dr. P. Jo h n s to n ). A ppropriate  cells and  [Cyto 
B] were u sed  in  these  experim ents.
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T he sp o n ta n e o u s  o r b a c k g ro u n d  level of m ic ro n u c le i (MN) in 
b inuclea te  cells gives a n  ind ication  of genetic stab ility  for each  cell 
type, x rs  h a d  a  h igher b ack  g round  level of MN and  fu rtherm ore  a 
sp o n tan eo u s loss of X ray  sensitivity  w as noted in  x rs-5  cells (Jeggo,
P. A. e t al 1983).
T he  o rig in s  of MN a re  v a rie d  from  w hole c h ro m o so m es to  
frag m en ts  of ch ro m atid s . Identify ing cen trom eres in  a  MN m ay 
help  to determ ine its  origin. Knowing the  origins of MN induced  by 
d rugs m ight p red ic t the  m ode of action  of M N -inducing agents. For 
exam p le , co lcem id  b in d s  to tu b u lin  p re v e n tin g  m ic ro tu b u le  
a sse m b ly  th is  in d u c in g  a  h ig h  p e rc en ta g e  of MN c o n ta in in g  
k inetocho re  (Thom son, E. J .  e t al 1988). It is n o t know n if RBS 
induced  MN are  the  re su lt of acen tric  fragm ent form ation  or whole 
chrom osom e loss. If RBS is a  sp ind le  poison  th e n  th e  increasing  
frequency of MN shou ld  n o t be  significantly different betw een these  
two cells types. However the  re su lt show ed th a t  x rs-5  cells h ad  a  
significantly increased  n u m b er of MN after trea tm e n t w ith  RBS Fig. 
4-2-2). T herefore we m ay  sp e cu la te  th a t  RBS in d u ced  MN are 
cau sed  by m ech an ism s o th er th a n  sp indle in terference. Sim ilarly, 
cell survival after th e  tre a tm e n t of RBS w as significantly  lower in 
x rs cells. The possible m ode of action  of RBS associated  cytotoxicity 
for cell killing m ay  be d ue  in  p a r t  to DNA dam age w ith in  ta rg e t 
cells.
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C onclusion
RBS h a s  a  cytotoxic effect on d ifferen t h u m a n  u ro th e lia l cells 
p h e n o ty p e s . T he  level o f c y to to x ic ity  is  re la te d  to  d ru g  
concen tra tion  an d  the  period of exposure to the  d ru g  . The grow th 
in h ib ito ry  effect of RBS is e n h an c ed  by ligh t irra d ia tio n  and  
decreased  by  haem oglobin. T his m ay indirectly  ind icate  th a t  n itric  
oxide is partly  responsib le  for the  cytotoxic effect of RBS.
U sing  co lony  g row th  in  p la s tic  p la te s  a n d  th e  in d u c tio n  of 
m icronucle i a s  a s sa y s  of cell dam age  c au se d  by  RBS. It w as 
concluded th a t  x rs-5  cells, a  DNA rep a ir deficient m u ta n t of CHO 
cells, a re  m ore sensitive  to RBS th a n  its c o u n te rp a rt. This re su lt 
held  tru e  for b o th  a ssay  techn iques. T his suggests  th a t  RBS m ay 
cause  som e kind of DNA dam age w ith in  the ta rge t cells.
F u tu re  w ork inc lud ing  quan tifica tion  of the  level of NO cau sin g  a  
given level of cytotoxicity m ay  provide m ore conclusive evidence as 
to th e  role of n itric  oxide in  th e  cytotoxic effect of RBS. A m ore 
detailed  s tu d y  in to  th e  n a tu re  of the  differential response  seen  for 
CHO an d  x rs  cells m ay provide a n  in sigh t in to  th e  DNA dam age 
w hich is caused  by RBS.
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DNA F inger Printing
Genomic DNA Extraction
Materials
Lysis buffer
10% sodium  dodecyl su lfa te  (SDS) [Sigma]
Proteinase K [N orthum bria Biloogicals Limit]2 5 : 2 4 : 1  p h e n o l / c h l o r o f o r m / i s o a m y l
a lcoho l(pheno l/ch lo ro fo rm )
7.5M am m onium  acetate  [Fison U.K.]
TE buffer,pH  8.
Cell preparation
Confluent cells in  flask harvest w ith trypsin  or EDTA.
S u sp en d  and  sp in  cells twice w ith  COLD PBS (spin a t 1000 
rpm  forlO m inutes).Do cell coun t a t second w ash  for approxim ate cell num ber.
Remove PBS and  s tan d  the  cell pellet on ice.Cell lysis and protein digestion
R esuspend  cells in  lysis buffer evenly. ( 1ml lysis buffer per 1.2- 
2 .0x10^ cells)
Aliquot into 1 ml in  eppendorfs.
Add lOOpl p ro te inase  K a t lO m g/m l.
Add 250pl of 10% SDS. Mix w ith  cu t off blue tip.
In cu b a te  overn igh t w ith  gentle  sh ak in g  a t 50® C tu b e  cover 
w ith  paraffin  film to prevent inciden tal leaking.Extraction o f nucleic acids
Do the m easu rem en t of volum e of lysan t by tu rn ing  the  scale of 
p ipetm an .
E x tra c t w ith  an  equal volum e buffered  pheno l, m ix gently, 
centrifuge a t ISOOOrpm for 5 m inu tes.
P repare  a  tu b e  w ith  h a lf  original volum e of pheno l an d  h a lf 
o rig in a l vo lu m e of 24 :1  (v/v) ch lo ro fo rm  : iso a m y
alcoho l. (phenol /  chloroform )
Remove as m u ch  as  possible  of top layer c lear fluid in to  the  
above p repared  tube, m ix and  centrifuge a t 13000 rpm  for 5 
m inutes.Remove top layer an d  re p e a t ex trac tio n  w ith  h a lf  volum e 
phenol/chloroform -isoam y alcohol once again.
Remove top layer and  ex tract w ith one volume chloroform .
Purification of DNA
T ran sfe r the  top a q u eo u s layer to a  new  tu b e  a n d  add  h a lf 
original volum e of 7.5M  am m onium  ace ta te  and  2 volum es 
100% icy cold ethanol.
DNA shou ld  p recip ita te  im m ediately.
H ook o u t th e  DNA pp t. in to  a  ep p endo rf co n ta in in g  70% 
ethanol.
Rinse twice w ith 70% ethanol and  squeezing on side of tube.
Lift into clean eppendorf w ith m inim al e thanol and  leave to dry 
abou t an  hour in fum e hood.
Dissolve it in  lOOpl of TE pH 7.6 overnight a t 50®C w ater ba th .
Reagents and solutions
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Lysis bu fferrlOOmM NaCl, lOmM Tris.Cl, pH 8 [Sigma], 25mM 
EDTA, pH 8
TE solution: lOmM Tris.Cl , ImM  EDTA, pH 8
7.5M  am m on ium  a ce ta te  : d issolve 289 .05g  of am m on iu m  
acetate  in  150ml HgO, add HgO to 500m l
Buffering phenol
Add 0.5g of 8-hydroxyquinoline[Sigm a] to a  2 -liter g lass beaker containing a  s tir bar.
G ently p o u r in  500m l of liquified phenol or m elted crysta ls of 
red istilled  phenol.[A ldrich, UK]
Add 500m l of 50mM Tris base.
S tir 10 m in u te s  a t  low speed  w ith  m agnetic s tir re r  a t room  
tem p era tu re .
Let p h ases  separa te  a t room  tem peratu re .
G ently  d ecan t th e  top(aqueous) p h ase  in to  a  su itab le  w aste  recep tac le .
Add 500m l of 50mM Tris-Cl, pH8.
Repeat stir and  decan t aqueous phase.
Add 250m l of 50mM  Tris-Cl, pH8, or TE buffer and  sto re  a t 
4®C in light-tight bottle.
For u se  in  DNA purification  procedure, m ix 25 volum e phenol 
w ith  24  vo lu m e ch lo ro fo rm  a n d  1 vo lu m e iso am y l 
alcohol[Sigma].
Agarose m inigel electrophoresis
Materials
E lectrophoresis buffer (TBE)
E th id ium  brom ide so lu tion
E lectrophorisis-g rade  agarose
DNA m olecular w eight m arkers.
30 wells B iorad horizontal m inigel ap p ara tu s .Preparing th e  gel
0.8gm s of agarose (Agarose 15 Eletron) dissolve w ith  80 m l of 
TBExl in microwave oven , add eth id ium  brom ide Ip g /m l of 
agarose.
Seal the  open ends of gel casting  platform  w ith cellatape.
Level the  gel tray.
Pour in  the  m elted agarose while it cool to 55°C and  in se rt the  
gel comb.
A fter th e  gel h a s  h a rd en ed , rem ove th e  tape  from  th e  open 
ends of the  gel platform  and  w ithdraw  the gel comb carefully.
Place the  gel c astin g  p latform  con ta in ing  th e  se t gel in  the  
e lectrophoresis tank .
Add sufficien t e lec trophoresis  buffer(TBExl) to cover the  gel 
to a  dep th  of ab o u t 1 m m  , m ake su re  no a ir pockets are  
trapped  w ith in  the  well.Loading and running the gel
3 pi glycerol dye and  2 pi DNA sam ple load in to  each  well. 
Avoid m ixing of sam ples betw een wells.
Load a  well w ith know n concen tra tion  of DNA as a  reference.
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C heck the  leads are  a ttac h ed  correctly  so th a t  the  DNA will 
m igrate into the  gel tow ard the anode or positive lead.
R un  the  gel a t 80-100 volt for 45 m inu tes .Turn off the  power. 
View the  gel above the  ultra-violet light, th is  show  if the  DNA is 
degraded a s  well a s  its  concentration .
Reagents and solutions
G lycero l dyes: 50%  glycero l[S igm a], lOOmM EDTA pH
8 .0[B D H ,disodium  salt], 0.1%  xylene cyanol[Sigm a], 0.1%  
brom ophenol blue[BDH], w ater to volume. 
lOx TBE for 1 liter: 109g Tris [BDH], 9.3g EDTA , 55g Boric 
acid [BDH, HBO3] 
lO m g /m l e th id iu m  b ro m id e : D isso lve  0 .2 g  e th id iu m
brom ide [Sigma] in  20 ml HgO m ix well and  sto re  a t 4°C in 
dark.
Measure the concentration o f DNA by Fluorometer
MaterialsM achine: Hoefer Scientific  In s tru m e n t (San F ran sisco  USA), 
DNA Fluorom eter Model :TKD 100.
W orking dye solution
DNA m olecular w eight m arkerCalibration
W ear gloves to hand le  the  cuvette well.
2 pi of s tan d ard  DNA and  2 ml of working dye so lu tion  add into 
the  cuvette C alibrate the  m achine accordingly.
Pour o u t the  s ta n d a rd  so lu tion  and  rin se  cuvette  w ith  1 ml 
w orking dye solution.
measure2 ml w ork ing  dye so lu tio n  in  cuvette  sh o u ld  read  zero if 
m easu rem en t is too h igh  th e n  rin se  cuvette  again  u n til it 
read  zero.Mix 2 pi of sam ple DNA and  2 ml of working dye so lu tion  and  
read  the  concentra tion .
D igestion o f DNA w ith restriction endonucleases
Materials
R e str ic tio n  e n d o n u c le a se s  (H ealll), an d  (lOx) re s tr ic tio n  
endonuclease  buffer[Gibco]M ethods
After ru n  th e  m inigel, know ing the  qua lity  and  q u a n tity  of 
sam ple  DNA th e n  s ta r t  to  c u t th e  DNA w ith  re s tric tio n  
endonuclease.If the  concen tra tion  is in  the  u su a l range(250-500pg/m l).
Use 60 pi of sam ple DNA add 
8 pi of lOx sa lts 
8 pi of BSA (1 m g/m l)
4 pi of Hae 111
Mix by tak in g  up  an d  dow n in  p ipette  and  leave in  37°C 
incuba to r overnight.
f l p p e n d î K  I
Reagents and solutions
lOx Hae III buffer: 0 .1m l of 5M NaCl, 0 .06m l of IM  TrisHCl 
(pH7.4), 0 .06m l of IM  MgClg, 0 .01m l of IM  d ith io th re ito l 
(DTT), 0 .67m l of distilled  w ater
Extract d igested  DNA
Materials
Sam e as  genomic DNA extraction except lysis buffer.
Extract DNA
Add sam ple  volum e of p heno l/ch lo ro fo rm  to d igest m ix and  
sp in  a t 13000 rpm  for 5 m inutes.
Remove su p e rn a ta n t to eppendorf contain ing  sam ple volum e of 
chloroform , m ix and  sp in  a t 13000 rpm  for 5 m inu tes.Purification of DNA
Remove s u p e rn a ta n t to eppendorf con tain ing  1 /1 0  volum e of 
2.75M  sodium  acetate  and 3x volum e of cold 100% ethanol.
S p in  to  pelle t DNA, p o u r off e th an o l and  w a sh  w ith  70% 
ethanol.Remove as m uch  as ethanol as possible and dry in vacuum .
Add 20pl of TE to sam ple and  leave to dissolve.Test for d igestion and concentration of DNA
T est DNA for com plete digestion in  minigel.M easu re  c o n c e n tra tio n .E th e r  on th e  m inigel or u se  DNA 
fluorim eter.
D ilute, if necessary , the  concen tra tion  to som e s ta n d a rd .(500 
pg/m l). This allows th e  loading the  sam e volum e in to  every 
well.
Agarose Gel E lectrophoresis
Materials
Sam e as m inigel e lectrophoresis
In s tru m e n t:  20  w ells 20cm  x  20cm  gel size h o rizo n ta l 
e lectrophoresis a p p a ra tu sPreparing th e  gel
2.4gm s of agarose(Agarose 15 Eletron) in a beaker add 300m l 
of TBExl m ark  the level of fluid.
Cover w ith paraffin film w ith few hole on it.
M elt it in  m icrow ave oven m ake su re  agarose  pow der well 
dissolved.
Add MQ w ater back  to original w ater level.
Seal the  open ends of gel casting  platform  w ith cellatape.
Level the  gel tray.Pour in  the  m elted agarose while it cool to 55°C and  in se rt the  
gel comb.
A fter th e  gel h a s  h a rd en ed , rem ove the  tape  from  th e  open 
ends of the  gel platform  and  w ithdraw  the gel comb carefully.
Place the  gel c astin g  platform  con ta in ing  the  se t gel in  the 
e lectrophoresis tank .
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Add su fficien t e lec tropho resis  buffer(TBExl) to cover th e  gel 
to a  dep th  of abou t 5-10 m m  , m ake su re  no a ir pockets are  
trap p ed  w ith in  the  well.Loading DNA and running gel
Load wells w ith  equal am o u n t of sam ple  DNA an d  dye.There 
shou ld  be 1 /3  volum e dye in  each  well .Avoid m ixing sam ples 
betw een wells.
L am bda ladder m ark er and  und igest probe DNA ru n  along side 
w ith  sam ple DNA.
Leave sam ples to equilibrate  w ith  buffer for 10 m in u tes  before 
ru n n in g  gel.
C heck  th e  leads are  a tta c h e d  correctly  so th a t  the  DNA will 
m igrate in to  the  gel tow ard the  emode or positive lead.
R un the  gel a t 24 volts for 48 hours.
S top th e  pow er sup p ly  an d  change th e  whole ru n n in g  buffer solution.
Add 50 pi of lO m g /m l e th id iu m  brom ide in to  1 lite r  of ru nn ing  buffer solution.
R un  the gel a t 36 volts for 24 hours.
C heck the  gel on a  tran s illu m in a to r and  record  the  m igration 
d istance  of each  ladder.
Reagents and solutions
Lam bda ladder marker[Gibco]
L am bda phage DNA digested w ith  EcoR I gives a usefu l se t of 
b a n d s  w ith a  b an d  a t 40 ,90 ,112 ,116 ,132 ,180  Kbp.
F or 2 w ells : lOpl la m b d a  DNA (co n cen tra tio n  is  a b o u t 5 0 0 p g /m l)
Ipl of EcoR I[Gibco]
2pl of lOx sa lts  
7pl of distilled w ater
Mix, sp in  down and  p u t a t 37®C for 1.5-2 hours.
Add 20pl of glycerol dyes and  sp lit betw een two wells.
Southern Blotting 
Materials
UV tran sillu m in a to r 
0 .25N  HCl
Gel Soak 1 so lu tion  (dénatu ration  solution)
Gel Soak 2 solution (neutralization solution)SSC solution
G lass or m etal decanting trays
N itrocellulose m em brane(Zeta-Probe GT, BIO-RADW hatm an  3MMfilter paperM ethods
C heck condition of lanes of DNA on UV transillum inato r. 
M easure the  position of the  lam bda b an d s from the  well.
Soak gel in  0.25N  HCl and  rock the  tray  gently for 20 m inu tes depurination  of DNA.
P o u r off th e  HCl r in se  th e  gel w ith  d istilled  w a ter, th e n  
im m erse in Gel Soak l( lx )  and  rock  the  tray  gently  for 45 m inutes. D énatu ration  of DNA.
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Pour off the  Gel Soak 1 rin se  the  gel in d istilled  w ater and  
im m erse gel in  Gel Soak 2 (Ix) and  rock the  tray  gently for 
45 m inu tes .N eutralising of the  gel.
P u t a  piece of g lass larger th a n  the gel in  a p lastic  tray  raised  
off the  tray.Lay a  wick of W hatm an  3MM p ap er over the  g lass (wider th a n  
glass) so bo th  ends reach  in to  the  SSC. p o u r ab o u t IL of 
SSC (1 Ox) over the  wick and  roll o u t any  a ir  b u b b les  w ith  a 
10ml pipette. The 3 MM paper should  now form a  wick.
Lift the  gel o u t of the  Gel Soak 2 and  tu rn  over and  place on 
th e  wick. Remove a ir bubb les trap p ed  betw een gel and  wick 
by rolling a  p ipet over gel a s  above. It is essen tia l th a t  the  gel 
be tu rn ed  over. The DNA is n ear the  bottom .
C u t a  p iece  of m e m b ra n e  (Z e ta -P ro b e  GT B o lttin g  m em branes,BIO -RAD) slightly  sm aller th a n  the  gel. Do no t 
touch  it w ithou t w earing gloves.
Soak  m em brane  in  d istilled  w a te r and  place on top  of gel. 
Remove trapped  air bubb les as above.
Cover th e  gel w ith  cling film  leaving only the  m em b ran e  
uncovered.S oak  2 p ieces of 3 MM p ap er, c u t sligh tly  sm all th a n  the  
m em brane, in SSC(1 Ox) an d  p u t on top of m em brane.M ake 
su re  th a t  th e  piece of 3MM p a p er does n o t overhang the 
m em brane and  remove the trapped  air bubble as above.
Cover up  th e  en d s  of tra y  w ith  p la s tic  w rap  to m inim ize 
evaporation during  the  transfer.
Add paper towels being careful to avoid any  chance  of a sh o rt 
c ircuit.
P aper tow els a re  p laced  deep enough  th a t  th ey  keep  up  a  
steady  capillary p ressu re  and  do no t become sa tu ra ted .
C hange th e  p a p e r tow els every 5 m in u te s  for th e  firs t 15 
m inu tes, th e rea fte r every 15 m in u tes  for the first hour, and 
th en  leave overnight for 19 h o u rs  or so.After the  tran sfe r is com pleted, take  a p a rt the  pyram id so th a t 
the  m em brane is still lying on the  gel. On the  m em brane 
m ark  the  position  of the  wells and  date  and  n u m b er the 
m em brane using  a  very soft pencil.
U sing b lu n t forceps, rem ove the  m em brane an d  p lace it in  a 
tray  of SSC(2x) for 5 m inu tes to w ash  away debris.
Air dry for 20 m in u tes  on a  piece of filter paper, th en  bake in a 
p re-heated  vacuum  oven for 30  m inu tes a t 80®C in a piece of 
folded 3MM paper.Reagents and solutions
Gel Soak 1 (GSl) [5x for 2 liters]: 3 55 .5g NaCl, 80g NaOH.
Gel Soak 2 (GS2)[2x for 2 liters]: 142.2g NaCl, 4 8 4 .4g Tris pH 
8, pH w ith HCl takes abou t 200 ml.
SSC (20x for 1 liter): 175g NaCl (3M), 88g N a3C itra te .2H 20  
(0.3M), pH to 7.0 w ith IM  HCl.
0 .25  N HCl: 21 .5m l of concen tra ted  HCl in 2 liters of distilled 
w ater.
Making the probe
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The p lasm id  probe DNA is gifted by Dr. David P a rk in ’s Lab 
N ottingham .
Briefly describe the  charac teristic  of the  DNA 
A P air of tran sc rib ab le  vecto rs pSPT 18 and  pSPT 19 (from 
BCL) w ere  se le c te d  w h ic h  c o n ta in e d  o p p o se d  RNA 
polym erase prom oters from T7 and  SPG phages flanking the 
pUC18 m ultip le  cloning site. They also conferred am picilin  
resistance, and  are m ulticopy.
M in isa te llite  reg ions of 33 .6  a n d  33 .15  w ere lib e ra ted  by 
sequen tia l digestion of M13 RF DNA w ith Hind III and  EcoR 
I, purified  by e lectroelu tion  and  force cloned in to  the  H ind 
III/E co R  I s ite  of pSPT 18 an d  pSPT19 to yield four 
r e c o m b in a n ts  (pSPT 18 .6 , 19 .6 , 18 .15 , a n d  19.15)
p erm itting  e ither s tra n d  of e ith er probe to be p repared , by 
se lec tin g  T7 or SP6 p o ly m erase  for tra n s c r ip tio n . The 
recom binan ts  were transfo rm ed  by  the CaC12 m ethod into E. 
Coli. D H l a  recom bination  deficient h o st s tra in  to reduce the  
possib ility  of rea rran g em en ts . R ecom binan ts were selected  
by ampicillin.
Isolation of plasm id from E. Coli. (Stephen D. et.al. 1990.)
Materials
GTE solution 
LB m edium  
0.2M NaOH 
1% SDS
3M Potassium  aceta te  pH 4.8
absolu te  ethanol
70% ethano l
TE bufferM ethods
S crap e  the  frozen  su rface  of glycerol s to ck  w ith  a  ste rile  
inoculation  wire, and  s tre ak  onto a  fresh  LB am picillin plate. 
Incubate  the  plate overnight inverted a t 37®C.
Inoculate  5 ml LB am picillin b ro th  w ith a  single colony from a 
fresh  plate. Incubate  a t 37®C w ith  gentle ag itation  overnight. 
Prepare in  duplicate.
D ecant 1.6ml of the  overnight cu ltu re  into an  E ppendorf tube, 
an d  sp in  in  a  b en ch to p  cen trifuge  a t 13 ,000  rpm  for 2 
m inutes.
Com pletely rem ove th e  su p e rn a ta n t  from the  b ac teria l pellet, 
by tipping and  draining, 
carefully resu sp en d  the  pellet in 180 gl GTE solution.
Add 360 M-1 of a fresh ly  p rep ared  so lu tion  of 0.2M  N aO H /1% 
SDS, invert ten  tim es before placing on ice for 5 m inutes.
Add 270gl of 3 M p o tassiu m  ace ta te  (pH 4.8), invert ten  tim es 
before replacing on ice for 5 m inu tes. Do n o t vortex. 
C en trifu g e  a t  1 3 ,0 0 0  rp m  for 5 m in u te s , a n d  rem ove 
su p e rn a ta n t to a  clean 1.6ml Eppendorf tube.
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Add 1 volum e (800|al) of ab so lu te  e thano l to the  su p e rn a ta n t, 
vortex briefly, and  im m ediately  centrifuge a t 13,000 rpm  for 5 m inutes.
Carefully d iscard  the su p e rn a ta n t, and  w ash  the  plasm id  pellet 
w ith  1 m l of 70% e thano l,befo re  a final certrifu g a tio n  a t13.000 rpm  for 2 m inu tes.
D iscard  th e  su p e rn a ta n t, a n d  d ry  the  pellet u n d e r  reduced  p ressu re .
R esuspend  the  DNA pellet in  20 pi of sterile TE.Reagent and solutions
GTE solu tion : 25m M  Tris-HCl, pH 8.0, lOmM EDTA, 50mM glucose.
LB m edium  /lite r, agar p late , + ampicillin: lOg B actotryptone 
[Difco], 5 g Bacto yeast ex tract [Difco], NaCl lOg. A djust pH to
7.0  w ith  5N NaOH, for p lates, and  add 15g bacto -agar before 
autoclaving. Add am picillin to a  final concen tra tion  of 35-50 pg /m l.
Preparation o f RNA probe (follows Carter, R. et  al 1989) Linearize the vector
3pl (Ipg) of u n c u t plasm id DNA
1 pi of EcoR I for 19.6 or Hind III for 18.15 probe0.6pl lOx sa lt so lu tion
1.4pl of sterile distilled w ater
Spine down and incubate  in  37®C w ater b a th  for 1.5-2.5 hours.Transcription reaction
Add to the  linearized ab strac ted  DNA with
4 pi of 5x tran scrip tion  buffer
3pl of NTPs (lOmM each  of ATP,GTP,UTP, ImM  CTP)2pl of DTT (lOOmM)
Ipl of RNAsin (25u/pl)
3pi of 32P CTP (400 C i/m  mol)[Ameshan]
Ip l of T7 RNA polym erase (2 OU/pi)
Spin down and  incubate  in 37®C for 1 hour.
Removal o f incorporated nucleotide
Stop the  reaction  w ith 20pl of n ick  stop  mix.
T hrough a  1-ml colum n of Sephadex G-50 [Pharm acia, Sweden] 
equilib rated  w ith  TE to remove un inco rpera ted  nucleotides. 
C o u n t th e  ra d ia tio n  a c tiv ity  of th e  p ro b e  w ith  liq u id  
sc in tilla tio n  a n a ly s is  [T ricrab 1600TR C anberra  p a ck a rd  USA].
Reagents and solutions
T ra n sc r ip tio n  b u ffe r (x5) 200m M  Tris-H Cl pH 7.5 , 30m M  
MgC12, lOmM sperm idine, 50mM NaCl.
RNAsin : (Am ershan, N120Y).
T7 RNA polym erase :[pharm aciaj.
NTPs, DTT, tra n sc r ip tio n  buffer: (from Prom ega R iboprobe 
Gem ini 11 kit).
Nick stop  mix: 0.9% (w/v) b lue d ex tran  [Sigma], 0.03% (w /v) 
brom ocresol purp le  [BDH] 20mMEDTA.
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Sp in-C olum n procedure for separation  rad ioactively  labeled  DNA from unincorporated NTP precursors
Materials
TE buffer
6.5 in. P asteu r p ipet
G lass wools welled colum n res in  (Sephadex G -50 or Biogel P- 
60 ,BIO-RAD)
1 m l syringe
Plug the  bottom  of a  1-ml d isposab le  syringe w ith clean glass 
wool.
Swirl th e  colum n res in  to m ake an  even su sp en s io n , and  fill 
th e  syringe w ith  the  suspension .place th e  syringe co n ta in in g  th e  re s in  in to  a  polypropylene 
tu b e  th a t  is  su ita b le  for c e n tr ifu g a tio n  in  a  d e sk to p  
centrifuge.Spin a t 3000 rpm  for 3 m inu tes in  order to pack  the  colum n.
Load the  sam ple in  the  cen ter of the  colum n and  sp in  a t 3000 
rpm  for 3 m inutes.
R inse the  sam ple tube  w ith 2 volum e of TE and  reload into the 
colum n.
Spin  a t 3000  rpm  for 3 m inu tes. Collect all th e  liquid a t the  
bottom  of the  tube  contain ing  the  labeled RNA.C ount the rad iation  activity of the  probe.
Prehybridizing, hybridizing, and washing the filter
Materials
BLOTTO solution 
SDS
SSC solution 
hybridization cham ber M ethods
M ake u p  p reh y b rid iza tio n /h y b rid iz a tio n  fluid(e.g. 1% BLOTT 
,2% SDS , lx  SSC)
Prehybridize the  m em brane a t 64®C over night.
Add up  to 6x10^ cpm  RNA probe to the  hybridization cham ber.
hybridize a t 64°C over night, 
w a sh  th e  m em b ran e  a t  65®C on sh a c k  w ater b a th  for 45 
m in u te s  w ith  severa l c h an g e s  of w a sh  so lu tion (e .g . Ix  
SSC,0.1% (w/v) SDS)
The dam p m em branes are  w rapped in saranw rap  
Exposed to X -ray film for 2 days w ith two in tensifing  sc reens 
followed by 14 days w ithou t screen.Reagents and solutions
BLOTTO so lu tio n  (100m l of 10% solu tion): lOg of n o n -fa t 
po sered  m ilk (Marvel), 0 .2g  of sod ium  azide. Add 10 \xl 
d iethylpyrocargonate (DEPC), Incubate  a t 42°C for 4-6 ho u rs  
to remove DEPC.
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Preparation of Roussin’s black salt
R ou ssin 's  b lack  sa lt  (RBS), Sodium  heptanltrosyl-tri-|L i3-sulphido- 
te traferra te : Na[Fc4 S 3 (NO)7 ]
S odium  n itrite  (NaN02) and  sod ium  su lph ide (Na2 S) were stirred  
and  heated  u n d e r n itrogen un til boiling. F errous su lp h a te  so lu tion  
(F eS O ^.) w as a d d ed  from  a  d ro p p in g  fu n n e l (DE) to  th e  
accom pan im en t of b lack  frothing, quelled by the  add ition  of 20% 
am m onia so lu tion . The resu ltin g  m ix ture  w as hot-filtered  th rough  
p re-heated  Hyflo to remove iron oxide and  the  residue  w ashed w ith 
h o t/b o ilin g  w ater. The filtra te  w as cooled on ice and  crude RBS 
p re c ip ita te d  o u t of so lu tio n . T he p rec ip ita te  w as filtered  off, 
recrystallized from h o t w ater and  dried in  a vacuum  desiccator. RBS 
w as sto red  in  the  dark , u n d e r  n itrogen and  a t -10®C. P urity  w as 
a sse ssed  using  in fra-red  spectroscopy w here th ree  peaks are  seen  
a t 1795,1747 and  1707 cm-l-
Appendix III
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Absorption spectrum of RBS Shaded area shows range
of wavelenghts available using argon-ion laser (Spectra Physics 
model 16 8 -0 9 ). The figure shows 4 5 7 .9nm to be the optimal 
available wavelength for irradiation of RBS.
Appendix lU
7 . 6  THE LEVEL OF DETECTABLE STEM CELL FACTORRELEASED BY A HUMAN UROTHELIAL CELL LINE . IS REDUCED WITH THE DEVELOPMENT OF TUMORiQENICITY.H#l#o-H#l#n Wang *, Simon N. Robinson, Jaan Mafvlllo and Andrew C. RIchaa, School of Biological & Medical Sclancaa,Univaraity of St Andrawa, Scotland, U.K.
Wa report the development of a tumorlgenie human urothelial cell line from a non-tumorlgenlc cell line and the observation of a reduction In the level of detectable Stem Cell Factor (SCI^ released by these cella.The SV-HUC-1 cell line wee derived from human urothelium Immortalized by Infection with wlld'type Simian Virus 40 (Christian, B.J. at al, 1907, Cancer Research 47 : 0066). This cell line did not produce tumours when innocuiated Into athymic mice, but if these cells were grown for 6 months In chemically-defined culture medium without serum, hormones, or growth factors, a new variant of the cell line was selected which did produce tumours. The tum ours appeared after 20 weeks and were present In 4/20 mice. Tissue explant culture of these tum ours created a continuously passaged cell line. Subsequent Injection of these cells Into athymic nude mice produced tumours In all the recipients. The levels of human stem cell factor (SCF) In medium conditioned by tumorlgenie and non-tumorlgenlc cells srsre quantified by means of enzyme linked Immunosorbent assay (Quantlklne kit). The results Indicate that the cells released less SCF when they became tumorlgenie.The biological activity of SCF can t>e assayed by cloning haematopoietic cells In soft agar In combination with other cytokines when high proliferative potential colony forming cells (HPP-CFC) are stim ulated to produce large co lon ies.Conditioned medium prepared from the cell lines ac ts  synergistlcally with rM-CSF (macrophage colony stimulating facto r) and rGM-CSF (g ranu locy te-m acrophage co lony  stimulating factor) to produce large colonies from cloned bone marrow cells. These large colonies are not produced by any of the factors singly. Similar colonies are produced in the presence of rSCF plus rM-CSF plus rGM-CSF. It thus seem s likely that human urothelial cells In culture can produce biologically active SCF.It has been proposed that tha developm ent of tumorlgenlcity Is a multi-step process and SCF, which is reported to prevent spoptosis (programmed cell death), may play a possible role In this process.Acknowledgements. We would like to acknowledge the support of the National Defence Medical College, Taipei, ROC (H.W.) and the LRF and AlCR.
Presented in the  3 5 th  an n u a l m eeting of B ritish  A ssociation for 
C ancer R esearch  (March, 1994; B irm ingham ).
